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ABSTRACT 
 
 Cyclopalladated complexes (CPCs) possess a number of important properties and 
have been used in various application studies. However, preparation and uses of optically 
active CPCs with an (sp3)C–Pd bond have not been thoroughly investigated.   
 In this dissertation, the synthesis and applications of new enantiopure CPCs derived 
from naturally occurring and optically active D-camphor and L-fenchone are described. 
The preparation of these CPCs, which contain an (sp3)C–Pd bond, was accomplished by 
cyclopalladation of D-camphor O-methyloxime, L-fenchone O-methyloxime, L-fenchone 
oxime and camphor N,N-dimethylhydrazone using Pd(II) salts such as Pd(OAc)2 and 
Pd(MeCN)2Cl2. 
 Phosphination reactions of CPCs derived from D-camphor O-methyloxime and L-
fenchone O-methyloxime, as well as other CN-, CS- and CP-dimeric CPCs having an 
(sp3)C–Pd bond, were investigated using KPPh2. These alternative CPCs were obtained 
from 8-methylquinoline, tri-(O-tolyl)phosphine, 2,6-dimethylthioanisole and 
trimesitylphosphine. In each case, when the CPC reacted with 4.5 equiv. of KPPh2, the 
corresponding NP-, SP- and PP-ligands were isolated in 13–51% yield. Reactions using 
only 1 equiv. of KPPh2 gave µ-chloro-µ-diphenylphosphido-CPCs as main products in 26–
56% yield. 
 Proposed structures of new compounds obtained in the reactions were confirmed 
by spectroscopic methods and in some cases by X-ray crystallography. Purity and 
   
   
 xxii   
 
elemental composition of the synthesized complexes and organic compounds were 
confirmed by either satisfactory elemental analysis or high resolution mass spectra data. 
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CHAPTER I 
INTRODUCTION 
I.1. Cyclopalladated Complexes Containing an (sp3)C‒Pd Bond  
 Cyclopalladated complexes (CPCs) are organometallic compounds with a sigma 
C‒Pd bond, intramolecularly stabilized by a dative bond between Pd and a heteroatom to 
form three-, four-, five-, six- or seven-membered palladacycles. The heteroatoms 
commonly involved in CPC formation include N and P and more rarely S, Se, As and O. 
 Cyclopalladated compounds have been known since the beginning of 1960s. In 
1963, Kleiman and Dubeck investigated the reaction of dicyclopentadienylnickel (NiCp2) 
and azobenzene (1) under both solvent and solvent-free conditions to furnish a new 
complex 2 (Scheme 1).1  
 
Scheme 1. Synthesis of compound 2 and CPC 3 from azobenzene. 
 In 1965, Cope and Siekman reported an analogous reaction with PdCl2 in an 
alcoholic solution to generate the first known palladacycle (3) (Scheme 1).2 Soon after this 
study, five-membered palladacycles were obtained when N,N-dimethylbenzylamines were 
reacted with PdCl2 under similar conditions.
2 These first palladacycles contained an
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 aromatic (sp2)C‒Pd bond.2 Cope et al. later investigated the reaction between Pd(II) 
reagents and allylic amines.3 They found that N,N-dimethyl-2-methylallylamine (4) reacted 
with Li2PdCl4 or PdCl2 in an alcohol to give the corresponding CPCs 6 and 7 (Scheme 2).
3 
These are the first examples of the palladacycles with an (sp3)C‒Pd bond.3 
 
Scheme 2. Synthesis of CPCs from N,N-dimethyl-2-methylallylamine. 
 Cyclometallation reactions have been observed with many transition metals, 
including Ru, Rh, Os, Pt, Ir, Fe, Ni, Co, Mn and others.2, 4-8 Organopalladium compounds 
are especially valuable for several reasons. The C‒Pd bond is known to react with 
numerous reagents to reliably yield functionalized products.9-13 This versatility is in part 
due to the tolerance of palladium reagents to many functional groups and also due to the 
selective reactivity of cyclopalladated intermediates at the C‒Pd bond.14-16 Thus, 
cyclopalladation is an excellent route to many different bond linkages, including carbon-
carbon, carbon-oxygen, carbon-nitrogen, carbon-sulfur, carbon-phosphorus and carbon-
halogen bonds. Furthermore, the compatibility of palladium reagents such as Pd(OAc)2 
with a variety of directing groups enables the use of a wider variety of substances compared 
to other transition metal reagents. Finally, most reactions involving palladacycles are not 
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sensitive to moisture and air, making the synthesis of complex organic molecules more 
facile.  
  Aliphatic palladacycles (here and later, all CPCs and palladacycles with an (sp3)C‒
Pd will be called aliphatic) have a characteristic σ-bond between palladium and an sp3‒
hybridized carbon of the ligand.17-19 The (sp3)C‒H bond is generally inert due to the 
absence of either empty low-energy orbitals or filled high-energy orbitals, which can 
overlap with metal orbitals.20, 21 Thus, reports of CPCs with an (sp3)C‒Pd bond are far 
outnumbered by those of palladacycles containing an (sp2)C‒Pd bond.  
I.2. Classification of CPCs with an (sp3)C‒Pd Bond 
 CPCs containing an (sp3)C‒Pd bond are broadly divided into two types: benzylic 
(e.g., 8‒10 in Chart 1) and aliphatic (e.g., 5‒7 in Scheme 2). Benzylic CPCs are those in 
which the metal is bonded to a benzylic carbon, while palladium in aliphatic CPCs is 
bonded to an sp3-hybridized carbon. The organic moiety of both benzylic and aliphatic 
CPCs can be either an anionic four-electron (CY) or six-electron (YCY) donor (Figure 1).4, 
22 CPCs of the latter type are examples of pincer complexes. 
 
Figure 1. CY- and YCY-palladacycles. 
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Chart 1. Examples of benzylic CN-palladacycles. 
 While all YCY-type complexes are mononuclear, the CY-analogs can be mono-, di-
, and trinuclear.4, 22 Di- and trinuclear complexes can exist as cis and trans geometric 
isomers with halogen, acetate or other bridging moieties (Figure 2).4, 22 Acetato-bridged 
trinuclear aliphatic CPCs derived from 1-tert-butylpyrazole,23 N,N-
dimethylneopentylamine24 and 2-tert-butyl-4,4-dimethyl-2-oxazoline25 have been reported 
by the research groups of Alonso, Hiraki, and Balavoine, respectively. Preparation of the 
acetato-bridged trinuclear benzylic CPC derived from 2-(dimethylamino)toluene has been 
discussed by Pfeffer.26, 27 Although acetate and chloride are the most common bridging 
ligands in CPCs with (sp2)C‒Pd bonds, N,O-imidate ligands like succinimidate, 
phthalimidate and maleimidate28, 29 as well as carboxylato groups like oxalato, n-
alkylcarboxylato, n-oxaalkylcarboxylato, p-alkoxyphenylacetato and p-alkoxybenzoato 
have also been reported.30  
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Figure 2. Trans and cis geometric isomers of CPCs. 
 CPCs can also be classified based on the donor heteroatom bonded to the metal, 
e.g., CN-, CP-, CS- and CO-type palladacycles. The donor atom Y is responsible in part 
for the ring size of CPCs since it delivers the palladium reagent to a particular C‒H bond 
where palladation occurs. While CY-type benzylic CPCs contain mostly five- or six-
membered palladacycles,31-34 their aliphatic counterparts can also be three-35, 36 or four-
membered.37-39  
I.2.1. CN-Palladacycles 
 Common directing groups for benzylic CN-CPCs include the pyridine, aniline and 
imine moieties. Hartwell et al. synthesized the first example of a benzylic CN-palladacycle 
(10) from 8-methylquinoline in 1970 via C‒H bond activation using Li2PdCl4.40 Thereafter, 
many research groups reported other examples, particularly those derived from 2-
substituted 8-alkylquinolines,41-47 ortho-alkyl-substituted N,N-dialkylanilines,27, 48-50 and 
N-mesitylbenzylideneamines.51-55 In 1978‒1981, Deeming and Rothwell studied the 
cyclopalladation of 8-alkylquinolines with various substituents (Me, Br, CHO, CH=NMe, 
CH2OH and CO2H) at the 2 position.
42, 43, 47 They determined that the 2-substituted 
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derivatives of 8-alkylquinolines were readily palladated using Pd(OAc)2 when the 
substituent was either CH=NMe, CH2OH or CO2H, while every attempt to metalate the 
analogs with Me, Br, or CHO groups did not work.42, 43, 47 During the same time, Pfeffer et 
al., while studying reactions of ortho-alkyl-substituted N,N-dialkylanilines with LiPdCl4, 
observed demethylation at the NMe2 group to give N-alkylanilines.
26, 27, 56 Reactions of 
ortho-alkyl-substituted N,N-dialkylanilines with Pd(PhCN)2Cl2 and Pd(OCCF3)2 provided 
coordination complexes.26, 27, 56 They were able to palladate only ortho-methyl-substituted 
N,N-dialkylanilines using Pd(OAc)2 to get trinuclear CPCs which were converted to the 
dinuclear chloro-bridged analogs upon treatment with LiCl.26, 27, 56 The dinuclear µ-Cl-CPC 
was subsequently reacted with AgOAc to regenerate the acetate-complexes.26, 27, 56 The 
research groups of Gómez, Sales, Liu, Fernández and Munno have investigated the 
cyclopalladation of N-mesitylbenzylideneamines using Pd(OAc)2.
52-55, 57 Palladation 
preferentially took place at the aromatic carbon to give five-membered endo-
palladacycles.52-55 The six-membered analogs generated via palladation at a benzylic 
carbon required higher temperatures.52-55 
 Aliphatic CN-palladacycles have been reported with a variety of nitrogen-
containing directing groups: oxime (including their O-substituted derivatives), hydrazone, 
ketazine, oxazoline, pyridine, amine, benzothiazole, pyrazole, urethane and acetanilide. 
Aliphatic five- and six-membered oxime palladacycles 12 include those with ordinary 
oxime (NOH), O-methyl oxime (NOMe) or O-acetyl oxime (NOAc) directing groups.17, 58-
65 In 1978, Shaw et al., synthesized the first example of a CPC58 containing an NOH 
directing group while those containing the NOAc directing group were introduced 
simultaneously in 1985 by the groups of Nishilyama,60 and Baldwin.59, 61 CPCs with a 
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hydrazone directing group (13a) are usually five-membered and were first introduced by 
Shaw and his collaborators in 1978.58 Such CPCs have an sp3 nitrogen coordinated to the 
Pd center. In 1983, Galli and Gasparrini reported a case of a hydrazone CPC (13b) in which 
the sp2 nitrogen was coordinated to the Pd center.66 This could be attributed to the stability 
of five-membered palladacycles compared to the six-membered rings that are formed if 
coordination occurs at the sp3 nitrogen.66 In 1994 and 1995, Echavarren et al. worked on 
the synthesis of the PPh3 adducts of type 13 CPCs upon reaction of the preligand (N,N-
dimethylhydrazone) with Pd(PPh3)2Cl2 and NaOAc in MeCN.
67, 68 Shaw et al. synthesized 
five-membered ring CPCs of type 14 containing ketazine as the directing group.63 Clinet 
et al. worked on the five-membered ring CPCs derived from oxazoline (type 15).25 Our 
group also reported such CPCs.18, 69 In 1983 through 1992, Hiraki and his collaborators 
studied five- and six-membered ring CPCs (16) containing the pyridine moiety as the 
directing group.70-72 Recently, Rourke et al. reported five-membered ring CPCs 16 
containing the pyridine moiety as the directing group.73, 74 Aliphatic CN-palladacycles (17) 
containing the amino directing group were introduced in 1967 by Cope et al.3 and since 
then many of such CPCs have been reported.19, 24, 75-85 In 1986, Hiraki et al. reported five-
membered CPCs (18) with the benzothiazole moiety as the directing group,86 while in 
1992, Alonso et al. synthesized five-membered CPCs (19) with the pyrazole moiety as the 
directing group.23 In 1994, Henderson et al. reported four-membered palladacycles 20 and 
21 derived from urethane and acetanilide ligands.87-89 
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Chart 2. Aliphatic CN-palladacycles with different directing groups. 
I.2.2. CP-Palladacycles 
 Benzylic CP-CPCs are usually five-membered and synthesized from aryl- or 
benzylphosphines. Benzylic CPCs 22 were first reported in 1972 by Shaw et al.90 and since 
then many groups have either worked on their synthesis or their application as catalysts in 
cross-coupling reactions.31, 32, 91-105 Recently, Hou et al. prepared rare six-membered 
benzylic CPCs 23.101 Joshaghani et al. also recently synthesized a benzylic biphenyl-based 
phosphine CPC 25.93 A unique three-membered benzylic palladacycles 24 was obtained 
from bidentate derivatives of a phosphaalkene.106  
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Chart 3. Benzylic CP-palladacycles. 
 The majority of aliphatic CP-CPCs prepared from alkylphosphines are five-
membered. Examples include palladacycles (type 26) obtained by the palladation of 
tBu2
iPrP and iPr3P.
107-109 Four-membered P-containing palladacycles are also known. In 
1977, Goel et al. synthesized the four-membered ring CPC 27 from tBu3P.
37-39 Later, 
Werner and Kraus developed a method to form similar palladacycles from tBu3P and 
tBu2PhP by the reaction of their coordination complexes with AgOAc.
110 Interestingly, 
Milstein isolated the dinuclear five-membered aliphatic CP-palladacycle 28 with a mono-
bridging diphosphine.108 
 
Chart 4. Examples of CP-palladacycles. 
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I.2.3. CS-Palladacycles 
 Like phosphorus, sulfur is a relatively soft donor atom and well suited for the soft 
Lewis acid Pd(II). Both benzylic and aliphatic palladacycles containing a sulfur directing 
group have been reported.  
 In 1989, Pfeffer et al. reported benzylic five-membered CS-CPCs (29) synthesized 
from 2,6-dimethylthioanisole.111, 112 More recently, Vicente et al. discussed the synthesis 
of benzylic five-membered CS-CPCs from aryldithioacetals.113, 114 
 Aliphatic CS-palladacycles can be derived from a sulfide, thioamide, or thiourea. 
The first sulfide-derived palladacycle 30 was published by Okawara et al. in 1976.35. That 
complex had a rare three-membered ring.35 The five-membered ring sulfide palladacycles 
of type 31 were reported by the groups of Holton and Pfeffer.75, 82, 111, 112 An unusual 
method was described by Albéniz et at. for four- to six-membered palladacycles of type 30 
by insertion reactions at the Pd-aryl bond.115 Leaver et al. made available the five-
membered thioamide-derived aliphatic CS-CPC 32.116 Groups of Dunina and Pfeffer 
reported related five-membered thioamide-derived CPCs 33.111, 117, 118 
 
Chart 5. Examples of CS-palladacycles. 
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I.2.4. CO-Palladacycles 
 Despite the fact that oxygen-containing moieties are relatively hard ligands, CO-
CPCs have also been reported. Palladacycles derived from aldehydes (34) were obtained 
by the groups of Elsevier, Vrieze, Sen and Osakada.119-123 Singh et al. also reported the 
aliphatic CO-palladacycle 35 with a hydroxyl donor moiety.118, 124 Recently, Lindsell et al. 
observed the oxidation addition of 2-hydroxymethylbenzyl chloride with Pd(PPh3)4 in 
toluene to afford the benzylic CPC 36.125 
 
Chart 6. Example of CO-palladacycles. 
I.2.5. CC-Palladacycles 
 In 1999, Catellani et al. reported the CC-palladacycles 37, in which one of the 
carbon atoms bonded to the palladium center was sp3-hybridized while the other was sp2-
hybridized.126-129 Earlier in 1998, Hashni et al. obtained complex 38 with both carbon 
atoms sp3-hybridized.130, 131 
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Chart 7. Examples of CC-palladacycles. 
I.2.6. Pincer Palladacycles 
 Pincer palladacycles contain ligands with three or sometimes four chelating atoms. 
They can be subdivided based on the number (tridentate or tetradentate) and type of 
chelating atoms, e.g., tridentate CNO,132, 133 NCN,134 NCO,135 NNC,136-138 CNN,139, 140 
CNC,138, 141 CNS142 and PCP143-148 and tetradentate CNNC138, 149 and CNNO.150  
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Chart 8. Examples of pincer palladacycles. 
I.2.7. Spiro Palladacycles 
 These are bis-chelated mononuclear palladacycles formed by two bidentate ligands 
bound to a single Pd center. They have a characteristic C2 axis perpendicular to the plane 
of the molecule and passing through the Pd center. The chelation at the Pd center must be 
trans; cis48 chelations give mononuclear CPCs which are not spiro. There are only three 
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types of the ligands which were used to prepare such complexes. The research group of 
Newkome has synthesized five- and six-membered spiro palladacycles 50 and 51 from 
pyridine and pyrazine derivatives, respectively (Chart 9).138, 151 Fedorov et al. reported the 
spiro CPC 52 from the reaction of 3,3-dinitropropylamine with PdCl2.
152 
 
Chart 9. Examples of spiro palladacycles. 
I.3. Synthesis of Palladacycles Containing an (sp3)C‒Pd Bond 
 The methods available for the synthesis of palladacycles include C‒H activation 
with a Pd(II) reagent, oxidative addition, transmetalation and nucleophilic addition. 
I.3.1. Pd(II)-Promoted C‒H Bond Activation 
 Direct cyclopalladation using Pd(II) salts such as Pd(OAc)2, M2PdCl4 (M = Na, Li, 
K) and Pd(MeCN)2Cl2 is the most common method for synthesizing palladacycles in 
general and those containing an (sp3)C‒Pd bond in particular. Ligands that have been 
palladated using this method include amines,24, 56, 76, 77, 136, 152 imines,51-55, 132, 150 
pyridines,42, 43, 47, 70-72, 133, 134, 138-141, 151 pyrazines,151 hydrazones,58, 63, 66-68 oximes,58, 59, 61, 63 
pyrazoles,23, 149 ketazines,63 oxazolines,18, 25, 69 phosphines,31, 32, 37, 90, 91, 97, 100, 101, 105, 107, 109, 
110, 143-148, 153 sulfides,111 thioureas,111, 116, 117 thioamides,116 acetanilides,89 and thiazoles.86 
Pd(OAc)2 in acetic acid, benzene or toluene is the most common way to achieve palladation 
at an (sp3)C‒H bond.17-19, 23, 25, 31, 32, 42, 51, 54, 70, 72, 86, 111, 132, 134, 153, 154 For example, in 1990, 
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Clinet et al. reported, the synthesis of CPC 15 through the activation of an (sp3)C‒H bond 
on the tert-butyl group of 2-tert-butyl-4,4-dimethyl-2-oxazoline using Pd(OAc)2 in AcOH 
followed by chloride substitution (Scheme 3).25 
 
Scheme 3. Synthesis of aliphatic CPC 15 from 2-tert-butyl-4,4-dimethyl-2-oxazoline 53. 
 Alkali salts of tetrachloropalladate, though weaker palladating agents than 
palladium acetate, have also been used for palladations at (sp3)C‒H bonds.40, 42, 43, 59, 62, 64, 
149, 153 In 1972, Cheney and Shaw succeeded in cyclopalladating di-tert-butyl-O-
tolylphosphine 55 using Na2PdCl4. The product was the racemic P*-chiral 
phosphapalladacycle 56 with an (sp3)C‒Pd bond,153 which turned out to possess a very 
high catalytic activity in C‒C coupling reactions.92, 94-96, 155-158 Dunina et al. reported the 
resolution of P*-chiral phosphapalladacycle rac-56 using potassium (S)-prolinate (Scheme 
4).100 
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Scheme 4. Synthesis of the optically active P*-chiral benzylic CP-CPC (SpSp)-56. 
 Synthesis of aliphatic CPCs through C‒H activation can also be achieved by 
transcyclopalladation.34, 159, 160 Transcyclopalladation is a ligand-exchange reaction 
between a nonmetallated preligand and a palladacycle to form a new CPC.159 This reaction 
often requires the presence of either AcOH or CF3CO2H as a reaction promoter.
159, 160 In 
1984, Ryabov et al. reported the synthesis of CPC 8, which has a benzylic (sp3)C‒Pd bond, 
in 64% yield in the reaction of palladacycle 58 with 8-methylquinoline (59) at 50 °C for 
24 h in AcOH‒CHCl3.159 Later, the same researchers increased the yield of complex 8 to 
94% upon using the acetate-bridged CPC 58.161 The same reaction was also performed on 
SiO2 without a solvent. In order to remove the product from SiO2, the dimeric complex 8 
was converted to the more soluble triphenylphosphine adduct 60 upon treatment with PPh3 
(Scheme 5).34 The yield of 60 was 46%. 
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Scheme 5. Trancyclopalladation of 8-methylquinoline with CPC 58 on SiO2. 
 Ryabov in one of his reviews on mechanism of C‒H bond activation stated that 
cyclopalladation through C‒H bond activation follows an electrophilic mechanism when 
an aromatic ligand is involved.6 The other suggested mechanistic routes include oxidative 
addition and σ-bond metathesis.8 It is now obvious that there is no single mechanism for 
C‒H bond activation that is applicable to all types of substrates and Pd(II) reactants.136 
Furthermore, the mechanisms of C‒H bond activations for aromatic and aliphatic 
substrates should be different. Cyclopalladation at (sp3)C‒H bonds is usually believed to 
proceed through the transition state which exhibits agostic (three-center two-electron) 
interactions between the C‒H bond and the metal atom.162 Agostic interactions have been 
observed for metallations at (sp3)C‒H bonds using transition metal reagents.73, 163-165 In 
2009, Rouke and his group reported the X-ray structure of an agostic complex while 
working on the metallation of 2-tert-butyl-6-(4-fluorophenyl)pyridine using K2PtCl4.
73 
Later, they were able to obtain an X-ray structure for the agostic complex when Pd(OAc)2 
was used as the metallating agent.74 
Challenges in the Synthesis of Aliphatic Palladacycles Through C‒H Bond Activation 
 Besides the inertness of (sp3)C‒H bonds, synthesis of aliphatic palladacycles 
through C‒H bond activation has two other fundamental challenges: (1) how to selectively 
palladate an (sp3)C‒H bond in the presence of a competing aromatic (sp2)C‒H bond and 
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(2) how to achieve palladation of 2° and 3° carbons instead of primary, particularly those 
in the tert-butyl moiety.  
 In general, aromatic C‒H bond activation is favored over aliphatic C‒H bond 
activation.54 Nonetheless, several research groups have reported palladation at a (sp3)C‒H 
bond in the presence of a competing aromatic C‒H bond achieved using the appropriate 
palladation agent and conditions.67, 68, 76, 139, 140, 166 In 1994, Echavarren and Cardenas 
reported the palladation of acetophenone N,N-dimethylhydrazone (61) at the aliphatic C‒
H bond using Pd(PPh3)2Cl2 and NaOAc in MeCN to furnish palladacycle 63.
67, 68 When 
the researchers used Na2PdCl4 and NaOAc in MeOH, they observed exclusive palladation 
at the ortho position of the aromatic ring to give palladacycle 62.67 In the 1H NMR spectrum 
of complex 62, two N-methyl groups gave rise to a singlet at δ 3.09 ppm confirming that 
the sp3-hybridized nitrogen atom is not the donor atom (Scheme 6). In contrast, two N-
methyl substituents of 63 appeared as two singlets, proving diastereotopicity of these two 
groups and, therefore, Pd coordination with the (sp3)-N atom. Compound 62 remained 
unchanged when it was refluxed with NaOAc in MeCN. This observation allowed the 
authors to conclude that it is not an intermediate in the formation of aliphatic CPC 63.  
 
Scheme 6. Synthesis of palladacycles 62 and 63 from acetophenone N,N-
dimethylhydrazone 61. 
 Cinellu et al. reported that the selective palladation of an unactivated (sp3)C‒H 
bond in the presence of a competing aromatic (sp2)C‒H bond in 6,6ʹ-dimethoxy-2,2ʹ-
   
   
 19   
 
bipyridine (64) depends on the solvent used.140 They observed that the use of a protic 
solvent like AcOH led to metalation at the unactivated (sp3)C‒H bond to give palladacycles 
66a,b.140 The use of the same Pd reagent in the aprotic solvent toluene led to palladation at 
the (sp2)C‒H bond to yield complex 65 (Scheme 7).140 
 
Scheme 7. Solvent effect on the cyclopalladation of preligand 64. 
 Dunina et al. observed a similar but opposite effect when they used different 
solvents in the reaction of 1-thiobenzoylpyrrolidine (67) with PdCl2 or K2PdCl4.
117 
Reaction of 67 with K2PdCl4 in the protic solvent MeOH gave CPC 68 with an (sp
2)C‒Pd 
bond, while the use of the aprotic solvent HMPA and PdCl2 led to palladation at (sp
3)C‒H 
bond to furnish CPC 69 (Scheme 8).117 
 
Scheme 8. Solvent effect on the cyclopalladation of preligand 67 by PdCl2. 
  Both Sales’ and Minghetti’s groups have shown that regioselectivity of palladation 
can be governed by using different temperatures.54, 139 In 1991, Sales et al. studied the 
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palladation of N-mesitylbenzylideneamine 70 using Pd(OAc)2. They observed that 
refluxing the reaction mixture led to metallation at the (sp3)C‒H bond to give palladacycle 
72.54 When the reaction was carried out at lower temperatures, palladation preferentially 
took place at the aromatic (sp2)C‒H bond to furnish compound 71 (Scheme 9).54 These 
data suggest that complex 72 with the benzylic C–Pd bond is more thermodynamically 
stable than its anlog 71. 
 
Scheme 9. Temperature effect on the cyclopalladation of preligand 70 using Pd(OAc)2. 
 The research groups of Sales and Minghetti together with that of Fernandez have 
investigated the ring size preference in the palladation of (sp3)C‒H bonds.53, 54, 139 
Minghetti et al. obtained the six-membered palladacycle 74 upon reaction of preligand 73 
with Pd(OAc)2 in AcOH under reflux.
139 Palladacycle 74 was converted quantitatively to 
the five-membered-ring analog 75 upon refluxing in AcOH (Scheme 10).139 This is an 
example of the general trend that five-membered aliphatic palladacycles appear to be more 
stable than related six-membered aromatic palladacycles.167-169   
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Scheme 10. Effect of reaction conditions on the cyclopalladation of preligand 73. 
 In 2004, while studying the palladation of (R)-4-phenyl-2-oxazolines using 
Pd(OAc)2 in AcOH, our research group observed regioselectivity towards the formation of 
endo-palladacycles derived from imines.170 Later, our group also investigated reactions of 
(S)-2-tert-butyl-4-phenyl-2-oxazoline 76 with Pd(II) salts in an effort to determine whether 
the endo-effect-driven regioselectivity would lead to metalation at the (sp3)C‒H.69 This 
reaction provided endo-palladacycle 77 with the (sp3)C‒Pd as the major product while the 
alternative exo-palladacycle 78 with an (sp2)C‒Pd bond, was isolated in much lower yield 
(Scheme 11).69 It is noteworthy that palladacycle 77 was obtained exclusively when the 
reaction was performed solvent-free on silica gel (Scheme 11).18  
 
Scheme 11. Palladation of preligand 76. 
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 As a rule, aliphatic palladations proceed with very high selectivity for 1° (sp3)C‒H 
bonds especially those in the tert-butyl fragment.167 The reason for such selectivity appears 
to be due to the possibility of β-hydride elimination in cyclopalladated complexes with 2° 
and 3° (sp3)C‒Pd bonds. In the case of metalation of the tert-butyl group, β-elimination is 
impossible because of the absence of β-hydrogens. Sanford et al. has reported the selective 
palladation and subsequent oxygenation of a 1° (sp3)C‒H bond in the presence of a 
competing 2° (sp3)C‒H bond in 3-methyl-2-pentanone O-methyl oxime 79 (Scheme 
12).171-173 Compound 79 could undergo both 1° (sp3)C‒H bond and 2° (sp3)C‒H bond 
palladation to form two different five-membered palladacycles; however, no traces of the 
palladation product at the 2° (sp3)C‒H bond were observed due to a more statistically 
probable β-hydride elimination.171, 172 Palladation occurred at the 1° (sp3)C‒H bond of the 
methyl group to give palladacycle 80, which has just a single β-hydrogen. 
 
Scheme 12. Regioselectivity in the palladation of 3-methyl-2-pentanone O-methyl oxime. 
 Recently, McNally et al. reported the cyclopalladation of aliphatic amines using 
Pd(OAc)2.
19 The amines used in this study (e.g., 83) have C‒H bonds in the positions that 
could not give rise to conventional five-membered-ring palladacycles.19 Metalation of 
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these amines led to strained four-membered palladacycles.19 The effect of β-hydride 
elimination on selectivity was evident when the researchers selected amine 83, which could 
undergo cyclopalladation at an (sp3)C‒H bond of either methyl or ethyl group.19 
Cyclopalladation of amine 83 at one of the three methyl group would give a strained four-
membered palladacycle, while metalation at the ethyl group would furnish a conventional 
five-membered ring.19 Interestingly, palladation took place at the methyl group to give the 
four-membered palladacycle 84 (Scheme 13). No product of cyclopalladation at the 1° 
(sp3)C‒H bond of the ethyl group was obtained.  
 
Scheme 13. Selectivity in palladation of aliphatic amines 83 and 85. 
 McNally et al. isolated four-membered CPCs by selecting aliphatic amines that 
possess no C‒H bonds in the positions amenable to the formation of five-membered rings 
(Scheme 13).19 These four-membered CPCs are the first (and only) examples of their 
kind.19, 174, 175 Interestingly, four-membered metalacycles were also obtained when 
McNally and his collaborators used amines capable of forming five-membered analogs.19  
I.3.2. Oxidative Addition 
 Oxidative addition can be used for the synthesis of palladacycles with an (sp3)C‒
Pd bond when C‒H bond activation is impossible in the preligand. In this method, the two-
electron donor group of an alkyl halide oxidatively adds to a Pd(0) or Pd(II) source 
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increasing both its formal oxidation state and coordination number by two.21 This approach 
is particuclarly convenient for the preparation of palladacycles with an (sp2)C‒Pd bond.4  
 The synthesis of palladacycles with an (sp3)C‒Pd bond through direct oxidative 
addition is still a great challenge due to the relative inertness of alkyl halides toward Pd(0) 
reagents. However, in 1975, Okawara et al. reported the direct oxidative addition of 
chloromethyl methyl sulfide (87) to Pd(PPh3)4 to give the aliphatic palladacycle 30 in 87% 
yield (Scheme 14).35, 36, 176-178  
 
Scheme 14. Synthesis of the aliphatic palladacycle 30 by oxidative addition. 
I.3.3. Transmetalation 
 Transmetallation is another method to form a C‒Pd bond.4, 179, 180 In this reaction, 
Pd replaces a metal within an organometallic compound.180 Organolithium reagents are the 
most commonly used to furnish palladacycles, particuclarly those with an (sp3)C‒Pd 
bond.48, 180, 181 Tin, silicon and magnesium have also been used, though to a lesser extent.60, 
180, 182-184 
 There are several examples of using transmetalation to obtain aliphatic CPCs. Thus, 
attempts by Strohmann et al. to palladate silane 88 at the 1° carbon using Pd(OAc)2 did not 
work.181 Ligand 88 was recovered from the reaction mixture unchanged and palladium 
black was observed.181 When silane 88 was treated with tBuLi in n-pentane at -90 °C, 
metallation took place at the methyl group to give the organolithium derivative 89 in 90% 
yield. The organolithium reagent 89 was then treated with trans-PdCl2(SMe2)2 in THF at -
78 °C to form the aliphatic dimeric chloro-bridged CPC 90 in 72% yield (Scheme 15).181 
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Scheme 15. Synthesis of the silicon-containing aliphatic CN-palladacyle 90 by 
transmetallation. 
 Pfeffer and co-workers have used transmetallation to access the silicon-containing 
dimeric chloro-bridged CPC 94, which is difficult to synthesize using other methods.48, 49 
The organolithium reagent 91 did not react with Pd(SEt2)Cl2.
48 However, the same 
compound 91 readily underwent transmetalation with the dimeric chloro-bridged N,N-
dimethylbenzylamine-derived CPC 92 in Et2O to furnish compound 93 in 60% yield 
(Scheme 17).48 Refluxing compound 93 with trans-Pd(SMe2)Cl2 in toluene gave 
complexes 92 and 94 (Scheme 16).49 
 
Scheme 16. Synthesis of the silicon-containing alkyl palladacyle 94 by transmetallation. 
 Nishiyama et al. synthesized ketoxime-based aliphatic palladacyles by 
transmetallation of stannyl and silyl ketoximes (e.g., 95) with Pd(PhCN)2Cl2 in CH2Cl2.
60 
Complex 96 was isolated in 78% yield from the reaction of (E)-β-tributylstannyl ketoxime 
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95 with 1 equiv. of Pd(PhCN)2Cl2 at 0 °C for 30 min in CH2Cl2 (Scheme 17). For 
comparison, Shaw and his co-workers have reported that direct cyclopalladation of 
alipahatic oxime derivatives using Pd(II) salts typically takes three days at rt to furnish 
CPCs with yields up to 70%.63 This is strong evidence that (sp3)C‒Pd bond is formed faster 
during transmetallation than in case of C‒H bond activation to access ketoxime-based 
aliphatic palladacycles. However, this transformation suffers significant drawbacks, which 
are 1) the use of highly poisonous tin derivatives and 2) a laborious synthesis of the tin 
derivatives prior to transmetallation. 
 
Scheme 17. Synthesis of the ketoxime-based aliphatic palladacyle 96 by transmetallation. 
 Cámpora et al. have reported the synthesis of CC-palladacycle 99 via 
transmetallation.183 The Grignard reagent 98 underwent transmetallation by Pd(COD)Cl2 
in THF followed by base-catalyzed (sp2)C‒H activation to afford palladacycle 99 in 80% 
yield (Scheme 18).183 
  
Scheme 18. Synthesis of the CC-palladacyle 99 by transmetallation. 
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I.3.4. Nucleophilic Addition 
 The preparation of palladacycles through nucleophilic addition involves the 
formation of a carbon-carbon or a carbon-oxygen bond between the β-carbon of an allylic 
amine or sulfide and a nucleophile. This reaction spontaneously results in the formation of 
a carbon-palladium bond at the δ-carbon of the allylic and homoallylic amine or sulfide. 
The nucleophile used in this reaction is either an alcohol or a stable enolate ion such as 
sodiodiethylmalonate; the palladating agent most often used is Li2PdCl4. Nucleophilic 
additions have been used in the synthesis of diverse types of palladacycles including those 
with an (sp3)C‒Pd bond.3, 44, 75, 80-83 As mentioned above (Scheme 2), the first CPC with an 
(sp3)C‒Pd bond was prepared by this method from allylic amines.  Later in 1977, Kjonaas 
et al. expanded the substrate scope in this reaction to include the allylic sulfide 100.75, 82 
They also found that carbon nucleophiles like sodiodiethylmalonate can also be used in 
this method (Scheme 19).75, 82 
 
Scheme 19. Synthesis of palladacyle 31 by nucleophilic addition. 
I.3.5. Miscellaneous Methods 
I.3.5.1. Modification of a Preformed Palladacycle 
 It is also possible to obtain one palladacycle from another. For example, a 
preformed (sp2)C‒Pd bonded palladacycle can then undergo a rearrangement or insertion 
reaction at the C‒Pd bond to generate an (sp3)C‒Pd bonded palladacycle.113, 114, 185, 186 In 
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2004, Solé et al. reported the synthesis of azapalladacycle 102 by the oxidative addition of 
N,N-dialkyl-2-iodoaniline 101 to Pd(PPh3)4 or Pd2(dba)3/PPh3.
185 As expected, the strained 
four-membered ring in complex 102 underwent carbene insertion into the C‒Pd bond to 
give the more stable five-membered ring palladacycle 103 (Scheme 20).185 
 
Scheme 20. Synthesis of palladacycle 103 by carbene insertion at the C‒Pd bond of CPC 
102. 
 Vicente and his collaborators have reported the unusual rearrangement of ortho-
palladated aryldithioacetals.113, 114 The oxidative addition of aryldithioacetal 104 to 
Pd(dba)2 gave the unexpected iodine-bridged palladacycle 107 (Scheme 21).
114 When this 
reaction occurred in the presence of TlOTf and 2,2'-bipyridine (bipy), the expected 
monomeric product 105 was obtained (Scheme 21).114 Compound 105 rearranged to 
palladacycle 106 upon refluxing in 1,2-dichloroethane (Scheme 21).114 This rearrangement 
resulted from the cleavage of one (sp2)C‒Pd and one (sp3)C‒S bond and the formation of 
one (sp3)C‒Pd and one (sp2)C‒S bond. 
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Scheme 21. Synthesis of palladacycle 107 by a rearrangement of CPC 106. 
I.3.5.2. Modification of a Preformed Pd‒Aryl Unit 
 Oxidative addition of an aryl halide to a Pd(0) source is the first step in another 
method used for preparation of CPCs.180 The aryl‒Pd compound 109 then reacts with an 
norbornene followed by treatment with a base to form a CC-palladacycle 111.180 Catellani 
et al. have worked extensively on the synthesis of CC-palladacycles using this 
methodology.126-129, 187 In the example shown in Scheme 16, the first step of this 
transformation was oxidative addition of phenyl iodide 108 to Pd(0)L2 to give compound 
109. The subsequent insertion of norbornene into the (sp2)C‒Pd bond of compound 109 
provided the stable product 110. Compound 110 then underwent base-catalyzed 
intramolecular C‒H activation to furnish CC-palladacycle 111 (Scheme 22).126  
 
Scheme 22. Synthesis of palladacycle 111 by modification of the preformed Pd‒aryl unit 
109. 
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I.4. Applications of Palladacycles Containing an (sp3)C‒Pd Bond 
 CPCs containing an (sp2)C‒Pd bond have been used in synthetic organic chemistry 
as 1) catalysts or precatalysts in the Mizoroki-Heck,95, 96, 104 Suzuki57, 92, 96 and other 
reactions,92, 101, 188-194 2) reagents for chiral resolution of racemic ligands,195 3) reagents for 
chiral coordinative derivatizing agents to determine optical activity,195 4) chiral 
auxiliaries,195 and 5) ligand modifications using reactions at the Pd‒C bond.196 CPCs 
containing an (sp3)C‒Pd bond have mostly been used as catalysts92-96, 98, 101, 154, 197 and to a 
lesser extent in ligand modifications using reactions at the Pd‒C bond.62, 84, 85, 119, 198 To the 
best of our knowledge, aliphatic CPCs have never been utilized as reagents for chiral 
resolution of racemic ligands and chiral coordinative derivatizing agents, as well as chiral 
auxiliaries. 
I.4.1. Use as Catalysts or Precatalysts 
 The first CPC with an (sp3)C‒Pd bond used as a catalyst in cross-coupling reactions 
is the Herrmann palladacycle 114.96 The catalytic activity of complex 114 in the Heck 
reaction surpassed that of all previously used catalysts in the same transformation.96 The 
exceptional stability and a possibility of activating less reactive chloroarenes made this and 
related complexes target compounds for potential application in industries.22, 96 Herrmann 
et al. obtained 100% yield of product 115 when CPC 114 was used as a catalyst in the 
reaction of 4-bromobenzaldehyde (112) with n-butyl acrylate (113) (Scheme 23).96 The 
product yield of this reaction remained the same when the equivalence of the catalysts was 
reduced to thousand times its initial amount.96 Kinetic studies showed that the standard 
catalyst, a mixture of Pd(OAc)2 and triarylphosphine, was deactivated at temperatures 
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above 120 °C due to the breaking of a P‒C bond in the phosphine.96 This led to the 
deposition of Pd black usually observed in Heck reactions and explained why this catalyst 
cannot be used for less reactive chloroarenes and deactivated bromoarenes, which are often 
unreactive under mild reaction conditions and require temperatures above 120 °C.96, 199 For 
comparison, thermal gravimetric/mass spectrometric studies of compound 114 indicated 
that it decomposes only at temperatures above 250 °C; hence it can be used in Heck 
reactions requiring high temperatures.96 
 
Scheme 23. Catalytic activity of CPC 114 in Heck reaction. 
  In an effort to compare the catalytic activity of pincer palladacycles with an (sp3)C‒
Pd and an (sp2)C‒Pd bond, Milstein and his group used three PCP pincer CPCs in a Heck 
reaction.200 They reported that iodobenzene (116) reacted with tert-butyl acrylate (117) in 
the presence of catalytic amounts of the PCP pincer complex 119 containing an (sp2)C‒Pd 
bond to furnish product 118 in 4% yield (Scheme 24).200 To their surprise, when the PCP 
pincer complex 120 with an (sp3)C‒Pd bond was used, this reaction gave product 118 in 
100% yield (Scheme 24).200 They screened many reagents and reaction conditions, and in 
each case the PCP pincer complex 120 provided better yields of the product than the PCP 
pincer complex 119.200 Although both pincer complexes showed very high thermal stability 
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with no decomposition up to 180 °C, CPC 120 had a higher turnover rate.200 Complex 120 
was an effective catalyst even in Heck reactions of nonactivated aryl bromides, in which 
CPC 119 was not.200 The researchers concluded that the higher catalytic activity of CPC 
120 could be due to electronic factors since the metal center in CPC 120 is more electron 
rich than in CPC 119.200  
 
Scheme 24. Catalytic activity of PCP pincer CPCs in Heck reaction. 
 To examine whether the Herrmann palladacycle 114 was also effective in Suzuki 
reactions, Beller et al. used this complex as a catalyst in cross-coupling reactions of aryl 
halides with arylboronic acids.95 These researchers found that 4-bromoacetophenone (112) 
reacted with phenylboronic acid (121) in the presence of compound 114 to give the desired 
4-acetylbiphenyl (122) in yields above 90% (Scheme 25).95 Complex 114 was also found 
to be effective in Suzuki reactions with less reactive chloroarenes.95 
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Scheme 25. Catalytic activity of CPC 114 in Suzuki reaction. 
 Liu and her group have used the imine-derived CPC 124 as a catalyst57 in a similar 
Suzuki-Miyaura reaction (Scheme 26).57 They reported a quantitative yield of the product 
even though these reactions were carried out in air and protic solvents.57 The use of 
activated aryl chlorides like p-nitrophenyl chloride and p-acetylphenyl chloride both gave 
100% yields of the respective products.57 However, they observed poor conversions for 
deactivated aryl halides and phenyl chloride.57, 199 Deactivated aryl halides had electron-
donating groups on the benzene ring.199  
 
Scheme 26. Catalytic activity of CPC 124 in Suzuki-Miyaura reaction. 
 Recently, Joshaghani et al. described the use of the biphenyl-based phosphine-
derived CPC 127 as a catalyst in Suzuki couplings (Scheme 27).93 Previously, the 
researchers reported high catalytic activity of 2-(diphenylphosphino)-2'-methylbiphenyl in 
the presence of Pd(0) in several coupling reactions, which they assumed was due to the 
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formation of the palladacycle intermediate 127.93 CPC 127 was synthesized and tested as 
a catalyst for Suzuki cross-coupling reactions.93 The catalytic activity of CPC 127 
improved with increasing reactivity of the aryl chloride used.93 They observed quantitative 
yield of the product when highly activated aryl chlorides with electron-withdrawing groups 
were used.93 It is worth noting that compound 127 was still effective in the reactions with 
electron-rich aryl halides like 3-chloroanisole (126).93 They also observed that the catalytic 
activity of CPC 127 surpassed that of its preligand.93 
 
Scheme 27. Catalytic activity of CPC 127 in Suzuki-Miyaura reaction. 
 Hou and his group have observed a rather different phenomenon. When CP-CPCs 
containing either an (sp3)C‒Pd or (sp2)C‒Pd bond were used as catalysts in the reaction of 
oxabicyclic alkenes and terminal alkynes, different products were obtained.101 When the 
reaction of 7-oxabenzonorbornadiene (129) with phenylacetylene (130) was catalyzed by 
CP-CPC 132 containing an (sp3)C‒Pd bond, the cyclic ether 133 was formed as the major 
product (Scheme 28).101 A switch to alcohol 134 was observed when CP-CPC 131 with an 
(sp2)C‒Pd bond was used (Scheme 28).101 DFT calculations showed that this selectivity 
resulted from the difference in trans effects of the carbon donors in the CPCs.101 The (sp3)C 
atom possess a greater trans effect than the (sp2)C because the former is a stronger donor.101 
In the transition state (TS1) leading to compound 134, the O‒Pd bond being formed is trans 
to the (sp2)C‒Pd bond of CPC 131. This trans-(sp2)C,O geometry resulted in predominant 
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β-O elimination. In the transition state TS2 leading to compound 133 the C‒Pd bond being 
broken is trans to the (sp3)C‒Pd bond of CPC 132. This trans-(sp3)C,O geometry favored 
protonolysis.101 
 
Scheme 28. Reaction of oxabicyclic alkenes with terminal alkynes using CPCs. 
 The Herrmann palladacycle has also been used in palladium-catalyzed 
homocoupling of aryl iodides.92 Luo et al. observed homocoupling of 4-iodotoluene (135) 
in DMF in the presence of complex 114 to give product 136 in 87% yield (Scheme 29).92 
The yield of the products changed only a little when substituents on the benzene ring were 
varied.92 However, the reaction was faster with arenes having electron-withdrawing 
substituents than with those bearing electron-donating groups.92  
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Scheme 29. Palladium-catalyzed homocoupling of 4-iodotoluene using CPC 114. 
I.4.2. Ligand Modifications Using Reactions at the Pd‒C Bond 
 Similarly to other organometallic compounds, CPCs can react with a number of 
substrates resulting in ligand modifications. Only a small fraction of these reactions involve 
CPCs with (sp3)C‒Pd bonds. For example, the research group of Sheppard has reported the 
synthesis of novel compounds via cyclopalladation of lanosterol and cholesterol.62 These 
products could potentially be used as new adjuvant saponins.62 Holton, R. A. synthesized 
a prostaglandin by using the cyclopalladation of cyclopentadiene as the first step.84 Lindsell 
et al. have utilized reactions at the Pd‒C bond of the benzylic CPC 138 to prepare lactone 
140, which is a precursor of pharmaceutical agents.125 Their lactone synthesis started with 
the oxidative addition of 2-hydroxymethylbenzyl chloride (137) to Pd(PPh3)4 in toluene to 
afford CPC 138.125 Insertion of CO into the Pd‒C bond of CPC 138 gave compound 140 
in 71% yield (Scheme 30).125 
 
Scheme 30. Synthesis of compound 140 using CPC 138 as a reactant. 
 Pfeffer et al. have accessed novel heterocyclic compounds containing a bridgehead 
nitrogen via reactions at the Pd‒C bond of the 8-methylquinoline-derived CPC 8.198 The 
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researchers reacted CPC 8 with 1 equiv. of dimethyl acetylenedicarboxylate to afford 
compound 141 in 91% yield (Scheme 31).198 
 
Scheme 31. Synthesis of compound 141 by the ligand modification method.
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CHAPTER II 
GOALS OF THE STUDY 
II. 1. Types of Optically Active Cyclopalladated Complexes 
 Known optically active CPCs possess either 1) a chiral center,201 2) chiral 
plane,202 3) chiral axis203 or 4) a combination of two chiral elements.204 The first 
examples of optically active C*-chiral CPCs were derived from α-arylalkylamines and 
were reported as early as 1971 (Chart 10).201, 205 Later in the 1980s, Sokolov et al. 
introduced the planar chiral 1-dimethylaminoethylferrocene-derived complex 142 (Chart 
10).204, 206 Presently, there are many examples of optically active CPCs, which include 
both mono- and dinuclear CN-, CS-, and CP-complexes as well as mononuclear SCS, 
NCN, PCP and PCN pincer derivatives. The majority of optically active CPCs reported in 
literature have an (sp2)C–Pd bond,192 although optically active aliphatic CPCs have also 
been known (Chart 10).32, 207-209, 133
 
Chart 10. Examples of optically active CPC containing 1) a chiral center [(RC)-141, (RC)-
8, (SP,SP)-56 and (SPl,RC)-142], 2) chiral plane [(SPl,RC)-142] and 3) chiral axis [(Ra,Ra)-
131].
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II.1.1. Optically Active Cyclopalladated Complexes Containing an (sp2)C–Pd Bond 
 Optically active CPCs containing an (sp2)C–Pd bond are the most abundant group 
of chiral CPCs and can be differentiated by the type of chirality into those with a chiral 
plane, chiral center or chiral axis. CPCs with central chirality contain one or more chiral 
atoms, which can be C, N, P or S. Chart 11 provides examples of C*-chiral CPCs 78 (see 
Scheme 11) and 141 (Chart 10),201 C*- and N*-chiral complex 143,210 C*- and S*-chiral 
analog 144,211 CS-CPC 69 (see Scheme 8)117 and C*- and P*-chiral CPC 145 (Chart 11).212 
Examples of CPCs with only planar chirality include CN-CPCs 146213 and 147214 (Chart 
11). The majory of planar chiral CPCs also contain a chiral center, e.g., 148 and 149 (Chart 
11).214 Phosphapalladacycle 131 derived from binaphthalene exhibits axial chirality (see 
Chart 10).203 
 
Chart 11. Examples of optically active CPCs with an (sp2)C–Pd bond. 
 Pincer CPCs with a stereocenter have been studied by several groups.215 216 217 133 
218 219 194 Examples of these pincer complexes include CNO-44 (see Chart 8),133 NCN-
150,215 NCNO-151,216 OCNO-152,217 PCP-153 and PCP-154,219 PCN-155194 and SCS-
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156 (Chart 12).218 There are also reports of pincer complexes with axial chirality, e.g., 
PCP-157220 as well as complexes with both axial and central chirality, e.g., NCN-158 
Chart 12).221
 
Chart 12. Examples of optically active pincer complexes. 
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II.1.2. Optically Active Cyclopalladated Complexes with an (sp3)C–Pd Bond 
 Most aliphatic CPCs containing a chiral center exist as racemates due to the tedious 
process of chiral resolution. This is one of the reasons why only a limited number of 
optically active CPCs of this kind have been known to date. Their examples include 
phosphapalladacycles 56 (see Scheme 4),207 161222 and 162,223 CS-CPC 69 (Scheme 8),117 
CC-CPC 38 (Chart 7),130, 131 pyrazole-derived CN-CPC 19 (Chart 2),23 and oxazoline-based 
CN-CPCs 159 and 160 (Chart 13).208, 209, 224  
 
Chart 13. Examples of optically active complexes containing an (sp3)C–Pd bond. 
II.2. Synthesis of Optically Active Cyclopalladated Complexes  
 Two common methods to access optically active CPCs with an (sp3)C–Pd bond 
have been reported: 1) cyclometalation of enantiopure preligands209, 225 and 2) chiral 
resolution of racemic cyclopalladated complexes.32, 133 The third approach, 
enantioselective palladation,226, 227 has also been used to prepare optically active CPCs, but 
all of them contain an (sp2)C–Pd bond. 
II.2.1. Cyclopalladation of Enantiopure Preligands  
 The most straightforward approach for preparation of optically active CPCs is 
cyclopalladation of preligands derived from naturally occurring optically active 
compounds. Examples include complexes obtained from (i) 4-substituted 2-oxazolines,228, 
229 which are prepared from readily available enantiopure α-amino alcohols, (ii) derivatives 
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of natural phenols L-(+)-tyrosine and (+)-estrone230 and (iii) derivatives of L-
phenylalanine231 and (R)-2-phenylglycine.232 Only a small fraction of known 
enantiomerically pure or scalemic CPCs have an (sp3)C–Pd bond (see Chart 13).32, 207-209 
 Our research group has also synthesized optically active CPCs via the 
cyclopalladation of enantiopure preligands. Previously, we studied the cyclopalladation of 
(S)-4-tert-butyl-2-methyl-2-oxazoline (165).209 Preligand 165 was synthesized according 
to a procedure reported by Meyers and Shipman from (S)-tert-leucinol and 
ethylacetimidate hydrochloride (Scheme 32).225 Reaction of 165 with Pd(OAc)2 in acetic 
acid gave the exo-palladacycle 160 (Scheme 32).209 The yield of the product was not high, 
possibly because 1) the structure of 165 allows only the less favored exo-cyclopalladation 
and 2) the difficulty associated with the activation of an (sp3)C–H bond.209 This is in 
contrast to the observed endo-cyclopalladation of (S)-2-tert-butyl-4-phenyl-2-oxazoline 
and 2-tert-butyl-4,4-dimethyl-2-oxazoline previously discussed in this dissertation (see 
Scheme 3).208 
 
Scheme 32. Synthesis of CPC (SC)-160 from (SC)-163. 
   
   
 43   
 
II.2.2. Synthesis of Optically Active Cyclopalladated Complexes through Chiral 
Resolution 
 Examples of preparation of optically active aliphatic CPCs using chiral resolution 
includes synthesis of 56 and 44. The preparation of enantiomerically pure 
phosphapalladacycle 56 by chiral resolution using optically active amino acid derivatives 
was described in Chapter I (see Scheme 4).32 The pincer CNO-complex 44 has also been 
successfully accessed through chiral resolution.133 Reaction of compound 166 with 
K2PdCl4 in EtOH followed by addition of pyridine gave rac-44, which upon stirring with 
S-(-)-1-phenylethylamine furnished a mixture of two diastereomers (Scheme 33).133 The 
diastereomeric mixture was separated using column chromatography, and a subsequent 
ligand exchange with pyridine gave both enantiomers of CPCs 44 (Scheme 33).133 
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Scheme 33. Synthesis of the optically active CPCs 44 by chiral resolution of rac-44. 
II.2.3. Synthesis of Optically Active CPCs through Enantioselective Palladation 
 All optically active complexes obtained by this method have an (sp2)C–Pd bond. 
The synthesis of optically active CPCs via enantioselective palladation was first introduced 
in 1979 by Sokolov and his research group.226 In this study, the researchers obtained dimer 
170 with 79% ee using 1 equiv. of (S)-N-acetylleucine (169) in the palladation of 
(dimethylaminomethyl)ferrocene (170) by Na2PdCl4 (Scheme 34).
226 Recently, Richards 
and Günay investigated the same reaction in an attempt to confirm the enantioselectivity 
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observed by Sokolov (Scheme 34).227 To obtain CPC 170, they used the same reaction 
conditions described by Sokolov. The product analysis by chiral chromatography provided 
96% ee.227 The research groups of Ryabov and Richards used enantioselective palladation 
to access other optically active CPCs.159, 233, 234 To the best of our knowledge, optically 
active aliphatic CPCs have never been prepared using this method. 
 
Scheme 34. Synthesis of the optically active CPC 170 via enantioselective palladation. 
II. 3. Applications of Optically Active Cyclopalladated Complexes  
 Optically active CPCs have many applications. For example, in asymmetric 
synthesis, they can play three roles: catalyst/precatalyst,189, 190, 235-238 chiral auxiliary239-241 
and reactant.14, 207, 242, 243 Optically active CPCs have also been used in chiral resolution,244-
247 for determination of enantiopurity of amines, phosphines and other substrates 
possessing ligand properties248-250 as well as functioning as a reference point for 
determination of absolute configuration.245, 246, 251-253 In the majority of the application 
studies (except for the use of CPCs as chiral catalysts), only a small group of optically 
active CPCs are commonly employed; they are derivatives of optically active 1-
phenylethylamine,248, 250 1-(1-naphthyl)ethylamine205 and 1-(2-naphthyl)ethylamine.254  
 Amongst the optically active CPCs obtained from compounds available in the chiral 
pool,255 only CPCs containing the oxazoline moiety were used in applications involving 
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chiral induction, predominantly as catalysts in asymmetric transformations.256, 257 
Moreover, the best results were obtained for quite complex structures, particularly those 
containing not only the oxazoline ring, but also a planar-chiral moiety.256, 257 Only a small 
fraction of known enantiopure or scalemic CPCs have an (sp3)C–Pd bond,32, 207-209 and 
none of them have been used as either resolving agents or catalysts in enantioselective 
transformations.   
II.4. Goals of the Present Study 
 As was presented above, enantiopure CPCs have many important applications. 
However, most of these complexes are derivatives of 1-phenylethylamine and have an 
(sp2)C−Pd bond. It is of interest to 1) prepare new types of enantiopure aliphatic CPCs 
from readily accessible chiral compounds, 2) characterize their structures using available 
spectrometric methods and 3) study them as chiral inductors in various asymmetric 
transformations.  
 Readily available enantiopure D-camphor and other bicyclic monoterpenoids 
possess rigid structures that may be an advantageous feature in asymmetric reactions; 
therefore, CPCs based on compounds of this type are important research targets. If new 
CPCs based on inexpensive compounds from the chiral pool become available, 
applications of metallacycles in catalysis can be broadened and enriched. In this 
dissertation, we proposed and studied the synthesis, structural pecularities and applications 
of new enantiopure CPCs derived from D-camphor and L-fenchone. Among various 
possible applications of the new camphor- and fenchone-based CPCs, we selected and 
investigated their transformations using KPPh2. 
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 Recently, our research group14, 15 and others258, 259 have shown that LiPPh2 and 
KPPh2 are capable of reacting with aromatic CPCs at the C–Pd bond to give hemilabile 
NP-ligands containing an (sp2)C−P bond. NP-, PP- and SP-bidentate ligands are efficient 
catalysts in a number of reactions. New types of chiral hemilabile NP-, PP- and SP-ligands 
obtained from inexpensive and naturally optically active compounds can greatly broaden 
and enrich the applications of these compounds in catalysis. In this dissertation, we 
proposed and studied the synthesis of new enantiopure NP- and other bidentate ligands 
through the reaction of aliphatic CPCs with KPPh2. Bidentate ligands having an (sp
2)C−P 
bond have primarily been synthesized using lithium-mediated substitution.260-262  
 The specific goals of the present study are: (1) to prepare D-camphor and L-
fenchone derivatives capable of forming cyclopalladated complexes; (2) to synthesize and 
structurally characterize new enantiopure CPCs based on D-camphor- and L-fenchone 
derivatives and (3) to investigate a possibility of the NP-ligand preparation by reactions of 
aliphatic CPCs with KPPh2 (Schemes 35 and 36). 
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Scheme 35. Proposed synthesis and applications of D-camphor-derived CPCs. 
 
Scheme 36. Proposed synthesis and applications of L-fenchone-derived CPCs.
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CHAPTER III 
RESULTS AND DISCUSSION 
III.1. Synthesis of CPCs 
III.1.1. Oxime of D-Camphor 
 There are a few reports about CPCs based on D-camphor; however, their structures 
are either quite complex (see structures 171 and 172 in Chart 14)263 or the bornane carbon 
framework is not a part of the metalacycle (compound 173).264 In 1983, Constable et al. 
reported unsuccessful attempts to cyclopalladate D-camphor oxime (HL) (174a) using 
Na2PdCl4.
265 The main product of the reaction was the corresponding coordination 
complex, PdCl2(HL)2. Attempts to convert the coordination complexes PdCl2(HL)2 and 
PdI2(HL)2 to their cyclopalladated analogs by heating in high-boiling solvents were also 
unsuccessful.265 For comparison, the oximes of 2,2-dimethylcyclohexanone and related 
substrates undergo cyclopalladation using the same palladating reagent in high yields.64  
 
Chart 14. Known CPCs containing the D-camphor carbon framework.
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 The Sanford group reported Pd(OAc)2-catalyzed C–H bond oxygenation of O-
methyl camphor oxime (174b) using K2S2O8 in a mixture of AcOH and Ac2O (100 
oC, 12 
h, 63%)172 or PhI(OAc)2 in AcOH (100 
oC, 12 h, 75%).172, 173 The same year, Thu et al. 
disclosed the results of the Pd(OAc)2-catalyzed amidation of the same camphor derivative 
using K2S2O8 and H2NCOR (R = p-ClC6H4) and resulting in the conversion of the 1-methyl 
group to 1-CH2NHSO2R (80 
oC, 14–20 h, 93%).266 Both groups suggested that the 
reactions preceded through the formation of a cyclopalladated intermediate; however, no 
attempts were made to isolate it.  
Synthesis of Compounds 174-178 and Spectral Characterization 
 On the basis of the aforementioned literature data, O-methyl camphor oxime 174b 
was chosen as a simple preligand for synthesis. First, attempts were made to obtain oxime 
174b following the procedure, according to which a solution of D-camphor, methoxyamine 
hydrochloride and pyridine in isopropanol was refluxed for 7 h.267 The 1H NMR spectrum 
of the reaction mixture showed that only ca. 10% of D-camphor was converted to the 
oxime. The Booth method,268 following which a mixture of D-camphor, methoxyamine 
hydrochloride and pyridine was stirred at rt for 48 h, was also unsuccessful in our hands. 
When a mixture of D-camphor, methoxyamine hydrochloride and NaOAc in ethanol was 
refluxed for 5 h following the procedure by Kumar and Verma,269 the desired product was 
prepared in 25% yield. When two-fold excess of methoxyamine hydrochloride and NaOAc 
was used and the reaction time was increased to 24 h, the pure product was isolated in 74% 
yield (Scheme 37). According to the 1H NMR, the prepared oxime was a 92:8 mixture of 
two geometrical isomers. Refluxing HONH2.HCl with D-camphor and NaOAc in EtOH 
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for 48 h gave preligand 174a in 80% yield. The structure of 174a was confirmed using 1H 
and 13C NMR spectra. 
 
Scheme 37. Preparation of oxime 174 from D-camphor. 
 The coordination complex PdCl2(HL)2 (175) was prepared as a reference 
compound before attempting the cyclopalladation of the oxime. The coordination complex 
175 was isolated in 67% yield by stirring camphor oxime 174b with 0.5 equiv of Na2PdCl4 
at rt for 18 h (Scheme 38). According to the NMR spectroscopy data, the compound was a 
mixture of two isomers in ca. 9:1 ratio, possibly due to the presence of E and Z isomers in 
the starting oxime, although the existence of trans/cis forms of the complex in the solution 
cannot be excluded. 
 
Scheme 38. Preparation of the coordination complex 175. 
 Cyclopalladation of oxime 174b was first tested with equimolar amounts of 
Na2PdCl4 and NaOAc by stirring the reagents in abs. MeOH at rt. Analytical TLC and 
1H 
NMR spectrum of the product indicated that this reaction gave only complex 175 (33% 
yield). Repeating this reaction at reflux for 6 h still showed only the coordination complex.  
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An equimolar mixture of camphor oxime 174b and Pd(OAc)2 was then stirred in glacial 
acetic acid at 80 °C for 5 h. After treatment with LiCl, the chloro-bridged CPC 177 was 
obtained in 66% yield (Scheme 39). The dimeric complex was converted to the 
mononuclear triphenylphosphine adduct 178 in 98% yield by stirring a 2:1 mixture of PPh3 
and CPC 177 in acetone at rt (Scheme 39).  
 
Scheme 39. Preparation of dimeric and mononuclear complexes 177 and 178. 
 The proposed structures of the obtained coordination and cyclopalladated 
complexes 175, 177 and 178 were supported by NMR spectroscopy. Signal assignment in 
the 1H and 13C NMR spectra was done using DEPT, COSY and HMQC spectra. Purity and 
elemental composition of the compounds were proven by satisfactory elemental analysis. 
 The 1H NMR spectra of the free oxime and the coordination complex contained 
four 3H singlets confirming the presence of one methoxy and three methyl groups in their 
structures. The striking difference between the two spectra was a significant downfield 
shift of the singlet belonging to the 1-Me group of complex 175 from δ 1.02 to 2.42 ppm.  
Such downfield shifts of some signals in the spectra of coordination complexes in 
comparison to those of free ligands have been observed earlier56, 111, 270, 271 and can be 
explained by the position of the corresponding hydrogens above or below the PdCl2N2 
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plane of the coordination complex.272  Such positioning of the C–H bond is considered a 
possible step of cyclopalladation.23  
 As expected, 1H NMR spectra of the cyclopalladated derivatives 176 and 178 had 
signals of only two methyl groups instead of three (in addition to the singlet of the NOMe 
fragment). Each of the two diastereotopic hydrogens in the PdCH2 group provided a 
doublet (or a doublet of doublets due to 3JH,P for one of the hydrogens in complex 178): 
2J 
= 8 Hz at 2.22 and 2.58 ppm for 177 and 2J = 10 Hz at 0.53 and 1.86 ppm for 178. The 
observed coupling constants and chemical shift values are similar to those reported 
previously for other dimeric CPCs and PPh3 derivatives with the (sp
3)C–Pd bond.208, 209  
 It is noteworthy that the 1H and 13C NMR spectra in C6D6 of the dimeric CPC 177 
showed doubling of some signals (in a 5:3 ratio). This can be explained by the presence of 
two geometrical isomers, cis and trans. Such isomerism is well known for dimeric CPCs25, 
273 including those with the (sp3)C–Pd bond.23   
 The 1H, 13C and 31P NMR spectra23 of the mononuclear CPC 178 had one set of 
signals that suggests the existence of only one isomer in a solution. This complex appears 
to have the trans-P,N geometry as practically all known PPh3 adducts of CN-
cyclopalladated complexes. The 1D NOE experiment with the irradiating frequency 
corresponding to the resonance frequency of the ortho hydrogens of the PPh3 ligand (δ 7.78 
ppm) showed a positive enhancement of the signal at 1.86 ppm, which belongs to one of 
the hydrogens of the CH2Pd fragment. Also, the 
1H NMR signal of one of the hydrogens 
of the CH2Pd group (δ 0.53 ppm) appeared as a doublet of doublets with 2JHH = 10 Hz and 
3JHP = 8 Hz. A similar value of the 
3JHP coupling constant observed for only one of the two 
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hydrogens of the CH2PdP fragment was reported for a related PPh3 complex with trans-
P,N geometry proven by X-ray crystallographic study.209  
 When the cyclopalladation O-methyl camphor oxime (174) was achieved in our 
lab, we learned that Kuchin et al. just published the cyclopalladation of a closely related 
derivative of camphor, N-benzylimine 179 (Scheme 40).274, 275 When our work was 
compared with Kuchin’s, we concluded that their spectral data and ours were similar 
(Scheme 40).274, 275 
 
Scheme 40. D-Camphor-derived palladacycle 180 with the (sp3)C−Pd bond. 
X-ray Crystallographic Study of CPC 177 
 The X-ray single crystal study of complex 177 unambiguously proved its dimeric 
and cyclopalladated structure. The molecular structure of the compound and the numbering 
scheme are presented in Fig. 3. Several crystallographic studies of chloro-bridged dimeric 
five-membered CN-CPCs with the (sp3)C–Pd bond have been reported, including 
structures 90, 181–184, which will be used for comparison (Chart 15).63, 181, 276, 277 Only 
one of these studies describes the molecular structure of a cyclopalladated oxime with a 
(sp3)C–Pd bond (184); that oxime was obtained from tert-butyl methyl ketone.63  
   
   
 55   
 
 
Figure 3. ORTEP drawing of the molecular structure of CPC 177. Thermal ellipsoids are 
shown at the 50% probability level. 
 
Chart 15. Examples of chloro-bridged dimeric CN-CPCs with the (sp3)C–Pd bond and a 
known molecular structure. 
 Complex 177 crystallizes from hexane/dichloromethane in the orthorhombic 
crystal system and in the space group P212121. The dimeric molecule consists of two 
independent halves, which are slightly different in their structural parameters. The structure 
showed trans geometry of the cyclopalladated ligands typical for the majority of known 
chloro-bridged CN-CPCs with a five-membered palladacycle in solid state. The Pd2Cl2 ring 
in 177 is almost planar as in many other chloro-bridged CN-CPCs with trans-configuration. 
Four torsion angles in the Pd2Cl2 ring are between 7.28 and 7.89 Å. The Pd…Pd distance 
in the complex is 3.500 Å, which is similar to those reported for CN-CPCs with trans-
geometry.278 For comparison, the closest analog 184 has very rare cis ligand geometry in 
solid state and displays a significant bending of the Pd2Cl2 ring that results in an unusually 
short Pd…Pd distance of 2.99 Å.63   
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 The Pd–Cl bond trans to the metalated carbon is longer, 2.4996 Å, than that trans 
to the nitrogen, 2.3311 Å (∆ 0.1685 Å), (here and later, the given values represent the 
average of two numbers obtained for each half of the dimeric molecule). Similar findings 
were reported for trans complexes 90, 181–183, in which the Pd–Cl bond length differences 
are 0.188, 0.156, 0.128 and 0.162 Å, respectively.181, 276, 277 For three representative chloro-
bridged dimeric CN-CPCs with (i) the (sp2)C–Pd bond, (i) a five-membered palladacycle 
and (iii) trans ligand geometry, the difference between two Pd–Cl bonds (cis and trans to 
the aromatic carbon) has also been observed, although that difference is smaller, 0.1053, 
0.125 and 0.131 Å.4, 170, 228, 279 These data reflect a stronger trans influence of (i) the carbon 
donor atom compared to nitrogen and (ii) the (sp3)C atom compared to (sp2)C.  
 The (sp3)C–Pd bond length in 177 is 2.019 Å. This value is within the range 
reported for complexes 90, 181–184 (1.959–2.034 Å). The (sp2)N–Pd bond in 177 is a little 
bit longer than the (sp3)C–Pd bond, 2.037 Å, as it is reported for other chloro-bridged 
dimeric CN-CPCs with the (sp2)N and (sp2)C donor atoms and trans geometry of 
cyclopalladated ligands.170, 228, 279, 280 For comparison, in complexes 182 and 184, the 
(sp2)N–Pd bond lengths are 1.996(13) and 1.986(1) Å, respectively.63, 277  
 In complex 177, the bite angles C(10)-Pd-N(1) and C(30)-Pd(2)-N(2) are 82.14(10) 
and 82.39(10)o, respectively. This value falls in the range reported for compounds 181–
183: 84.5(1), 80.7(7) and 82.9(6) o, respectively.276, 277 In complex 183 with a silicon atom 
in the metalacycle, the angle reaches 86.81(9)o.181 For comparison, the C-Pd-N angle for 
chloro-bridged CPCs with the (sp2)N and (sp2)C donor atoms varies from 80.3 to 81.2o;170, 
228, 279 for the corresponding complexes with (sp3)N and (sp2)C, the C-Pd-N bite angle is 
slightly larger, 80.6−82.8o.278, 280 
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 Both palladium atoms in complex 177 are nearly in square-planar coordination with 
a slight tetrahedral distortion. The angle between the planes {N(1)Pd(1)C(10)} and 
{Cl(1)Pd(1)Cl(2)} is only 0.56o; the angle between the corresponding planes 
{N(2)Pd(2)C(30)} and {Cl(1)Pd(2)Cl(2)} is just slightly bigger, 3.26o. It appears that such 
almost ideal square-planar geometry is a characteristic feature of aliphatic palladacycles.209  
 Two metalacycles of dimer 177 can be described as slightly twisted envelopes with 
C(10) and C(21) serving as the envelope flaps. To estimate the distortion of each 
metalacycle from planarity, the sum of absolute values of intrachelate torsion angles was 
used as was proposed by Dunina.281 For one of the rings in CPC 177, the sum is 65.67o 
with the average angle of 13.13o. For the second metalacycle, the sum is 31.7o with the 
average angle of 6.34o. The closely related dimer 181 displays a significantly higher 
distortion of the metalacycle with the sum of torsion angles equal to 158o, with an average 
angle of 31.6o.276 For comparison, chloro-bridged CN-CPCs with the (sp2)C and (sp3)N 
donor atoms have the sum of intrachelate torsion angles in the range of 99–135.5o.  
III.1.2. N,N-Dimethylhydrazone of D-Camphor  
 The N,N-dimethylhydrazone of D-camphor (185) was first reported by Chelucci et 
al. in 1986 in their study of pyridoannelation of hindered ketones.282 As mentioned before, 
aliphatic CPCs containing the hydrazone directing group have been investigated by 
Cardenas et al.67, 68 There are no literature reports on the attempted cyclopalladation of 
compound 185 or its involvement in palladium-catalyzed reactions. 
 Preligand 185 was synthesized as a single isomer (1H and 13C{1H} NMR data) in 
89% yield following the published procedure by Chelucci et al.282, 283 D-Camphor, N,N-
dimethylhydrazine and a catalytic amount of 4-toluenesulfonic acid were refluxed for 
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seven days in ethanol to give product 185 in 89% yield (Scheme 41). The product of this 
reaction can exist as two geometric, E/Z, isomers. According to 1H and 13C{1H} NMR data, 
the hydrazone was isolated as a single geometric isomer. To determine whether the 
compound has either E or Z geometry, an NOE test was carried out. Irradiation of the 
protons on the NMe2 group during the NMR experiment showed positive NOE for the endo 
hydrogen on C(3). Based on this observation, it could be concluded that compound 185 has 
the E geometry.  
 
Scheme 41. Synthesis of camphor N,N-dimethylhydrazone 185. 
 
Figure 4. Expected and observed NOE effect upon irradiation of the NMe2 group on 185. 
 
 Cyclopalladation of the camphor hydrazone 185 was attempted using a variety of 
conditions; the successful results are summarized in Table 1. All reactions in AcOH 
resulted in deprotection of the carbonyl group to give camphor. Palladation of 185 using 
Pd(OAc)2 in MeCN or toluene furnished the desired product 186, although in low yields. 
The yield of compound 186 was increased to 72% when Na2PdCl4 was used in the presence 
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of the weak base NaOAc in MeCN. The best yield (92%) of the cyclopalladated complex 
was achieved with Pd(MeCN)2Cl2/NaOAc in MeCN (Scheme 42). 
  
Scheme 42. Cyclopalladation of camphor N,N-dimethylhydrazone 185. 
Table 1. Cyclopalladation of camphor N,N-dimethylhydrazone 185. 
Entry Pd source/base Rxn temp. 
(°C) 
Rxn time (h) Solvent Yield of 
186 (%) 
1 Pd(OAc)2 reflux 4 MeCN 44 
2 Na2PdCl2/AcONa reflux 4  MeCN 72 
3 Pd(OAc)2 60 6 PhMe 46 
4 Pd(CH3CN)2Cl2/NaOAc reflux 4  MeCN 92 
 
 Cyclopalladation of 185 occurred at the methylene group. This conclusion was 
made based on the 1H and 13C{1H} NMR spectra of CPC 186 which showed signals of the 
three methyl groups on the camphor moiety in addition to the nonequivalent methyl groups 
on the (sp3)N atom. This suggested that palladation takes place at C(3) (the methylene 
carbon) and the (sp3)N atom is coordinated to the Pd center leading to the possibility of 
endo/exo palladation. The 1H and 13C{1H} NMR spectra of product 186 were complex. 
This complexity is not only due to possible formation of endo and exo isomers but also cis 
and trans isomers (Chart 16). In addition, conformational flexibility of trans- and cis-186 
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is plausible, resulting in three diastereomers for each conformation. This was observed by 
Perera et al. for complexes of molybdenum derived from 3-diphenylphosphino-(1R)-(+)-
camphor dimethylhydrazone.284 
 
Chart 16. Possible isomers of CPC 186. 
 Repeated attempts to get only one isomer by varying the reagents and reaction 
conditions gave the same mixture (1H and 13C{1H} NMR data). All efforts to separate the 
isomers by preparative thin-layer chromatography (TLC) using different eluents were 
unsuccessful. The mixture of CPCs was refluxed in MeOH in the hope that it would 
isomerize to give a single isomer, but instead deprotection of the carbonyl group occurred 
to give D-camphor. Refluxing CPCs 186 over 6 h in aprotic solvents like MeCN and 
toluene also led to the breakdown of the complex with the deposition of Pd black. 
Separation of CPCs 186 by recrystallization using common solvents was unsuccessful. 
 Because the 1H and 13C{1H} NMR spectra for the dimeric complex 186 were 
difficult to interpret, it was reacted with 2 equiv. of PPh3 in acetone to give the mononuclear 
triphenylphosphine adduct 187 (Scheme 43). The 1H and 13C{1H} NMR spectra of 
complexes 187 showed a mixture of two stereoisomers in a 1:1 isomeric ratio, one with an 
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endo C−Pd bond (endo-187) and the other with an exo C−Pd bond (exo-187, Scheme 43). 
Attempts to separate the isomers by preparative TLC using different eluents were also 
unsuccessful. Similar to dimers 186, deprotection of the carbonyl group occurred to give 
D-camphor when the mixture of complexes 187 was refluxed in MeOH. Refluxing 
complexes 187 in aprotic solvents like MeCN and toluene also led to the breakdown of the 
complex with the deposition of Pd black. Separation of CPCs 187 by recrystallization using 
common organic solvents failed. 
 
Scheme 43. Reaction of camphor N,N-dimethylhydrazone CPC 186 with PPh3. 
 There are many reports of the conversion of dimeric CPCs to their mononuclear 
adducts by reaction with Na(acac).74, 285-289 Na(acac) was prepared by slow addition of a 
solution of NaOH to acetylacetone. CPC-186 was also converted to the mononuclear 
acetylacetonate adducts endo- and exo-188 in 96% yield by stirring with 3 equiv. of 
Na(acac) in CHCl3 (Scheme 44). The yield of endo- and exo-188 was similar to those 
reported in the literature (80–98%). The 1H and 13C{1H} NMR spectra of product 188 
showed a mixture of two diastereomers, which differ by stereochemistry at C(3) (Scheme 
44). Attempts to separate the two isomers using preparative TLC were unsuccessful. 
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Scheme 44. Reaction of the camphor N,N-dimethylhydrazone CPC 186 with Na(acac). 
 
 The best ratios of endo- and exo-188, 83:17 for the former and 19:81 for the latter, 
were obtained using preparative TLC (silica gel, 1:2 ethyl acetate‒hexane). The 83:17 
mixture of endo and exo complexes were left in CDCl3 for 3 weeks resulting to a 3:2 ratio 
of endo and exo complexes which suggested a slow isomerization of the former compound 
to the latter. The two isomers can be differentiated by a distinct 1H NMR signal of the 
hydrogen bonded to C(3). The singlet at δ 3.99 ppm was assigned to isomer exo-188 with 
the endo hydrogen at C(3) since no coupling is expected between hydrogens of C(3) and 
C(4). The exo hydrogen of C(3) in isomer endo-188 was coupled with both the hydrogen 
of C(4) and the exo hydrogen of C(5) providing a triplet at δ 4.82 ppm with a coupling 
constant of 3.5 Hz. These data point to the fact that endo-188 has C‒Pd bond in endo 
position, while exo-188 is the exo isomer as shown in scheme 44. The identity of the endo 
isomer could further be confirmed by comparing the 1H NMR signals of the three methyl 
groups of the camphor fragment as they appear in three compounds: preligand 185 and 
complexes endo- and exo-188. The three methyl groups of the camphor moiety of the endo 
isomer are arranged in a similar pattern to those of the preligand 185 while those in the exo 
isomer are not. The interaction of the acac ligand with (pro-S)-Me at C(7) in the exo isomer 
led to a downfield shift of its 1H NMR signal.    
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X-ray Crystallographic Study of CPC 186 
 The X-ray single crystal study of complex 186 unambiguously proved its dimeric 
and cyclopalladated structure. The molecular structure of the compound and the numbering 
scheme are presented in Fig. 4. To the best of our knowledge, there are no reported crystal 
structures for CN-CPCs with a 2° (sp3)C–Pd bond. However, several crystallographic 
studies of chloro-bridged dimeric five-membered CN-CPCs with 1° (sp3)C–Pd bonds have 
been reported, including structures 90, 177, 181–184, which will be used for comparison 
(Chart 17).63, 181, 276, 277 Only two of these studies describe the molecular structure of a 
cyclopalladated hydrazone with a (sp3)C–Pd bond (182, 183); these hydrazones were 
obtained from tert-butyl methyl ketone.277  
 
Figure 5. ORTEP drawing of the molecular structure of CPC 186. Thermal ellipsoids are 
shown at the 50% probability level. 
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Chart 17. Examples of chloro-bridged dimeric CN-CPCs with an (sp3)C–Pd bond and a 
known molecular structure. 
  
 Complex 186 crystallizes from hexane/dichloromethane in the monoclinic crystal 
system and in the space group P21. The dimeric molecule consists of two independent 
halves, which are slightly different in their structural parameters. The structure showed 
trans geometry of the cyclopalladated ligands typical for the majority of known chloro-
bridged CN-CPCs with a five-membered palladacycle in solid state. The Pd2Cl2 ring in 186 
is almost planar as in many other chloro-bridged CN-CPCs with trans configuration. Four 
torsion angles in the Pd2Cl2 ring are between 2.17 and 2.38 Å. The Pd…Pd distance in the 
complex is 3.466 Å, which is similar to those reported for CN-CPCs with trans-
geometry.278 For comparison, the closest analog 177 has a Pd…Pd distance of 3.500 Å 
while another close analog, 184, possesses very rare cis ligand geometry in solid state and 
displays a significant bending of the Pd2Cl2 ring that results in an unusually short Pd…Pd 
distance of 2.99 Å.63   
 The Pd–Cl bond trans to the metalated carbon is longer, 2.4906 Å (here and later, 
the given values represent the average of two numbers obtained for each half of the dimeric 
molecule), than that trans to the nitrogen, 2.3374 Å (∆ 0.1532 Å). Similar findings were 
reported for trans complexes 90, 177, 181–183, in which the Pd–Cl bond length differences 
are 0.188, 0.169, 0.156, 0.128 and 0.162 Å, respectively.181, 276, 277 For three representative 
chloro-bridged dimeric CN-CPCs with (i) the (sp2)C–Pd bond, (ii) a five-membered 
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palladacycle and (iii) trans ligand geometry, the difference between two Pd–Cl bonds (cis 
and trans to the aromatic carbon) has also been observed, although that difference is 
smaller, 0.1053, 0.125 and 0.131 Å.4, 170, 228, 279 These data reflect a stronger trans influence 
of (i) the carbon donor atom compared to nitrogen and (ii) the (sp3)C atom compared to 
(sp2)C.  
 The (sp3)C–Pd bond length in complex 177 is 1.982 Å. This value is within the 
range reported for complexes 90, 177, 181–184 (1.959–2.034 Å). The (sp3)N–Pd bond 
(2.078 Å) in 186 is a little bit longer than the (sp3)C–Pd bond (1.982 Å), as it is reported 
for other chloro-bridged dimeric CN-CPCs with the (sp2)N and (sp3)C or (sp3)N and (sp3)C 
donor atoms and trans-geometry of cyclopalladated ligands.17, 170, 228, 279, 280 For 
comparison, in complexes 177, 182 and 184, the (sp2)N–Pd bond lengths are 2.037(2) 
1.996(13) and 1.986(1) Å, respectively 63, 277 while in complex 183 the (sp3)N–Pd bond 
length is 2.063(1) Å.277 
 In complex 186, the bite angles C(3)-Pd(1)-N(2) and C(3A)-Pd(1A)-N(2A) are 
equivalent, 80.8(2)o. This value falls in the range reported for compounds 177, 181–183: 
82.27(10), 84.5(1), 80.7(7) and 82.9(6) o, respectively.17, 276, 277 In complex 183 with a 
silicon atom in the metalacycle, the angle reaches 86.81(9)o.181 For comparison, the C-Pd-
N angle for chloro-bridged CPCs with the (sp2)N and (sp2)C donor atoms varies from 80.3 
to 81.2o;170, 228, 279 for the corresponding complexes with (sp3)N and (sp2)C, the C-Pd-N 
bite angle is slightly larger, 80.6−82.8o.278, 280 
 Both palladium atoms in complex 186 are nearly in square-planar coordination with 
a slight tetrahedral distortion. The angle between the planes {N(2)Pd(1)C(3)} and 
{Cl(1)Pd(1)Cl(1A) is only 6.02o; the angle between the corresponding planes 
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{N(2A)Pd(1A)C(3A)} and {Cl(1)Pd(1A)Cl(1A)} is just slightly bigger, 3.60o. It appears 
that such almost ideal square-planar geometry is a characteristic feature of aliphatic 
palladacycles.209  
 Two metalacycles of dimer 177 can be described as slightly twisted envelopes with 
C(10) and C(21) serving as the envelope flaps. To estimate the distortion of each 
metalacycle from planarity, the sum of absolute values of intrachelate torsion angles was 
used as was proposed by Dunina.281 For one of the rings in CPC 177, the sum is 65.67o 
with the average angle of 13.13o. For the second metalacycle, the sum is 31.7o with the 
average angle of 6.34o. The closely related dimer 181 displays a significantly higher 
distortion of the metalacycle with the sum of torsion angles equal to 158o, with an average 
angle of 31.6o.276 For comparison, chloro-bridged CN-CPCs with the (sp2)C and (sp3)N 
donor atoms have the sum of intrachelate torsion angles in the range of 99–135.5o.  
III.1.3. N,N-Diphenylhydrazone of D-Camphor 
 Previously, Kuchin et al. synthesized CPC 190 from camphor N-benzylimine 189 
using Pd(OAc)2 in toluene at 60 °C. Preligand 189 can undergo either palladation at the 
(sp2)C of the phenyl group or at the (sp3)C of the camphor moiety. This research group 
observed regioselective metalation at the (sp2)C of the phenyl group of camphor N-
benzylimine 189 to give CPC 190 in 45% yield (Scheme 45).274, 275, 290  
 
Scheme 45. D-Camphor-derived palladacycles with the (sp2)C−Pd bond. 
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 It was of interest to investigate regioselectivity of cyclopalladation for the related 
preligand, N,N-diphenylhydrazone of D-camphor 191. There are no literature reports on 
N,N-diphenylhydrazone of D-camphor 191. Attempts were made to obtain hydrazone 191 
following the published procedure for the synthesis of the phenylhydrazone of D-camphor 
192 by Schantl et al.291 According to their procedure, N,N-diphenylhydrazine, D-camphor 
and a catalytic amount of AcOH were refluxed for 3 h in ethanol (Scheme 46). 1H NMR 
spectrum of the reaction mixture indicated the presence of the product in ca. 70% yield, 
but upon purification the N,N-diphenylhydrazone of D-camphor completely decomposed 
to D-camphor.  
 
Scheme 46. Synthesis of camphor N,N-diphenylhydrazone 191. 
III.1.4. Phenylhydrazone of D-Camphor 
 The phenylhydrazone of D-camphor (192) was synthesized in 50% yield following 
the published procedure by Schantl et al.291  According to their procedure, D-camphor, 
phenylhydrazine and a catalytic amount of AcOH were refluxed for 3 h in ethanol (Scheme 
47). The structure of the phenylhydrazone product was confirmed using 1H NMR 
spectroscopy. As the authors mentioned, elevated temperatures or traces of acids readily 
converted phenylhydrazone 192 to D-camphor. It is worth noting that we observed 
decomposition of this compound immediately after purification even at rt as the brown oily 
product was turning green. All attempts to cyclopalladate the freshly prepared compound 
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192 using Na2PdCl2/AcONa, Pd(OAc)2 or Pd(CH3CN)2Cl2/NaOAc at rt in aprotic solvents 
such as MeCN and toluene failed due to too rapid decomposition of the preligand to the 
starting carbonyl compound. 
 
Scheme 47. Synthesis of camphor phenylhydrazone 192. 
III.1.5. O-(Diphenylphosphinyl)oxime of D-Camphor 
The aim of this work was to access a chiral aliphatic CP-palladacycle based on D-
camphor. The presence of a phosphorus atom in the desired CPC allows one to use 31P 
NMR spectroscopy for characterization. There are no reports of O-(diphenylphosphinyl)
oxime of D-camphor 193 in literature. The synthesis of the acetone analog has been 
reported by the research groups of Harger and Jennings.292-294 According to their procedure, 
diphenylphosphinic chloride, D-camphor oxime and Et3N were stirred at rt in 
CH2Cl2/petroleum ether for three weeks (Scheme 48). The 
1H NMR spectrum of the 
reaction mixture showed ca. 91% conversion to product 193; however, several attempts to 
isolate this compound in pure form were unsuccessful. 
 
Scheme 48. Synthesis of O-(diphenylphosphinyl)oxime of D-camphor 193. 
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III.1.6. tert-Butylimine of D-Camphor 
The tert-butylimine of D-camphor 194 has not been reported in literature. TiCl4 has 
been shown to be a very effective catalyst for the condensation of sterically hindered 
ketones and alkyl amines to furnish N-alkylimines.295-297 Based on this information, D-
camphor, tert-butylamine and TiCl4 were refluxed in benzene for three weeks (Scheme 49). 
Analysis of the reaction mixture using 1H NMR spectroscopy showed no conversion to the 
product. 
 
Scheme 49. Failed attempt to obtain tert-butylimine of D-camphor 194. 
III.1.7. Thiocamphor 
  A sulfur-containing D-camphor derivative 195 was synthesized in order to attempt 
preparation of the corresponding CS-palladacycle. Since there was a report of the 
cyclopalladation of thioketones,117 we decided to obtain thioketone 195 (also known as 
thiocamphor). Attempts to synthesize this compound by refluxing D-camphor with 
Lawesson’s reagent in toluene were unsuccessful.298 The reaction gave a complex mixture 
that was difficult to separate. The Polshettiwar and Kaushik procedure, according to which 
D-camphor and P4S10/Al2O3 were refluxed in MeCN for 2 h, gave thiocamphor in 51% 
yield (Scheme 50).299 The structure of thiocamphor 195 was confirmed using 1H NMR 
spectroscopy. All attempts to cyclopalladate thiocamphor using Na2PdCl2/AcONa, 
Pd(OAc)2 or Pd(CH3CN)2Cl2/NaOAc led to the formation of D-camphor. 
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Scheme 50. Synthesis and the failed cyclopalladation of thiocamphor 195. 
III.1.8. Oxime of L-Fenchone 
 After succeeding to synthesize and cyclopalladate D-camphor O-methyloxime, we 
decided to try a closely related bicyclic derivative, L-fenchone. Since there is not a single 
report in the literature on the cyclopalladation of any L-fenchone derivative or their 
involvement in palladium-catalyzed reactions, we thought that it would be interesting to 
study their cyclopalladation. The rigidity of inexpensive and naturally optically active L-
fenchone could be an advantageous feature in cyclopalladation and subsequently in the 
applications of the fenchone based CPCs.  
Preparation of CPCs Based on L-Fenchone Oximes and their Spectral Characterization 
 Readily available and inexpensive L-fenchone was converted to two preligands: 
oxime 196a and its O-methyl derivative 196b (Scheme 51). Oximes 196b were synthesized 
using the Kumar and Verma procedure269 according to which a mixture of L-fenchone, 
methoxyamine hydrochloride and NaOAc in ethanol was refluxed for 48 h furnishing the 
desired product in ca. 50:50 isomeric ratio. All attempts to get a single isomer or 
predominantly one isomer ratio did not work. Palladation of oxime 196b using Pd(OAc)2 
in AcOH with the hope that isomerization would occur during this process instead gave an 
inseparable mixture of CPCs. The Jennequin procedure was used to prepare compound 
196a according to which a mixture of L-fenchone, hydroxylamine hydrochloride 
(HONH2
.HCl) and pyridine was refluxed in EtOH for 48 h to afford oxime 196a in 64% 
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yield .267 The 1H and 13C NMR spectra of 196a contained only one set of signals suggesting 
that the oxime was in the form of one isomer.  When HONH2
.HCl was replaced with its O-
methyl analog, oxime 196b was isolated in 82% yield. The 13C NMR spectrum of 196b 
contained two sets of signals; the 94:6 ratio of two geometric isomers was determined by 
integration of two MeO signals in the 1H NMR spectrum. 
 
Scheme 51. Preparation of preligands 196a,b from L-fenchone. 
 Cyclopalladation of oximes 196a,b was accomplished using the same reagent and 
conditions as reported for the preparation of CPC 17717: Pd(OAc)2, AcOH, 80 
oC, 5 h.55, 60 
The dimeric acetato-bridged complexes 197a,b were converted in situ to their chloro-
bridged analogs 198a,b using LiCl in acetone. In a separate reaction, the latter complexes 
were converted to mononuclear derivatives 199a,b using PPh3 as a monodentate auxiliary 
ligand (Scheme 52). Chemical composition and purity of complexes 198a,b and 199a,b as 
well as the fenchone derivative 196b were confirmed by satisfactory elemental analysis. 
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Scheme 52. Preparation of L-fenchone-derived CPCs 198a,b. 
 
 Cyclopalladation of preligands 196a,b and the proposed structures of new 
complexes 198a,b were supported by NMR spectroscopy. The 1H NMR spectra of oxime 
196a300 and its O-methyl derivative 196b contained three 3H singlets in the region of 
1.20−1.35 ppm assigned to the methyl groups at positions 1 and 3. In the 1H NMR spectra 
of complexes 198a,b, one of the three singlets in that region was replaced by two one-
proton signals with the chemical shifts between 2.15 and 2.80 ppm. Compared to oximes 
196a,b, the DEPT spectra of dimers 198a,b contained one more CH2 signal (at 24.6 ppm 
for 198a and at 25.8 ppm for 198b). For comparison, the 1H NMR signals of two 
diastereotopic hydrogens of the PdCH2 group in the camphor-derived complexes 177 and 
180 appeared at 1.55 and 2.59 ppm (180) and 1.89 and 2.41 ppm (177); the 13C{1H} NMR 
signal of the carbon bonded to the metal in complexes 177 and 180 was observed at 30.2 
and 29.9 ppm, respectively.17, 275 13C{1H} NMR spectra of dimers 198a,b in CDCl3 
contained only one set of signals suggesting that these complexes exist in solution as one 
isomer. For comparison, the 13C{1H} NMR spectra of the camphor-derived dimeric 
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complex 177 in CDCl3 and C6D6 contained two sets of signals signifying the existence of 
this complex in solution as a mixture of cis and trans isomers.17 
 1H, 13C{1H} and 31P{1H} NMR spectra of mononuclear CPCs 199a,b in CDCl3 
contained only one set of signals suggesting that these complexes are single geometric 
isomers in solutions. The 13C{1H} NMR signals assigned to the carbon of the PdCH2 
fragment in compounds 199a,b appeared as singlets at 32.8 and 33.0 ppm. The fact that 
these signals appeared as singlets (3JC,P ≈ 0 Hz) may be indicative of the cis position of 
PPh3 relative to the methylene group bonded to the palladium.
24 For comparison, the sp3-
hybridized carbons bonded to the metal in the PPh3 derivatives of 177 and 180 of trans 
geometry provided singlets in the 13C{1H} NMR spectra at 35.1 and 27.0 ppm, 
respectively.17, 275 As reported for related PPh3 derivatives with the (sp
3)C−Pd bond and 
proven trans-N,P geometry,76, 208, 209 one of the two 1H NMR signals of the PdCH2 group 
in 199a,b appeared as a doublet (2JH,H = 10.1 and 10.7 Hz, respectively), while the other 
hydrogen gave a doublet of doublets due to additional splitting on the phosphorus atom 
(3JH,P = 7.2 and 9.0 Hz, respectively). One of the two hydrogens of the PdCH2 fragment in 
both complexes 199a,b provided a signal in a significantly higher field (at 1.09 ppm for 
199a and 0.84 ppm for 199b) compared to the other hydrogen (2.28 and 2.16 ppm, 
respectively). The significant signal shift to a higher field for one of the two hydrogens of 
the PdCH2 group in the 
1H NMR spectra of the PPh3 adducts 199a,b suggests that the 
hydrogen is under the influence of magnetic anisotropy caused by phenyl groups of the 
PPh3 auxiliary ligand.
301-303 This, in turn, suggests trans-N,P geometry of complexes 
199a,b. For comparison, both 1H NMR signals of the PdCH2 group in the chloro-bridged 
CPCs 198a,b were observed above 2.15 ppm. To note, the chemical shift of the signals in 
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the 31P{1H} NMR spectra of 199a,b (19.70 and 20.32 ppm relative to P(OEt)3, 
respectively) is within the range reported for related mononuclear CPCs with the (sp3)C−Pd 
bond, the PPh3 auxiliary ligand, and proven trans-N,P geometry.
76, 208, 209, 304 
X-ray Structural Analysis of Complexes 199a,b 
 Cyclopalladated structure of complexes 199a,b and their trans-N,P geometry were 
unambiguously proven by X-ray crystallographic studies. Molecular structures of the 
complexes and the numbering schemes are presented in Figures 5 and 6. Crystal, data 
collection, and refinement parameters for 199a,b are presented in Table 15–20. The data 
obtained for complexes 199a,b are compared to those reported for dimer 17717 and the 
closely related five-membered CN-palladacycles 200−204 containing the (sp3)C−Pd bond 
and PPh3 as the auxiliary ligand (Chart 18).
74, 76, 208, 209, 304  
 
Chart 18. Examples of PPh3 adducts of CN-CPCs with the (sp
3)C−Pd bond and a known 
molecular structure. 
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Figure 6. ORTEP drawing of the molecular structure of complex 199a. Thermal ellipsoids 
are shown at the 50% probability level. 
 
 
Figure 7. ORTEP drawing of the molecular structure of complex 199b. Thermal ellipsoids 
are shown at the 50% probability level. 
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 Bond lengths in 199a,b are similar to those reported for related complexes.17, 74, 76, 
208, 209, 304 It is noteworthy that the C−Pd bond (2.063 Å) in complex 199b is the longest 
among those found in the related complexes (2.000‒2.051 Å). Interestingly, the Pd−N bond 
(2.115 Å) in the same complex 199b is also the longest among the camphor- and fenchone-
derived CPCs 177 and 199a,b. The Pd−P bond (2.2218 and 2.2250 Å, respectively) in 
199a,b are the shortest among the related CN-palladacycles chosen for the comparison 
(2.2340‒2.2563 Å). 
 The values of the C(1)-Pd-N angle (81.43° and 79.25°, respectively) in both 
complexes 199a,b fall in the range of reported values for related compounds (78.15‒83.43 
°).17, 74, 76, 208, 209, 304 Other bond angles in 199a,b are also similar to those found in 
complexes 177 and 200−203.  
 The palladium atom in complexes 199a,b has square-planar coordination with a 
slight distortion. In both compounds, the torsion angles Pd-N-C(1)-P, Pd-C(1)-P-Cl, Pd-P-
Cl-N and Pd-Cl-N-C(1) have the same sign; therefore, the distortion can be described as 
pyramidal. The distance from the mean plane {PClC(1)N} to the metal in 199a,b is 0.049 
and 0.075 Å, respectively, indicating that the distortion is greater in 199b. The angle 
between the planes {NPdC(1)} and {PPdCl} is equal to 4.3o in 199a and 6.8o in 199b. For 
comparison, the angle between planes {NPdC(1)} and {PPdCl} in the reported 
mononuclear complexes 200 and 201 is equal to 7.7o (the average for four independent 
molecules) and 2.9o, respectively.208, 209  
 Palladacycle’s conformation in complexes 199a,b can be described as a slightly 
twisted envelope with the Pd atom serving as the envelope flap. The sum of absolute values 
of intrachelate torsion angles in the palladacycle of 199a is found to be 93.50o with the 
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average angle value of 18.70o. The metalacycle in 199b is more distorted than that in 199a: 
the sum of absolute values of intrachelate torsion angles in palladacycle 199b is equal to 
123.24o with the average angle value of 24.65o. These values suggest that distortion of 
palladacycles 199a,b from planarity is about average compared to related palladacycles.17 
For example, for the closely related dichloro-bridged dimer 177, the sum of the intrachelate 
torsion angles in palladacycle is 48.69o (the average for two palladacycles in the dimer), 
while the angle sum in the palladacycle of complex 200 is found to be 97.56o. The most 
distorted palladacycle appears to be in complex 201,209 where the sum of intrachelate 
torsion angles reaches 171.24o. 
 A notable feature of the crystal structure of complex 199a is the participation of the 
OH fragment in an intramolecular hydrogen bond with the Cl acceptor. There are two other 
reports of hydrogen bonding involving the oxime group in camphor-derived Pd(II) 
complexes.265, 305 One of these two studies describes the molecular structure of the 
coordination complex PdCl2L2, L = camphor oxime.
265 The authors drew attention to two 
hydrogen bonds involving one of the two Cl atoms and both hydroxyl groups suggesting 
that such a geometry makes the cyclopalladation difficult as it is impossible for the carbon 
atom of CH3(7) to approach the metal. All attempts to palladate camphor oxime with 
halogen-containing Pd salts were unsuccessful.265 Our own attempts to synthesize a CPC 
from this oxime using Pd(AcO)2 also failed. This makes the cyclopalladation of the closely 
related fenchone oxime 196a especially rewarding.  
III.2. Reactions of KPPh2 with CPCs having the (sp3)C–Pd Bond 
 Stoichiometric and catalytic transformations using palladium and other transition-
metal derivatives are rightfully considered a cornerstone of organic and organometallic 
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chemistry. During the last decade, a variety of atom-economical Pd-catalyzed C–H bond 
functionalization reactions have gained recognition as a powerful and versatile synthetic 
approach.306-317 Most recently, the focus of these investigations has shifted toward aliphatic 
C–H bond activation220, 306, 307, 318-321 because possible synthetic applications appear to be 
more diverse and, therefore, more useful. However, metal-catalyzed reactions at the 
(sp3)C–H bond are difficult to achieve in comparison to those at the (sp2)C–H bond171, 306, 
317 due to the absence of both empty low-energy orbitals and filled high-energy orbitals 
that facilitate interaction with orbitals from the metal.306, 322 To attain the C–H bond 
activation by a metal and to increase the regioselectivity of this process, a directing 
heteroatom or auxiliary is introduced into in the substrate structure.317, 323-329 As a result, 
the first step in many Pd-catalyzed C–H bond functionalization reactions is the formation 
of a palladacycle.330 Additionally, it has been noted that many examples of C–H bond 
activation, including cyclopalladation reactions, appear to occur under thermodynamic 
control; therefore, the outcome is dependent on the relative stability of the palladacycle 
and the strength of the nascent C–Pd bond.331 By analogy with data previously reported for 
Rh complexes,331 (sp2)C–Pd bonds are expected to be stronger then (sp3)C–Pd bonds; this 
may explain frequently observed4, 8, 332 (with rare exceptions)47, 51, 54, 63, 76, 136, 139, 208, 333 
regioselective aromatic cyclopalladation in the presence of a competing aliphatic fragment. 
Besides the C–Pd bond forming step, a typical catalytic cycle includes the reaction of this 
bond with a second reagent. Therefore, investigating possible Pd-catalyzed C–H bond 
functionalization transformations by a certain reagent, it is important to consider the 
reactivity of the corresponding C–Pd bond toward that chemical. The fact that 
palladacycles are intermediates of the auxiliary-directing Pd-catalyzed C–H bond 
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functionalization reactions warrants further studies of stoichiometric reactions of 
cyclopalladated complexes (CPCs), particularly those with the (sp3)C–Pd bond. 
 Despite the abundance of reported reactions at the C–Pd bond of palladacycles,137, 
196, 334 there are only a limited number of transformations involving the (sp3)C–Pd bond. 
Moreover, most of these infrequent studies describe reactions at the benzylic position. The 
earliest examples of reactions at the (sp3)C–Pd bond of CPCs were reported by the Pfeffer 
group.56, 335, 336 They investigated mono- and bis-insertions of hexafluorobutyne and other 
electron-deficient alkynes into the C–Pd bond of various CN-CPCs including dimeric 
complexes obtained from N,N-dimethyl-o-toluidine. Later, the same group reported 
reactions of benzyl isocyanide with several CS-CPCs, including one with a benzylic C–Pd 
bond and one with an aliphatic C–Pd bond (derived from methyl 2,2-dimethylphenyl 
sulfide and tert-butyl phenyl sulfide, respectively).112 The same CPCs were also tested in 
reactions with CO at rt; however, only the complex obtained from tert-butyl phenyl sulfide 
provided a new insertion product.112 The authors noted that (i) the yields of the isocyanide 
insertion products were comparable for all studied CPCs regardless of the hybridization of 
the carbon atom bonded to the metal and (ii) CS-palladacycles were more reactive towards 
insertion reactions of isocyanides and CO compared to CN-analogs. 
 In 1984, Carr and Sutherland studied the iodination of an aliphatic five-membered 
C,N palladacycle with I2.
65 Later, chlorinations using Cl2
337 and Et3BnNCl
137 were reported 
for one C,N and one C,S complex, respectively. In 2005, the Yu group described the 
iodination of 2,4-di-tert-butyl-2-oxazoline with I2 using stoichiometric and catalytic 
amounts of Pd(OAc)2.
338 The CPC used in the Yu study was first synthesized by Balavoine 
and Clinet, who reacted the complex with methyl vinyl ketone, MeI, n-BuI, allyl iodide 
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and CO with and without MeOH to give substituted oxazolines with new C–C bonds. 
However, no information was provided about the products formed in these reactions except 
for the yields.25 
 Several research groups reported oxidation of CN-CPCs obtained from oximes with 
bulky alkyl substituents.59, 61, 339, 340 The formation of an (sp3)C–(sp2)C bond was observed 
in the reaction of Me3SnPh with a CP-palladacycle having a benzylic C–Pd bond.341 All of 
these reports suggest that palladacycles with benzylic and aliphatic (sp3)C–Pd bonds can 
be used in the same reactions as analogous (sp2)C–Pd-bonded CPCs; however, no proper 
comparison of their reactivity can be made because of the limited data available.  
 Our group14, 15, 342 and others243, 258, 259 have investigated reactions of CPCs with 
lithium and potassium phosphides to form aminophosphines and related bidentate ligands 
(Scheme 53). All CPCs used in these studies contained an (sp2)C–Pd bond. In this section 
of the dissertation, we report our data on reactivity of CN-, CP- and CS-palladacycles with 
an (sp3)C–Pd bond toward KPPh2 and compare these results with the those reported for the 
(sp2)C–Pd-bonded CPCs in the same reaction.  
 
Scheme 53. Formation of bidentate ligands by reacting MPPh2 with dimeric CPCs 
containing an (sp2)C–Pd bond. 
 Previously, we showed that both LiPPh2 and KPPh2 are capable of reacting with 
dimeric chloro-bridged CPCs.14, 15 However, the outcome of the LiPPh2 reactions with 
CPCs was highly sensitive to the phosphide structure in the solution, which in turn, 
depended on the preparation method, concentration and age of the chemical. KPPh2 in a 
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solution appears to exist only in a monomeric form, and reactivity of the commercial 
reagent and the one prepared in our lab from ClPPh2 and K was proven to be the same. In 
the present investigation, we used only commercially available KPPh2 as a phosphide 
source.  
 The dimeric dichloro-bridged CN-CPC 177 derived from O-Me camphor oxime17 
was chosen as a model complex for our study. Complex 177 reacted with 4.5 equiv. of 
KPPh2 in THF at rt for 18 h to give the desired NP-ligand 205 in 21% yield (Scheme 54). 
The conditions used for this transformation were the same as those previously reported in 
reactions with CPCs derived from aromatic substrates,14, 15, 342 but the obtained yield of the 
phosphine was less than half.14, 15 Increasing the reaction temperature to 40 oC resulted in 
5% yield of 205. Considering that the bidentate ligand 205 might be coordinated to the 
metal, 1,2-bis(diphenylphosphino)ethane was added at the end of the room temperature 
reaction to release the NP-ligand in its free form. The yield, indeed, was improved, but not 
significantly (28%).  
 
Scheme 54. Reaction of CPC 177 with KPPh2. 
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 In an attempt to improve the yield of the camphor-based phosphine 205 and learn 
more about this reaction, the dimeric CPC 177 was reacted in THF with 1 equiv. of KPPh2 
(corresponds to a 1:2 ratio of Pd and PPh2). As in the previously reported reactions of CPCs 
with 1 equiv. of KPPh2,
15 no phosphine 205 was formed and only complex 206 was isolated 
(Scheme 54). The best yield of this complex (31%) was obtained when the reaction time 
was shortened to 1 h. 
 Then, the reaction of CPC 177 with 4.5 equiv. of KPPh2 was performed using the 
standard conditions (THF, 18 h, rt) with a modified purification procedure. Use of ethyl 
acetate instead of halogenated solvents allowed for isolation of the unstable complex 207 
(24%), which presumably has a dimeric structure with two PPh2 bridges. Phosphine 205 
was obtained from the same reaction in 17% yield. Further chromatographic purification 
of complex 207 using CH2Cl2 provided several compounds, some of which were isolated 
in a pure form or identified using 31P{1H} NMR data. The μ-Cl-μ-PPh2 complex 206 and 
HP(O)Ph2 were obtained in 16% and 5% yield, respectively, and phosphine 205 was 
detected by 31P{1H} NMR (<5% yield). The 31P{1H} NMR spectrum of one of the fractions 
contained the singlet of complex 207 at δ -64.7 ppm [in C6D6 relative to P(OEt)3] and two 
doublets, δ 21.8 and 113.5 ppm, JPP = 36 Hz. We hypothesize that these doublets belong to 
compound 208, which can be formed by reacting free phosphine 205 with complex 207 
(Scheme 55). The 31P{1H} NMR chemical shift of 123.2 ppm has been reported for 
complexes with the PAr2 group as a terminal ligand bonded to Pd(II)
343 (cf. the chemical 
shift of -7.8 ppm for the terminal PPh2 ligand bonded to Pt),
344, 345 while the chemical shifts 
in a range of 20–35 ppm are typical for tertiary phosphines bonded to Pd(II) as terminal 
ligands.342, 346 The value of the coupling constant suggests that there are two phosphorus 
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atoms in complex 208 that are cis to each other. Also, the values of the 31P NMR chemical 
shifts and the coupling constant of compound 208 are remarkably similar to the analogous 
complex 209 (Figure 8), which was previously isolated and fully characterized (including 
a satisfactory elemental analysis).347 According to the transphobia concept,348, 349 
complexes of type 208 and 209 are expected to have a terminal PPh2 group cis to the CH2 
fragment of the cyclopalladated ligand. Thus, we suggest that the diphosphido-bridged 
complexes of type 207 can a) slowly produce the corresponding N,P ligands (in this case 
205) as a result of reductive elimination and b) react with other ligands, including 
compound 205, to form mononuclear complexes of type 208 and 209. 
 
Scheme 55. Proposed reaction of dimer 207 with phosphine 205. 
 
Figure 8. Structure of complex 209. 
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 To test whether the μ-Cl-μ-PPh2 complex 206 could be converted to its di-μ-PPh2 
analog 207 and/or phosphine 205, it was reacted with 1 equiv. of KPPh2. Two compounds 
were isolated after preparative TLC: free N,P ligand 205 in 23% yield and complex 207 in 
14% yield. It is noteworthy that the μ-Cl-μ-PPh2 CPC obtained from N,N-
dimethylbenzylamine can also be converted to the corresponding free aminophosphine in 
38% yield by reacting with LiPPh2.
342  
 Next, we studied whether the free phosphine could be obtained directly from the 
di-μ-PPh2 CPC 207 by reacting it with 2.5 equiv. of KPPh2 in THF. To our surprise, after 
18 h at rt, no free phosphine 205 was detected in the 31P{1H} NMR spectrum of the reaction 
mixture. Chromatographic separation of the reaction mixture allowed for 31% recovery of 
the starting complex 207. Carrying out the same reaction over 36 h provided no free 
phosphine either.  In the third experiment, which lasted 96 h, the non-coordinated NP-
ligand 205 was finally isolated in 27% yield. Therefore, the di-μ-PPh2 CPC 207 can be 
converted to compound 205 by reaction with KPPh2; however, this produces the NP-ligand 
much more slowly than the direct reaction of CPC 177 with 4.5 equiv. of KPPh2 in THF. 
In another experiment, the di-μ-PPh2 dimer 207 was treated with 2 equiv. of LiCl before 
addition of 2.5 equiv. of KPPh2. The 
31P{1H} NMR spectrum of the reaction mixture after 
18 h at rt already contained the signal of non-coordinated phosphine 205 suggesting that 
the reaction of complex 207 with KPPh2 to give phosphine 205 is faster in the presence of 
chloride ions.  
 The 31P{1H} NMR spectra of the sample from the reaction of CPC 177 with 4.5 
equiv. of KPPh2 (rt, 18 h) had signals of free phosphine 205, complex 207, PPh2PPh2 and 
its monoxide, as well as several compounds, which we could not identify, including two 
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complexes apparently having two different P atoms cis to each other and separated by two 
bonds (JPP = 30–40 Hz). The formation of PPh2PPh2 and its monoxide was also observed 
in all other reactions of CPCs with metal phosphides.  
 Encouraged by our results for the camphor-based complex 177, we tested the 
fenchone-derived CPC 198353 in reactions with KPPh2. The reaction of CPC 198 with 4.5 
equiv. of KPPh2 in THF furnished the enantiopure NP-ligand 210 (δ -37.1 ppm) in 51% 
yield (Scheme 57). Using 1 equiv. of KPPh2, CPC 198 was converted to the µ-Cl-µ-PPh2-
bridged derivative 211 (δ 2.2 ppm) in 56% yields (Scheme 57). 1H, 13C{1H} and 31P{1H} 
NMR data for complex 211 suggest that this and other µ-Cl-µ-PPh2-bridged CPCs reported 
in the literature,14, 15, 342 as well as the others described in this study, exist in solutions as 
single isomers with trans-N,P geometry. 
 
Scheme 56. Reactions of the fenchone-derived CPC 198 with KPPh2. 
 
 The 8-methylquinoline-derived complex 21242 studied next differs from the 
previously used CPCs 177 and 198 by having a benzylic carbon bonded to the metal. 
Reactions of CPC 212 with 4.5 equiv. of KPPh2 at rt gave only 8-methylquinoline (Scheme 
58). The isolation of free preligands was previously reported in KPPh2 reactions with CPCs 
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containing an (sp2)C–Pd bond14 as well as in the Pd-catalyzed phosphination reactions of 
aryl triflates with PPh3.
354 The formation of such products can be explained by β-hydride 
elimination of the alkoxide-containing Pd(II) intermediate,14 which could be formed after 
the adventitious cleavage of a C–O bond in THF by the phosphide.342 
 
Scheme 57. Reactions of CPCs 212 with KPPh2. 
 
 When 1 equiv. of KPPh2 was used in the reaction, the µ-Cl-µ-PPh2-brigded 
derivative 214 was isolated in 56% (Scheme 58). The 31P{1H} NMR spectrum of complex 
214 had a singlet at δ 10.2 ppm [CDCl3 relative to P(OEt)3] and matched the data for this 
complex prepared by a different method.347 
 Complex 212 had a limited solubility in THF. To test if the more soluble complex 
μ-OAc-212 could provide the phosphination product 215, the reaction of this CPC with 4.5 
equiv. of KPPh2 at rt was carried out. Preparative TLC provided a mixture of the desired 
product 215 and its oxide 216. In the next experiment, air was bubbled through the reaction 
mixture for 18 h before preparative TLC. The change in the work-up resulted in the 
isolation of compound 216 in 21% (Scheme 59). This reaction is the first example of 
converting acetato-bridged CPCs to the corresponding phosphines (or phosphine oxides) 
using metal phosphides. 
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Scheme 58. Reaction of CPC μ-OAc-212 with 4.5 equiv. of KPPh2. 
 
 It was of interest to investigate KPPh2 reactivity toward CPCs with donor atoms 
other than nitrogen such as trimesitylphosphine-derived complex 217103 containing a 
benzylic C–Pd bond. This compound reacted with 4.5 equiv. of KPPh2 at rt to provide only 
the free preligand 218 (Scheme 60). 
 
Scheme 59. Formation of compound 218 in the reaction of CPC 217 with KPPh2. 
 
 Reactions of KPPh2 with two tri-ortho-tolylphosphine-derived complexes, 
dichloro-bridged dimer 219 and its acetato-bridged analog μ-OAc-21931 were investigated 
as well. In all experiments with these two CPCs, air was bubbled into the reaction mixtures 
before purification to ensure oxidation of the phosphine product. Reaction of complex 219 
furnished phosphine oxide 220 in 20% yield (Scheme 61). In contrast to the KPPh2 
reactions with the 8-methylquinoline-derived CPCs, the use of μ-OAc-219 instead of its 
chloro-bridged analog provided only traces of the phosphination product 220. It is worth 
mentioning that, according to 31P NMR data, only one of the two phosphino groups in the 
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product was oxidized. In both reactions, along with compound 220, tri-ortho-
tolylphosphine 211 was isolated as well (Scheme 61).  
 
Scheme 60. Reaction of complexes 219 and μ-OAc-219 with KPPh2. 
 
 Finally, the reactivity of the CS-CPC 222111 was studied. This complex reacted with 
4.5 equiv. of KPPh2 to provide the phosphination product 223 in low yield. Because of the 
rapid conversion of 223 to the corresponding oxide 224 during purification, the crude 
product was oxidized before preparative TLC. The best yield of the phosphine oxide was 
22%. It is noteworthy that a significant amount of the free sulfide 225 was isolated in all 
reactions of CPC 222 (Scheme 62). 
 
Scheme 61. Reaction of CPC 222 with KPPh2. 
 
2.2. Structure confirmation  
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 According to the literature,355, 356 non-coordinated tertiary phosphines provide 
31P{1H} NMR signals in the -70 to +70 ppm interval (relative to H3PO4), diphenyl-
substituted tertiary phosphines give signals with negative chemical shift values, and signals 
of phosphine oxides usually have positive chemical shift values between 10 and 30 ppm. 
The spectra of the synthesized phosphines 205 and 210 contained a single peak at -23.2 
and -37.1 ppm [relative to P(OEt)3], respectively. These phosphines were slowly, within a 
week, oxidized by oxygen in air to give corresponding phosphine oxides with 31P{1H} 
NMR signals at δ 15.1 and 15.0 ppm, respectively. 31P{1H} NMR spectra of phosphine 
oxides 216 and 224 exhibited singlets at δ 16.5 and 15.0 ppm, respectively, whereas the 
spectrum of product 9f with two phosphorus atoms contained two doublets at δ -45.1 and 
15.4 ppm (4JP,P = 9.2 Hz).  
 1H and 13C{1H} NMR signals of the CH2P fragment in compounds 205 and 210 
and 226, 216, 220 and 224 displayed JH,P and JC,P coupling constants. Diastereotopic 
hydrogens of the CH2P group in 205 and 210 and 226 (Figure 9) provided two doublets of 
doublets between δ 2.15 and 3.06 ppm. The 1H NMR signal of the benzylic CH2 group 
bonded to the phosphorus atom in phosphine oxides 216, 220 and 224 appeared as a doublet 
between δ 4.00 and 4.56 ppm. It is noteworthy that the values of the coupling constant 2JH,P 
for phosphines 205 and 210 were 3.5 and 4.1 Hz, while those for phosphine oxides 226, 
216, 220 and 224 were much larger: 16.0, 14.2, 9.6 and 14.1 Hz, respectively. The 
difference in the values of coupling constants when comparing phosphines to phosphine 
oxides was especially noticeable in 13C{1H} NMR spectra. The CH2P group in phosphines 
205 and 210 gave a doublet at δ 27.5 and 30.7 ppm with 1JC,P equal to 18 and 13 Hz, 
respectively. The 13C{1H} NMR signal of the same group in phosphine oxides 226, 216, 
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220 and 224 appeared between δ 27.3 and 36.6 ppm and displayed the coupling constant 
1JC,P in a range of 67−73 Hz. The oxidation of the phosphino group in compounds 226, 
216, 220 and 224 was also confirmed by IR spectroscopy. IR spectra of these compounds 
had an absorption band at 1187−1199 cm-1 assigned to the stretching vibrations of the P=O 
group.357 The elemental composition of phosphines 205 and 210 and phosphine oxides 213, 
221 and 225 was confirmed by HRMS data.  
 
Figure 9. Oxide of 205. 
 Pd(II) complexes with both a chloro and phosphido bridge are rather uncommon in 
the literature.15, 342, 358-361 Moreover, there are only two known cyclopalladated complexes 
of this type. They were obtained from N,N-dimethylbenzylamine15, 342 and its α-tert-butyl-
derivative.361 Three isomers can be predicted for such complexes; however, it was shown 
that in the solid form361 and in a solution,342 they exist as syn isomers with the trans-N,P 
ligand configuration. The μ-Cl-μ-PPh2 Pd(II) complex (206) obtained in this study 
presumably have a syn configuration with the PPh2 bridging ligand trans to both nitrogen 
atoms. The 31P{1H} NMR spectra of CPC 206 in CDCl3 exhibited a singlet at δ 4.9 ppm, 
respectively. In the 13C{1H} NMR spectra of this complex, the signal of the CH2Pd 
fragment appeared as a doublet (2JC,P = 2.2 Hz) at 19.4 ppm. For comparison, the reported 
complex of this type synthesized from N,N-dimethylbenzylamine provided the 31P NMR 
signal at δ 25.1 ppm (2JC,P = 1.8 Hz).342 The 1H NMR spectra of complex 206 confirmed a 
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1:2 ratio of the PPh2 group and cyclopalladated ligands in it structure. The elemental 
composition and purity of this compound was confirmed by satisfactory elemental analysis.   
 Di-μ-PPh2 complexes of Pd(II) and especially Pt(II) are well known.362-366 
However, to the best of our knowledge, only one cyclometallated derivative of this type 
has been reported, the Pt(II) complex derived from 7,8-benzoquinoline.367 Unfortunately, 
only the X-ray crystallographic data for this compound are available. The 31P{1H} NMR 
spectra of known di-μ-PPh2 Pd(II) complexes usually have the signals of the bridging PPh2 
group between -100 and -140 ppm.362, 363, 365, 368 In the present study, we were able to isolate 
complex, 207, which presumably have dimeric cyclopalladated structure with two bridging 
PPh2 ligands. The 
1H NMR spectrum of the oxazoline-derived analog of complex 207 
previously synthesized in our lab suggests a 1:1 ratio of the PPh2 fragment and the 
cyclopalladated ligand. The 31P{1H} NMR spectrum of the same compound in CDCl3 
exhibited a lone singlet at δ -85.1 ppm (-72.5 ppm in C6D6), which suggests the anti 
configuration of the cyclopalladated ligands. The 13C{1H} NMR signal of the CH2Pd 
fragment in oxazoline-derived analog of complex 207 appeared at δ 42.2 ppm as a triplet 
with JC,P equal to 55.1 Hz. Regrettably, the camphor-derived complex 207 could not be 
obtained in the pure form to allow its complete characterization by NMR spectroscopy. 
The 1H NMR spectrum of this compound was too complex to assign all signals; however, 
the signal integration suggested a 1:1 ratio of the PPh2 fragment and the cyclopalladated 
ligand. The only reliable spectroscopic data for this complex that can be reported are its 
31P{1H} NMR signal at δ -64.8 ppm in C6D6 and -76.9 ppm in CDCl3.  
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CONCLUSIONS 
 As a result of the experimental work, all three major goals (see page 47) have been 
accomplished. 
 1. Enantiopure D-camphor O-methyloxime, L-fenchone oximes and camphor N,N-
dimethylhydrazone were synthesized according to published procedures in 64‒89% yield 
from readily available compounds in the chiral pool. Structures of these preligands were 
confirmed using NMR spectroscopy.  
 2. Direct cyclopalladation of D-camphor O-methyloxime, L-fenchone oximes and 
camphor N,N-dimethylhydrazone with Pd(OAc)2 and/or Pd(MeCN)2Cl2, afforded new 
optically active aliphatic cyclopalladated complexes in 49‒92% yield. NMR spectral and 
single crystal X-ray crystallographic studies were used to confirm the presence of an 
(sp3)C–Pd bond in the complexes.  
 3. Phosphination reactions of new complexes derived from the O-methyloximes of 
D-camphor and L-fenchone as well as other dimeric CN-, CP- and CS-CPCs with an 
(sp3)C–Pd bond were investigated. Using 4.5 equiv. of KPPh2, CPCs were converted to the 
corresponding phosphines or phosphine oxides in 20–51% yield. When CPCs reacted with 
1 equiv. of KPPh2, unique mono-chloro-mono-phosphido-bridged CPCs were isolated in 
31‒56% yield. 
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CHAPTER VI 
EXPERIMENTAL 
VI.1. General Methods and Materials 
Routine 1H (500 MHz) and 13C{1H} (126 MHz) as well as DEPT, COSY, and 
HSQC NMR spectra were recorded on a Bruker AVANCE 500 NMR spectrometer. 
Chemical shifts are reported in ppm with SiMe4 as an internal standard (
1H and 13C) or 
P(OEt)3 as an external standard (
31P). Spin-spin coupling constants, J, are given in Hz.  
Spectra were recorded in CDCl3 unless stated otherwise.  IR spectra were recorded on a 
Perkin Elmer Spectrum 400 FT-IR/FT-FIR Spectrometer.  Melting points were measured 
on a Laboratory Devices Mel-Temp apparatus and are uncorrected.  Optical rotations were 
measured at rt on a Rudolph Autopol III automatic polarimeter in a 1-dm tube.  Elemental 
analyses were carried out by Atlantic Microlabs Inc., Norcross, GA.  Analytical TLC was 
performed on Whatman silica gel 60 (F254) 250 precoated plates.  Preparative TLC was 
carried out using 200 × 250 mm glass plates with an unfixed layer of Merck silica gel 60 
(230 mesh) containing ca. 5% of silica gel with fluorescent indicator (Aldrich). Compounds 
were visualized on TLC plates using UV light (254 nm) and/or iodine stain. Methoxyamine 
hydrochloride, hydroxylamine hydrochloride and L-(-)-fenchone were purchased from 
Acros Organics Co., PPh3 from Eastman Kodak, D-camphor {[α]D = +44.1o (c = 10.0, 
EtOH)} from Fisher Scientific.  These reagents were used as purchased as their purity was 
confirmed by 1H NMR spectroscopy. Pd(OAc)2 purchased from Aldrich was purified by 
dissolving in hot benzene, filtering the solution
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and removing the solvent on a rotavapor.  NaOAc and Pd(OAc)2 were dried in vacuum 
prior to use. Benzene, CH2Cl2, hexane and ethyl acetate were distilled over CaH2. Toluene 
and THF were dried by refluxing over K/benzophenone ketyl and distilled under Ar 
immediately before starting a reaction. These reagents were used as purchased. The 
enantiometric purity of L-(-)-fenchone was 97%, [α]24D - 48.9 (neat). Other chemicals were 
acquired from Sigma-Aldrich Co. and were used without purification unless indicated. 
VI.2. Preparation of D-Camphor Derivatives and Their Cyclopalladation 
 Compounds 174b, 185, 191, 192 and 195 were synthesized using published 
procedures.269, 282, 283, 291, 299 The NMR spectra of the obtained compounds matched those 
reported in the literature.  
VI.2.1. Synthesis and Characterization of New Compounds 
 (1R,4R)-1,7,7-Trimethylbicyclo[2.2.1]heptan-2-one O-Methyloxime (D-
Camphor O-Methyloxime (174b). Enantiopure D-camphor (0.2000 g, 1.314 mmol) was 
added to a solution of methoxylamine hydrochloride (0.3007 g, 3.600 mmol) and sodium 
acetate (0.4676 g, 5.700 mmol) in water (1.2 mL). Ethanol (2 mL) was added, and the 
mixture was refluxed for 48 h. The mixture was then filtered to remove any solid residue, 
and ethanol was evaporated under reduced pressure to get an oily residue. The crude 
product was purified by extraction using CH2Cl2 (5 mL × 3). The combined organic layers 
were dried over Na2SO4. After filtration, the solvent was removed on a rotavapor to obtain 
the pure product as a colorless oil in 74% (0.1744 g, 0.9625 mmol). According to the 1H 
NMR spectrum, the product was a mixture of two geometric isomers in a ratio of 92:8.  Rf 
0.60 (100:1 hexane‒acetone); [α]22D -29.7, [α]22546 -42.7, [α]22435 -67.9 (c 0.781, EtOH). IR 
(film, ν, cm-1): 1654 and 1667 (C=N), 1045 (N-O). 1H NMR (δ, ppm) [63]: 0.80 (s, 3H, 
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CH3), 0.91 (s, 3H, CH3), 1.02 (s, 3H, CH3), 1.22 (ddd, 1H, 
2J5endo,5exo = 12.8, 
3J5endo,6endo = 
9.3, 3J5endo,4 = 4.2, H(5endo)), 1.45 (ddd, 1H, 
2J6endo,6exo = 14.5, 
3J6endo,5endo = 9.3, 
3J6endo,5exo 
= 4.4, H(6endo)), 1.69 (td, 1H, 2J6exo,6endo = 
3J6exo,5exo = 12.0, 
3J6exo,5endo = 4.3, H(6exo)), 
1.82 (m, 1H, H(5exo)), 1.86 (t, 1H, 3J4,5exo = 
3J4,3exo = 4.3, H(4)), 1.98 (d, 1H, 
2J3endo,3exo = 
18.1, H(3endo)), 2.47 (dt, 1H, 2J3exo,3endo = 18.1, 
3J3exo,4 = 
4J3exo,5exo = 4.3, H(3exo)), 3.73 
(minor isomer) and 3.82 (major isomer) (two s, 3H, OCH3). 
13C{1H} NMR (δ, ppm): 11.2, 
18.6, 19.5 (three CH3), 27.4 (CH2, C(5)), 32.9 (CH2, C(6)), 33.6 (CH2, C(3)), 43.8 (CH, 
C(4)), 48.1 and 51.6 (two quat. C, C(1) and C(7)), 61.2 (OCH3), 169.2 (C=N).  
 (1R,4R)-Dichlorobis{2-(methoxyimino)-1,7,7-
trimethylbicyclo[2.2.1]heptane}palladium(II) (175). To a small, one-neck round-
bottomed flask containing a magnetic stirring bar and camphor oxime 174b (0.0245 g, 
0.135 mmol), Na2PdCl4 (0.0206 g, 0.0700 mmol) was added. Abs. MeOH (1 mL) was 
added as well, and the flask was covered with a stopper.  After stirring the mixture at rt for 
18 h, MeOH was removed on a rotavapor. The red-brown crude product was purified using 
preparative TLC (silica gel, 5:1 hexane‒acetone). The pure product was isolated as a 
yellow powder in 67% yield (0.0168 g, 0.0468 mmol). Mp: 180–182 °C; Rf 0.36 (99:1 
benzene‒acetone); [α]22D +50.3, [α]22546 +44.4 (c 0.0510, EtOH).  IR (Nujol mull, ν, cm-1): 
1655 (C=N). 1H NMR (δ, ppm): 0.84 (minor isomer) and 0.87 (major) (two s, 3H, CH3), 
0.94 (minor) and 0.98 (major) (two s, 3H, CH3), 1.22 (m, 1H, H(5endo)), 1.81–1.99 (m, 
4H, H(5exo, 6endo, 6exo, 4)), 2.29 (d, 1H, 3J3endo,3exo = 18.5, H(3endo)), 2.42 (s, 3H, CH3), 
2.80 (m, 1H, H(3exo)), 4.20 (major) and 4.51 (minor) (two s, 3H, OCH3). 
13C{1H} NMR 
(δ, ppm): 14.8, 19.2, 20.4 (three CH3), 27.2 (CH2, C(5)), 32.4 (CH2, C(6)), 38.6 (CH2, 
C(3)), 43.5 (CH, C(4)),  50.3 (C, C(7)), 55.4 (C, C(1)), 62.5 (OCH3, C(10)), 188.0 (C=N). 
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Anal. Calcd for C22H38Cl2N2O2Pd: C, 48.94; H, 7.09; N, 5.19. Found: C, 48.94; H, 7.18; 
N, 5.21%. 
 (1S,4R)-Di-µ-chlorobis{[2-(methoxyimino)-7,7-
dimethylbicyclo[2.2.1]heptyl]methyl-C,N}dipalladium(II) (177). To a 10-mL one-neck 
round-bottomed flask containing a magnetic stirring bar, camphor oxime 174b (0.0797 g, 
0.440 mmol), Pd(OAc)2 (0.0987 g, 0.440 mmol) and glacial acetic acid (19 mL) were 
added. The resulting mixture was stirred at 80 °C for 5 h. The solvent was removed under 
reduced pressure to give a brown oily residue of the crude acetate-bridged analog of 176. 
Abs. acetone (19 mL) was added to the crude product followed by introduction of LiCl 
(0.0746 g, 1.76 mmol). The mixture was stirred at rt for 18 h. The solution was then filtered 
through celite (h = 1 cm), and the flask with the filtrate was placed on a rotavapor to remove 
acetone. The crude product was purified using preparative TLC (silica gel, 99:1 benzene‒
acetone). The pure product was isolated as an orange-yellow powder in 66% yield (0.0936 
g, 0.145 mmol). Mp: 204‒206 °C; Rf 0.56 (99:1 benzene‒acetone); [α]22D -164, [α]22546 -
201, [α]22435 -307 (c 0.100, EtOH).  IR (Nujol mull, ν, cm-1): 1662 (C=N). 1H NMR (δ, 
ppm): 0.80 (s, 3H, CH3), 0.93 (s, 3H, CH3), 1.32 (t, 1H, 
2J5endo,5exo = 
 3J5endo,6endo = 9.4, 
H(5endo)), 1.89 (m, 4H, H(5endo), H(6endo), PdCHA, H(3exo)), 2.06 (m, 1H, H(6exo)), 
2.14 (t, 1H, 3J4,3exo = 
3J4,5exo = 4.0, H(4)), 2.41 (m, 2H, 
2J3endo,3exo = 18.1, 
3J3exo,4  = 4.0, 
H(3exo), PdCHB), 3.78 (s, 3H, OCH3). 
13C{1H} NMR (δ, ppm): 18.3 and 19.6 (two CH3), 
26.7 (CH2, C(5)), 31.9 (CH2, C(6)), 33.3 (CH2, C(3)), 46.7 and 66.4 (two quat. C, C(1) and 
C(7)), 47.6 (CH, C(4)), 62.2 (OCH3), 193.6 (C=N). 
1H NMR (C6D6, δ, ppm): 0.42 (s, 3H, 
CH3), 0.56 (s, 3H, CH3), 0.74 (ddd, 1H, 
2J5endo,5exo = 12.5, 
3J5endo,6endo = 9.2, 
3J5endo,6exo = 
4.2, H(5endo)), 1.34 (m, 1H, H(5exo)), 1.43 (d, 1H, 2J3exo,3endo = 19.0, H(3endo)), 1.47 (t, 
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1H, 3J4,5exo = 
3J4,3exo = 4.0, H(4)), 1.51 (m, 1H, H(6endo)), 1.71 (ddd, 1H 
2J6endo,6exo = 13.0, 
3J6exo,5exo = 9.2, 
3J6exo,5endo = 4.2, H(6exo)), 1.96 (dt, 1H, 
2J3endo,3exo = 18.8, 
3J3exo,4 = 
3J3exo,5exo 
= 4.0, H(3exo)), 2.22 (d, 1H, 2JH,H = 8.0, PdCH
A), 2.58 (d, 1H, 2JH,H = 8, PdCH
B), 3.79 (s, 
3H, OCH3). Minor isomer: 2.06 and 2.42 (two br. s, PdCH
A and PdCHB), 3.87 (s, 3H, 
OCH3). The isomer ratio in C6D6 solution was 5:2. 
13C{1H} NMR (C6D6, δ, ppm): 16.7 and 
18.1 (two CH3), 25.3 (CH2, C(5)), 30.5 (CH2, C(6)), 31.8 (CH2, C(3)), 45.0 and 65.0 (two 
quat. C, C(1) and C(7)), 46.2 (CH, C(4)), 60.9 (OCH3), 191.0 (C=N). Anal. Calcd for 
C22H36Cl2N2O2Pd2: C, 41.01; H, 5.63; N, 4.35. Found: C, 41.02; H, 5.69; N, 4.38%. 
 (1S,4R)-Chloro{[2-(methoxyimino)-7,7-dimethylbicyclo[2.2.1]heptyl]methyl-
C,N}(triphenylphosphine-P)palladium(II) (178). To a 25-mL round-bottomed flask 
containing a magnetic stirring bar and CPC 177 (0.0148 g, 0.0230 mmol), abs. acetone (8 
mL) and PPh3 (0.0121 g, 0.0460 mmol) were added. The resulting mixture was stirred at rt 
for 18 h. The solvent was removed under reduced pressure to give a pale-yellow residue. 
The crude product was purified using preparative TLC (silica gel, 1:2 ethyl acetate‒
hexane). The pure product was isolated as a pale yellow powder in 98% yield (0.0263 g, 
0.0450 mmol). Mp 198‒200 °C; Rf 0.40 (1:2 ethyl acetate‒hexane); [α]22D -237, [α]22546 -
277, [α]22435 -462 (c 0.0730, EtOH).  IR (Nujol mull, ν, cm-1): 1662 (C=N).  1H NMR (δ, 
ppm): 0.53 (dd, 1H, 2JH,H = 10, 
3JH,P = 8, PdCH
A), 0.56 (s, 3H, CH3), 0.84 (s, 3H, CH3), 
1.29 (ddd, 1H, 3J6endo,5endo = 12.5, 
2J5endo,5exo = 9.5, 
3J5endo,6exo = 4.2, H(5endo)), 1.61 (td, 
1H, 2J6exo,6endo = 
3J6endo,5endo = 12.5, 
3J6endo,5exo = 4.2, H(6endo)), 1.80 (m, 1H, H(5exo)), 1.86 
(d, 1H, 2JH,H = 10, PdCH
B), 1.96 (ddd, 1H, 2J6exo,6endo = 12.5, 
3J6exo,5exo = 9.3, 
3J6exo,5endo = 
4.2, H(6exo)), 2.02 (d, 1H, 2J3endo,3exo = 18.7, H(3endo)), 2.07 (t, 1H, 
3J4,5exo = 
3J4,3exo = 4.3, 
H(4)), 2.49 (dt, 1H, 2J3exo,3endo = 18.7, 
3J3exo,4 = 4.3, 
4J3exo,5exo = 3.5, H(3exo)), 4.12 (s, 3H, 
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OCH3), 7.40 (m, 9H, m- and p-PPh), 7.74 (m, 6H, o-PPh).  
13C{1H} NMR (δ, ppm): 18.2 
and 20.2 (two CH3), 27.0 (PdCH2)), 27.2 (CH2, C(5)), 33.4 (CH2, C(3)), 33.5 (CH2, C(6)), 
47.2 (CH, C(4)), 48.1 (C, C(7)), 63.3 (OCH3), 66.0 (C, C(1)), 128.5 (d, 
3JC,P = 10.1, m-
PPh), 130.7 (d, 4JC,P = 2.4, p-PPh), 131.7 (d, 
1JC,P = 51.6, ipso-PPh), 135.1 (d, 
2JC,P = 11.3, 
o-PPh), 192.2 (C=N). 31P{1H} NMR (δ, ppm): 20.4. Anal. Calcd for C29H33ClNOPPd: C, 
59.60; H, 5.69; N, 2.40. Found: C, 59.83; H, 5.68; N, 2.48%. 
Complexes 188. To a 25-mL round-bottomed flask containing a magnetic stirring 
bar and the CPC of camphor N,N-dimethylhydrazone (0.0385 g, 0.0574 mmol), chloroform 
(12 mL) and Na(acac) (0.0216 g, 0.0177 mmol) were added. The resulting mixture was 
stirred at rt for 18 h. The solvent was removed under reduced pressure to give a pale yellow 
residue. The crude product was purified using preparative TLC (silica gel, 1:2 ethyl 
acetate‒hexane) to give the pure product 188 as a pale yellow powder (0.0538 g, 0.0900 
mmol, 96%).  
 (1R,3S,4S)-Chloro{[2-(N,N-dimethylhydrazono)-1,7,7-
trimethylbicyclo[2.2.1]heptyl]methylenyl-C,N}(acetylacetonate-O,O)palladium(II) 
(endo-188). Mp: 120‒122 °C; Rf 0.80 (2:1 hexane‒ethyl acetate). IR (ν, cm-1, mineral 
oil): 1656 (C=N). 1H NMR (δ, ppm): 0.91, 0.93, 1.08 (three s, 9H, 3CH3), 1.31 (ddd, 1H, 
3J5endo,6endo ≈ 13, 2J5endo,5exo ≈ 9.2, 3J5endo,6exo = 4.0, H(5endo)), 1.70 (m, 1H, H(5exo)), 1.75 
(m, 1H, H(6endo)), 1.87 (s, 3H, acac CH3), 1.89 (m, 1H, H(6exo)), 1.91 (s, 3H, acac 
CH3), 2.02 (t, 1H, 
3J4,5exo ≈ 3J4,3exo ≈ 4.3, H(4)), 2.66, 3.02 (two s, 6H, 2NCH3), 4.82 (t, 
1H, 3J4,PdCH ≈ 4JPdCH,5exo ≈ 3.5, PdCH), 5.22 (s, 1H, acac CH). 13C{1H} NMR (δ, ppm): 
11.2, 20.0, 21.3 (three CH3), 26.3 (CH2, C(5)), 27.7, 28.7 (two CH3, (acac)), 37.2 (CH2, 
C(6)), 48.3 (PdCH)), 48.4 (C, C(7)), 48.9 (CH, C(4)), 51.92, 51.94 (two NCH3), 53.0 (C, 
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C(1)), 99.9 (CH, (acac)), 186.2, 188.1 (two C, (acac)), 200.3 (C=N). Anal. Calcd for 
C17H28N2O2Pd: C, 51.19; H, 7.08; N, 7.02. Found: C, 50.89; H, 6.89; N, 7.03%. 
 (1R,3R,4S)-Chloro{[2-(N,N-dimethylhydrazono)-1,7,7-
trimethylbicyclo[2.2.1]heptyl]methylenyl-C,N}(acetylacetonate-O,O)palladium(II) 
(exo-188). Mp: 120‒122 °C; Rf 0.75 (2:1 hexane‒ethyl acetate). IR (ν, cm-1, mineral oil): 
1656 (C=N). 1H NMR (δ, ppm): 0.89, 0.99 (two s, 6H, 2CH3), 1.33 (ddd, 1H, 3J5endo,6endo ≈ 
11.8, 2J5endo,5exo ≈ 8.9, 3J5endo,6exo = 2.9, H(5endo)), 1.42 (s, 3H, CH3), 1.69 (t, 1H, 3J4,5exo ≈ 
3J4,3exo ≈ 3.4, H(4)), 1.76 (m, 2H, H(5exo), (6endo)), 1.888 (s, 3H, acac CH3), 1.891 (m, 
1H, H(6exo)), 1.893 (s, 3H, acac CH3), 2.66, 3.04 (two s, 6H, 2NCH3), 3.99 (s, 1H, PdCH), 
5.21 (s, 1H, acac CH). 13C{1H} NMR (δ, ppm): 12.1, 20.7, 21.3 (three CH3), 27.9, 28.6 
(two CH3, (acac)), 29.3 (CH2, C(5)), 30.9 (CH2, C(6)), 46.8 (CH, C(4)), 46.9 (CH, PdCH)), 
50.7 (C, C(7)), 51.5 (C, C(1)), 52.1, 52.5 (two NCH3), 99.9 (CH, (acac)), 186.3, 188.0 (two 
C, (acac)), 198.6 (C=N). Anal. Calcd for C17H28N2O2Pd: C, 51.19; H, 7.08; N, 7.02. Found: 
C, 50.89; H, 6.89; N, 7.03%. 
VI.3. Preparation of L-Fenchone Derivatives and Their Cyclopalladation 
 (1R,4S)-1,3,3-Trimethylbicyclo[2.2.1]heptan-2-one oxime (196a). To a solution 
of hydroxylamine hydrochloride (0.5483 g, 7.891 mmol) in abs. EtOH (10 mL) was added 
L-(-)-fenchone (0.4290 g, 2.818 mmol).  Pyridine (0.60 mL, 7.5 mmol) was then added 
dropwise and the mixture was refluxed for 48 h. The mixture was filtered, and ethanol from 
the filtrate was evaporated under reduced pressure. 1M aq. HCl solution (30 mL) was added 
to the oily residue, and the product was extracted with Et2O (3  5 mL). The combined 
organic layers were dried over Na2SO4. After filtration, the solvent was removed on a 
rotavapor to obtain the pure product as a white powder (0.3041 g, 1.818 mmol, 64%). Mp: 
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149‒151 °C (lit. data 150-153 oC [14]); [α]24D +3.00 (c 0.406, EtOH); Rf 0.53 (100:1 
hexane‒acetone). IR (ν, cm-1, mineral oil): 1682 (C=N).  1H NMR (δ, ppm): 1.22 (s, 3H, 
CH3(8)), 1.30, 1.33 (two s, 3H each, CH3(9exo) and CH3(9endo)), 1.34 (m, 1H, H(7A)), 
1.45 (m, 1H, H(6endo)), 1.55 (m, 2H, H(6exo), H(5endo)), 1.72 (d, 2J7A,7B = 10.5 Hz, 1H, 
H(7B)), 1.79 (m, 1H, H(5exo)), 1.82 (d, J ≈ 1 Hz, 1H, H(4)), 8.61 (br s, 1H, OH).  13C{1H} 
NMR (δ, ppm): 17.1 (CH3(8)), 22.2, 22.9 (CH3(9exo) and CH3(9endo)), 25.2 (CH2, C(5)), 
34.2 (CH2, C(6)), 43.2 (CH2, C(7)), 44.2 (quat. C, C(3)), 48.6 (CH, C(4)), 50.1 (quat. C, 
C(1)), 172.5 (C=N). HRMS: [M + H]+ calcd for C10H18NO 168.1388, found 168.1449. 
 (1R,4S)-1,3,3-Trimethylbicyclo[2.2.1]heptan-2-one O-Methyloxime (196b). 
This compound was synthesized using the procedure described for oxime 196a in 82% 
yield (3.197 g, 17.63 mmol) using methoxylamine hydrochloride (5.000 g, 59.87 mmol), 
L-(-)-fenchone (3.255 g, 21.38 mmol) and pyridine (4.7 mL, 58 mmol) and abs. EtOH (50 
mL). According to the 1H NMR spectrum, the product was a mixture of two geometric 
isomers in a ratio of 94:6.  Bp: 86‒88 °C; [α]24D -20.0, [α]24546 -35.0, [α]24435 -67.0 (c 1.04, 
EtOH); Rf 0.66 (100:1 hexane‒acetone). IR (ν, cm-1, mineral oil): 1655 (C=N). 1H NMR 
(δ, ppm): 1.22, 1.23, 1.25 (three s, 9H, 3CH3), 1.31 (dd, 2J7A,7B = 10.0, 3J7,4 = 1.2, 1H, 
H(7A)), 1.43 (m, 1H, H(6endo)), 1.54 (m, 2H, H(6exo), H(5endo)), 1.70 (dq, 2J7A,7B = 10.0, 
3J4,7B ≈ 4J5exo,7B ≈ 4J5endo,7B ≈ 1.8 Hz; 1H, H(7B)), 1.78 (m, 2H, H(5exo), H(4)), 3.71 (minor 
isomer) and 3.75 (major isomer) (two s, 3H, OCH3). 
13C{1H} NMR (δ, ppm): 17.2, 22.5, 
23.4 (three CH3), 25.3 (CH2, C(5)), 34.4 (CH2, C(6)), 43.4 (CH2, C(7)), 48.6 (CH, C(4)), 
44.6 and 49.9 (two quat. C, C(1) and C(3)), 61.0 (OCH3), 172.6 (C=N).  Anal. Calcd for 
C11H19NO: C, 72.88; H, 10.56; N, 7.73. Found: C, 72.59; H, 10.35; N, 7.78%. 
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 (S,S)-Di-µ-chlorobis{[2-(hydroxyimino)-3,3-
dimethylbicyclo[2.2.1]heptyl]methyl-C,N}dipalladium(II) (198a). To a 25-mL one-
neck round-bottomed flask containing a magnetic stirring bar, fenchone oxime 196a 
(0.0527 g, 0.315 mmol), Pd(OAc)2 (0.0707 g, 0.315 mmol) and glacial acetic acid (5.6 mL) 
were added at rt. The resulting mixture was stirred at 80 °C for 5 h. The solvent was 
removed under reduced pressure to give a brown oily residue of the crude acetate-bridged 
dimer 197a. HPLC-grade acetone (5.6 mL) was added to the crude acetate-bridged dimer 
followed by introduction of LiCl (0.0534 g, 1.26 mmol). The mixture was stirred at rt for 
18 h. The solution was then filtered through celite (h = 1 cm), and the flask with the filtrate 
was placed on a rotavapor to remove acetone. The crude product was separated into several 
fractions using preparative TLC (silica gel, 9:1 toluene‒ethyl acetate). Complex 198a was 
isolated as an orange-yellow powder in 65% yield (0.0189 g, 0.0307 mmol). Mp: 189‒191 
°C; [α]24D -57, [α]24546 -70 (c 0.30, CH2Cl2); Rf 0.56 (9:1 toluene‒ethyl acetate).  1H NMR 
(δ, ppm): 1.20 (s, 3H, CH3), 1.27 (s, 3H, CH3), 1.39 (d, 2J7A,7B = 9.9, 1H, H(7A)), 1.59‒
1.71 (m, 2H, H(6endo), 5(endo)), 1.80‒1.87 (m, 2H, H(7B), H(5exo)), 1.95 (m, 1H, 
H(6exo)), 2.14 (s, 1H, H(4)), 2.29 (d, 1H, 2JA,B = 8.8, PdCH
A), 2.76 (d, 1H, 2JA,B = 8.8, 
PdCHB), 7.60 (br s, 1H, OH). 13C{1H} NMR (δ, ppm): 21.3 and 22.4 (two CH3), 24.6 (CH2, 
PdC) [24], 25.2 (CH2, C(5)), 34.0 (CH2, C(6)), 41.0 (CH2, C(7)), 43.9 and 65.6 (two quat. 
C, C(1) and C(3)), 54.1 (CH, C(4)), 190.4 (C=N). Anal. Calcd for C20H32Cl2N2O2Pd2: C, 
38.98; H, 5.23; N, 4.55. Found: C, 39.23; H, 5.23; N, 4.55%. 
 (S,S)-Di-µ-chlorobis{[2-(methoxyimino)-3,3-
dimethylbicyclo[2.2.1]heptyl]methyl-C,N}dipalladium(II) (198b). This compound was 
isolated as an orange‒yellow powder in 49% yield (0.1453 g, 0.2255 mmol) using the 
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procedure described for complex 198a and the following reagents: fenchone O-
methyloxime 196b (0.3164 g, 1.745 mmol), Pd(OAc)2 (0.3918 g, 1.745 mmol) and LiCl 
(0.2960 g, 6.981 mmol).  Mp: 202‒204 °C; [α]22D -172, [α]22546 -226, (c 0.416, CH2Cl2); Rf 
0.56 (9:1 toluene‒ethyl acetate). 1H NMR (δ, ppm): 1.19, 1.21 (two s, 6H, 2CH3), 1.38 (d, 
2J7A,7B = 10.2, 1H, H(7A)), 1.63 (m, 1H, 5(endo)), 1.74 (m, 1H, H(6endo)), 1.81 (m, 2H, 
H(7), H(5exo)), 2.01 (m, 1H, H(6exo)), 2.08 (d, J = 3.5, 1H, H(4)), 2.17 (br. s, 1H, PdCHA), 
2.58 (br. s, 1H, PdCHB), 3.78 (s, 3H, OCH3)). 
13C{1H} NMR (δ, ppm): 22.4 and 23.3 (two 
CH3), 25.3 (CH2, C(5)), 25.8 (PdC) [24], 33.9 (CH2, C(6)), 41.3 (CH2, C(7)), 44.6 and 64.9 
(two quat. C, C(1) and C(3)), 53.7 (CH, C(4)), 62.4 (OCH3), 198.6 (C=N). Anal. Calcd for 
C22H36Cl2N2O2Pd2: C, 41.01; H, 5.63; N, 4.35. Found: C, 41.28; H, 5.52; N, 4.28%. 
 (S,S)-Chloro{[2-(hydroxyimino)-3,3-dimethylbicyclo[2.2.1]heptyl]methyl-
C,N} (triphenylphosphine-P)palladium(II) (199a). To a 50-mL round-bottomed flask 
with a magnetic stirring bar, a solution of complex 198a (0.0505 g, 0.0820 mmol) in 
acetone (32 mL) and PPh3 (0.0430 g, 0.164 mmol) were added. The resulting mixture was 
stirred at rt for 18 h.  The solvent was removed under reduced pressure to give a white 
residue. The crude product was purified using preparative TLC (silica gel, 1:2 ethyl 
acetate‒hexane). The pure complex was isolated as a white powder in 99% yield (0.0921 
g, 0.0164 mmol). Mp: 148‒150 °C; [α]22D -76.0, [α]22546 -96.0, [α]22435 -212 (c 0.366, 
EtOH); Rf 0.65 (2:1 hexane‒ethyl acetate). 1H NMR (δ, ppm): 1.09 (dd, 1H, 2JH,H = 10.1, 
2JH,P = 7.2, PdCH
A), 1.22 (d, 1H, 2J7A,7B = 10.4, H(7A)), 1.27, 1.29 (two s, 6H, 2CH3), 1.52 
(m, 1H, H(6endo)), 1.58 (m, 1H, H(5endo)), 1.76 (br. d, 1H, 2J7A,7B = 10.4, H(7B)), 1.8−1.9 
(m, 2H, H(5exo), H(6exo)), 2.08 (poorly resolved d, 1H, J ≈ 1.0, H(4)), 2.28 (d, 1H, 2JH,H 
= 10.1, PdCHB), 7.41 (m, 9H, m- and p-PPh), 7.65 (m, 6H, o-PPh), 9.70 (s, 1H, OH). 
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13C{1H} NMR (δ, ppm): 21.0 and 22.1 (two CH3), 25.1 (CH2, C(5)), 32.8 (PdC)), 34.7 
(CH2, C(6)), 42.1 (CH2, C(7)), 42.9 (C, C(3)), 53.2 (CH, C(4)), 64.9 (C, C(1)), 128.3 (d, 
3JC,P = 10.8, m-PPh), 130.5 (d,
 4JC,P = 1.7, p-PPh), 131.0 (d, 
1JC,P = 49.6, ipso-PPh), 134.5 
(d, 2JC,P = 12.2, o-PPh), 187.9 (C=N). 
31P{1H} NMR (δ, ppm): 19.7. Anal. Calcd for 
C28H31ClNOPPd: C, 58.96; H, 5.48; N, 2.46. Found: C, 58.70; H, 5.68; N, 2.49%. 
 (S,S)-Chloro{[2-(methoxyimino)-3,3-dimethylbicyclo[2.2.1]heptyl]methyl-
C,N} (triphenylphosphine-P)palladium(II) (199b). This compound was obtained as a 
white powder in 74% yield (0.0579 g, 0.0991 mmol) using complex 198b (0.0430 g, 0.0667 
mmol) and PPh3 (0.0350 g, 0.134 mmol) and following the procedure described for 
compound 199a. Mp: 179‒181 °C; [α]24D -134, [α]24546 -169, [α]24435 -373 (c 0.348, EtOH); 
Rf 0.54 (2:1 hexane‒ethyl acetate). 1H NMR (δ, ppm): 0.84 (dd, 1H, 2JH,H = 10.7, 2JH,P = 
9.0, PdCHA), 1.18 (m, 1H, H(7)), 1.25, 1.27 (two s, 6H, 2CH3), 1.50 (m, 1H, H(6endo)), 
1.55 (m, 1H, H(5endo)), 1.72 (d, 1H, 2J7A,7B = 9.9, H(7A)), 1.82 (m, 1H, H(5exo)), 1.91 
(m, 1H, H(6exo)), 2.00 (unresolved d, 1H, H(4)), 2.16 (d, 1H, 2JH,H = 10.7, PdCH
B), 4.10 
(s, 3H, OCH3), 7.39 (m, 9H, m- and p-PPh), 7.71 (m, 6H, o-PPh). 
13C{1H} NMR (δ, ppm): 
22.8 and 23.4 (two CH3), 25.5 (CH2, C(5)), 33.0 (PdC)), 34.8 (CH2, C(6)), 43.4 (CH2, 
C(7)), 44.2 (C, C(3)), 52.9 (CH, C(4)), 63.5 (OCH3), 64.5 (C, C(1)), 128.5 (d, 
3JC,P = 10.7, 
m-PPh), 130.7 (s, p-PPh), 131.8 (d, 1JC,P = 50.3, ipso-PPh), 135.1 (d, 
2JC,P = 11.6, o-PPh), 
196.6 (C=N). 31P{1H} NMR (δ, ppm): 20.3. Anal. Calcd for C29H33ClNOPPd: C, 59.60; 
H, 5.69; N, 2.40. Found: C, 59.90; H, 5.71; N, 2.40%. 
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VI.4. Preparation of CPCs and Their Reactions with KPPh2  
 Complexes 177, 178, 212, 217, 219 and 222 were synthesized using published 
procedures.17, 25, 31, 42, 103, 111, 353 The NMR spectra of the obtained compounds matched 
those reported in the literature.  
VI.4.1. Synthesis and Characterization of New Compounds 
(R,R)-1-{(Diphenylphosphino)methyl}-7,7-dimethylbicyclo[2.2.1]heptan-2-
one O-Methyloxime (205). CPC 177 (0.0723g, 0.112 mmol) was added to a 25-mL 
Schlenk flask containing a magnetic stirring bar. The flask was evacuated and filled with 
Ar 5 times. Abs. THF (15 mL) was then added using a syringe followed by a 0.5 M solution 
of KPPh2 (1 mL, 0.5 mmol). During the dropwise addition of KPPh2 for 5 min, the yellow 
solution turned dark red. The mixture was stirred at rt for 18 h in Ar. The Schlenk flask 
was then placed on a rotavapor to remove THF. The dark-red solid residue was dissolved 
in CH2Cl2 (2 mL) and quickly separated into several fractions using preparative TLC (10:1 
hexane‒ethyl acetate). Fraction 3 corresponded to the pure product (0.0492 g, 0.135 mmol, 
21%, colorless oil).  [α]22D +154, [α]22546 +173 (c 0.0460, EtOH).  Rf  0.63 (10:1 hexane‒
ethyl acetate). 1H NMR (δ, ppm): 0.83 (s, 3H, CH3), 0.94 (s, 3H, CH3), 1.20 (m, 1H, 
H(5endo)), 1.64 (m, 1H, H(6endo)), 1.77 (m, 2H, H(5exo), H(6exo)), 1.84 (m, 1H, H(4)), 
1.95 (d, 1H, 2J3endo,3exo = 17.6, H(3endo)), 2.15 (dd, 1H, 
2JH,H = 15.0, 
3JH,P = 4.1, PCH
A), 
2.48 (ddd, 1H, 2J3exo,3endo = 17.6, 
3J3exo,4  ≈ 4J3exo,5exo ≈ 4.3, H(3exo)), 2.52 (dd, 1H, 2JH,H = 
15.0, 3JH,P = 4.1, PCH
B), 3.76 (s, 3H, OCH3), 7.32 (m, 6H, m- and p-PPh), 7.51 (m, 4H, o-
PPh). 13C{1H} NMR (δ, ppm): 19.8 and 20.1 (two CH3), 27.5 (d, 1JC,P = 18, PCH2), 27.8 
(CH2, C(5)), 30.9 (CH2, d, 
3JC,P = 12, C(6)), 33.7 (CH2, C(3)), 44.2 (CH, C(4)), 49.8 (quat. 
C, d, 3JC,P = 3.9, C(7)), 54.6 (quat. C, d, 
2JC,P = 14, C(1)), 61.8 (OCH3), 128.27, 128.47, 
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128.52, 128.76, 128.81 (all CH, m- and p-PPh; the signal at 128.81 ppm has a double 
intensity), 133.0 (CH, d, 2JC,P = 19, o-PPh
A), 133.7 (CH, d, 2JC,P = 20, o-PPh
B), 141.2 (quat. 
C, d, 1JC,P = 15, ipso-PPh
A), 141.3 (quat. C, d, 1JC,P = 17, ipso-PPh
B), 167.9 (quat. C, C=N). 
31P{1H} NMR (CDCl3, δ, ppm): -36.9. 31P{1H} NMR (C6D6, δ, ppm): -23.2. HRMS: [M + 
H]+ calcd for C23H28NOP 366.1981, found 366.1979. 
  (R,R)-µ-Chloro-µ-(diphenylphosphido)bis{[2-(methoxyimino)-7,7-
dimethylbicyclo[2.2.1]heptyl]methyl-C,N}dipalladium(II) (206). The reaction was 
performed as described above for 205 except that 1 equiv. of KPPh2 was used and the 
reaction time was 1 h. After solvent removal, the crude product was dissolved in ethyl 
acetate (2 mL) and separated into several fractions using preparative TLC (10:1 hexane‒
ethyl acetate). Fraction 2 corresponded to complex 206 (0.0198 g, 0.0249 mmol, 31%, 
orange solid). Mp: 194‒196 °C; Rf 0.50 (10:1 hexane‒ethyl acetate); [α]22D -189, [α]22546 -
190 (c 0.0650, EtOH).  IR (Nujol mull, ν, cm-1): 1674 (C=N). 1H NMR (δ, ppm): 0.62 (s, 
3H, CH3), 0.72 (s, 3H, CH3), 0.74 (m, 1H, PdCH
A), 1.27 (ddd, 1H, 3J5endo,6endo = 13, 
2J5endo,5exo = 9.6, 
3J5endo,6exo = 4.3, H(5endo)), 1.39 (d, 1H, 
2JH,H = 10, PdCH
B), 1.64 (td, 1H, 
2J6exo,6endo = 
3J6endo,5endo = 13, 
3J6endo,5exo = 4.5, H(6endo)), 1.79 (m, 1H, H(5exo)), 1.91 (d, 
1H, 2J3endo,3exo = 19, H(3endo)), 1.96 (ddd, 1H, 
2J6exo,6endo = 13, 
3J6exo,5exo = 9.6, 
3J6exo,5endo = 
4.3, H(6exo)), 1.99 (t, 1H, 3J4,5exo = 
3J4,3exo = 4, H(4)), 2.37 (dt, 1H, 
2J3exo,3endo = 19, 
3J3exo,4 
= 4J3exo,5exo = 4, H(3exo)), 3.97 (s, 3H, OCH3), 7.30 (m, 6H, m- and p-PPh), 7.84 (m, 4H, 
o-PPh). 13C{1H} NMR (δ, ppm): 18.5 and 20.2 (two CH3), 19.4 (d, 1JC,P = 2.2, PCH2), 27.3 
(CH2, C(5)), 33.4 (CH2, C(3)), 33.8 (CH2, C(6)), 46.8 (CH, C(4)), 48.2 (quat. C, C(7)), 62.7 
(OCH3), 65.9 (quat. C, C(1)), 127.9 (CH, d, 
3JC,P = 10, m-PPh), 128.5 (CH, d, 
4JC,P = 2.2, 
p-PPh), 134.4 (CH, d, 2JC,P = 12, o-PPh), 138.3 (quat. C, d, 
1JC,P = 32, ipso-PPh), 186.1 
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(quat. C, C=N). 31P{1H} NMR (CDCl3, δ, ppm): 4.9; 31P{1H} NMR (C6D6, δ, ppm): 18.0. 
Anal. Calcd for C34H46ClN2O2PPd2: C, 51.43; H, 5.84; N, 3.53%. Found: C, 51.14; H, 5.85; 
N, 3.49%. 
  (R,R)-Di-µ-(diphenylphosphido)bis{[2-(methoxyimino)-7,7-
dimethylbicyclo[2.2.1]heptyl]methyl-C,N}dipalladium(II) (207). The reaction was 
performed as described above for 205. The purification by preparative TLC was performed 
using 5:1 hexane‒ethyl acetate as an eluent. The use of halogenated solvents, such as 
CH2Cl2 and CHCl3, was avoided during all steps of the product purification. The upper 
fraction on the TLC plate corresponded to the product (0.0163 g, 0.0173 mmol, ca. 26%, 
brown solid). 31P{1H} NMR (CDCl3, δ, ppm): -76.9; 31P{1H} NMR (C6D6, δ, ppm): -64.3. 
 (S,S)-1-{(Diphenylphosphino)methyl}-3,3-dimethylbicyclo[2.2.1]heptan-2-one 
O-Methyloxime (210). The reaction was performed as described above for 205 using 
complex 198 (0.0794g, 0.123 mmol).  The reaction mixture was separated into several 
fractions using preparative TLC (10:1 hexane‒ethyl acetate).  Fraction 3 corresponded to 
compound 210 (0.0461 g, 0.126 mmol, 51%, colorless oil). [α]24D +138, [α]24546 +171, 
[α]24435 +246 (c 0.150, EtOH).  Rf  0.65 (10:1 hexane‒ethyl acetate). 1H NMR (δ, ppm): 
1.19, 1.25 (two s, 6H, 2CH3), 1.31 (d, 1H, 
2J7A,7B = 10.1, H(7A)), 1.42 (m, 1H, H(6endo)), 
1.50 (m, 1H, H(5endo)), 1.58 (br. d, 1H, H(7B)), 1.75 (m, 2H, H(4), H(5exo)), 1.92 (tq, 
1H, 2J6exo,6endo = 
3J6exo,5endo = 12.0, 
3J6exo,5exo ≈ 4J6exo,P ≈ 1.8, H(6exo)), 2.46 (dd, 1H, 2JH,H = 
14.7, 2JH,P = 3.5, PCH
A), 2.59 (dd, 1H, 2JH,H = 14.7, 
2JH,P = 4.1, PCH
B), 3.73 (s, 3H, OCH3), 
7.30 (m, 6H, m- and p-PPh), 7.47 (m, 4H, o-PPh). 13C{1H} NMR (δ, ppm): 22.5 and 23.1 
(two CH3), 25.0 (CH2, C(5)), 30.7 (d, 
1JC,P = 13.1, PCH2), 33.3 (d, CH2, 
3JC,P = 9.2, C(6)), 
41.2 (CH2, C(7)), 44.3 (CH, C(4)), 48.3 (d, C, C(3)), 52.6 (d, C, 
2JC,P = 16.7, C(1)), 61.2 
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(OCH3), 128.22, 128.27, 128.32 (m- and p-PPh), 132.8 (d, 
2JC,P = 19.2, o-PPh
A), 133.0 (d, 
2JC,P = 19.3, o-PPh
B), 139.9 (d, 1JC,P = 12.6, ipso-PPh
A), 140.0 (d, 1JC,P = 10.8, ipso-PPh
B), 
171.9 (C=N). 31P{1H} NMR (CDCl3, δ, ppm): -37.1. HRMS: [M + H]+ calcd for 
C23H28NOP 366.1981, found 366.1964. 
 (S,S)-µ-Chloro-µ-(diphenylphosphido)bis{[2-(methoxyimino)-3,3-
dimethylbicyclo[2.2.1]heptyl]methyl-C,N}dipalladium(II) (211). The reaction was 
performed as described above for the preparation of 206 using complex 198 (0.0817 g, 
0.1268 mmol). The reaction mixture was separated into several fractions using preparative 
TLC (10:1 hexane‒ethyl acetate). Fraction 2 corresponded to complex 211 (0.0180 g, 
0.0227 mmol, 56%, orange solid). [α]23D -121, [α]23546 -147, [α]23435 -204 (c 0.222, EtOH). 
Mp: 209‒211 °C; Rf  0.55 (10:1 hexane‒ethyl acetate). 1H NMR (δ, ppm): 1.05 (dd, 1H, 
2JH,H = 9.6,
 3JH,P = 4.8, PdCH
A), 1.14, 1.20 (two s, 6H, 2CH3), 1.17 (m, 1H, H(7A)), 1.53 
(m, 2H, H(6endo), 5endo)), 1.63 (m, 2H, H(7B), PdCHB), 1.80 (m, 1H, H(5exo)), 1.91 (m, 
2H, H(4), H(6exo)), 3.93 (s, 3H, OCH3), 7.29 (m, 6H, m- and p-PPh), 7.82 (m, 4H, o-PPh). 
13C{1H} NMR (δ, ppm): 22.5 and 23.0 (two CH3), 25.6 (CH2, C(5)), 25.7 (PCH2), 35.1 
(CH2, C(6)), 43.4 (CH2, C(7)), 44.0 (C, C(3)), 52.3 (CH, C(4)), 62.6 (OCH3), 64.3 (C, 
C(1)), 127.9, (d, 3JC,P = 10.2, m-PPh), 128.4 (s, p-PPh), 134.4 (d, 
2JC,P = 12.2, o-PPh), 138.6 
(d, 1JC,P = 31.1, ipso-PPh), 190.6 (C=N).  
31P{1H} NMR (CDCl3, δ, ppm): 2.2. Anal. Calcd 
for C34H46N2O2PClPd2: C, 51.43; H, 5.84; N, 3.53%. Found: C, 51.30; H, 5.84; N, 3.52%. 
 µ-Chloro-µ-(diphenylphosphido)bis(8-quinolinylmethyl-C,N)dipalladium 
(214). The reaction was performed as described above for preparation of 206 using CPC 
212 (0.0498 g, 0.0693 mmol). The reaction mixture was separated into several fractions 
using preparative TLC (10:1 benzene‒acetone). Fraction 1 corresponded to complex 214 
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(0.0258 g, 0.0359 mmol, 56%, orange powder). Mp: 237‒239 °C; Rf  0.65 (15:1 toluene‒
ethyl acetate). 1H NMR (δ, ppm): 3.02 (s, 2H, CH2), 7.35 (m, 6H, m- and p-PPh), 7.40 (t, 
1H, 3JH,H = 7.5, arom. CH), 7.45 (d, 1H, 
3JH,H = 7.0, arom. CH), 7.50 (dd, 1H, 
3JH,H ≈ 8.3, 
4JH,H ≈ 4.7, arom. CH), 7.56 (d, 1H, 3JH,H ≈ 7.7, arom. CH), 8.00 (m, 4H, o-PPh) 8.25 (dd, 
1H, 3JH,H ≈ 8.2, 4JH,H ≈ 1.3, arom. CH), 9.11 (m, 1H, arom. CH). 13C{1H} NMR (δ, ppm): 
25.7 (CH2, CH2), 120.9 (d, 
4JC,P = 2.7, CH), 123.4 (s, CH), 127.5 (s, CH), 127.9, (d, 
3JC,P 
= 10.0, m-PPh), 128.2 (d, 4JC,P = 2.5, CH), 129.0 (s, C), 129.3 (s, p-PPh), 134.1 (d, 
2JC,P = 
11.9, o-PPh), 137.7 (s, CH), 137.8 (d, 1JC,P = 32.1, ipso-PPh), 146.8 (s, CH), 149.6 (s, C), 
151.0 (d, 4JC,P = 1.9, C). 
31P{1H} NMR (CDCl3, δ, ppm): 10.2. Anal. Calcd for 
C32H26N2PClPd2: C, 53.54; H, 3.65; N, 3.90%. Found: C, 53.27; H, 3.80; N, 3.85%. 
 8-[(Diphenyloxophosphino)methyl]quinoline (216). Complex 212 (0.1636 g, 
0.2659 mmol) was added to an oven dried Ar-filled 50-mL Schlenk flask containing a 
magnetic stirring bar. The flask was evacuated and filled with Ar 5 times. Then abs. THF 
(17 mL) was added followed by a 0.5 M solution of KPPh2 in THF (3.2 mL, 1.6 mmol). 
During the dropwise addition, the orange solution turned dark red, and then black. The 
mixture was stirred at rt for 48 h in Ar. The reaction mixture was then filtered through 
celite (h = 1 cm), and the flask with the filtrate was placed on a rotavapor to remove solvent. 
The crude product was dissolved in CH2Cl2 and separated into several fractions using 
preparative TLC (10:1 ethyl acetate‒acetone). Fraction 1 corresponded to 8-
methylquinoline 213 (0.0450 g, 0.314 mmol, 48%, colorless oil). Fraction 3 corresponded 
to compound 216 (0.0321 g, 0.0231 mmol, 21%, colorless oil). Rf 0.40 (10:1 ethyl acetate‒
acetone). 1H NMR (δ, ppm): 4.56 (d, 2H, 2JH,P = 14.2, PCH2), 7.28 (t, 1H, 3JH,H = 4.2, arom. 
H(3)), 7.31 (m, 4H, o-PPh), 7.38 (dt, 2H, 3JH,H = 7.4,
 4JH,H = 1.3, p-PPh), 7.46 (t, 1H, 
2JH,P 
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= 15.4, arom. H(6)), 7.64 (d, 1H, 3JH,P = 8.2, arom. H(7)), 7.78 (m, 4H, m-PPh), 8.03 (dd, 
1H, 3JH,H = 8.2,
 5JH,H = 1.6, arom. H(5)), 8.05 (m, 1H, arom. H(4)),  8.76 (dd, 1H, 
3JH,H = 
4.1, 5JH,H = 1.6, arom. H(2)). 
13C{1H} NMR (δ, ppm): 21.2 (d, 1JC,P = 67.9, PCH2), 121.2 
(s, arom. CH(3)), 126.8 (d, 3JC,P = 2.8, arom. CH(6)), 127.2 (d, 
4JC,P = 1.0, arom. CH(7)), 
128.5 (d, 2JC,P = 11.6, o-PPh), 131.2 (d, 
2JC,P = 7.7, ipso-PPh), 131.55 (s, arom. CH(5)), 
131.56 (d, 2JC,P = 9.2, m-PPh), 131.8 (d, 
2JC,P = 2.3, p-PPh), 133.0 (s, arom. C(10)), 133.8 
(two s, (s, arom. CH(8)), 136.6 (s, arom. CH(4)), 146.7 (d, 2JC,P = 5.5, arom. CH(9)), 149.4 
(s, CH, arom. CH(2)). 31P{1H} NMR (CDCl3, δ, ppm): 16.5. IR (Nujol mull, ν, cm-1): 1199 
s (P=O). HRMS: [M + H]+ calcd for C22H19NOP 343.1199, found 344.1108. 
 [2-(Di-ortho-tolylphosphino)benzyl]diphenylphosphine oxide (220). Complex 
219 (0.0690 g, 0.0775 mmol) was added to an oven dried Ar-filled 25-mL Schlenk flask 
containing a magnetic stirring bar. The flask was evacuated and filled with Ar 5 times. 
Then abs. THF (10 mL) was added followed by a 0.5 M solution of KPPh2 in THF (0.7 
mL, 0.3 mmol). During the dropwise addition, the yellow solution turned dark red, and 
then brown.  The mixture was stirred at rt for 48 h in Ar and then 48 h in air. The reaction 
mixture was then filtered through celite (h = 1 cm), and the flask with the filtrate was placed 
on a rotavapor to remove solvent. The mixture was separated into several fractions using 
preparative TLC (10:1 ethyl acetate‒acetone). Fraction 1 corresponded to tri(O-
tolyl)phosphine 221 (0.001 g, 0.003 mmol, 2%, white powder). Fraction 2 corresponded to 
product 220 (0.00147 g, 0.0303 mmol, 20%, pale yellow oil). Rf  0.59 (10:1 ethyl acetate‒
acetone). 1H NMR (δ, ppm): 2.26 (s, 6H, CH3), 4.00 (d, 2H, 2JH,P = 9.6, PCH2), 6.61 (dd, 
2H, 3JH,P = 7.4, 
3JH,H = 4.6, arom. CH of C6H4-CH2P), 7.00 (dd, 1H, 
3JH,H = 7.6, 
4JH,P = 3.9, 
arom. CH of C6H4-CH2P), 7.05 (m, 3H, arom. CH(3), CH(5) of tolyl), 7.20 (t, 2H, 
3JH,H = 
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6.0, arom. CH(4) of tolyl), 7.23−7.30 (m, 3H, arom. CH(3), CH(6) of tolyl), 7.35 (td, 4H, 
3JH,P = 7.5, 
3JH,H = 2.8, o-PPh), 7.42 (t, 2H, 
3JH,H = 6.9, p-PPh), 7.74 (dd, 4H, 
3JH,P = 11.4, 
3JH,H = 7.4, m-PPh), 7.95 (t, 1H, 
3JH,H = 6.3, arom. CH of C6H4-CH2P). 
13C{1H} NMR (δ, 
ppm): 21.6, 21.8 (two s, CH3), 35.0 (dd, 
1JC,P = 67.2, 
3JC,P = 25.9, PCH2), 126.7(s, arom. 
CH(5) of tolyl), 127.8 (s, arom. CH(3) of tolyl), 128.8 (d, 3JC,P = 11.7, o-PPh), 129.3 (s, 
arom. CH(6) of tolyl), 129.6 (s, arom. CH(3) of tolyl), 130.5 (d, 4JC,P = 4.7, arom. CH(4) 
of tolyl), 131.2 (t, 4JC,P = 4.3, arom. CH of C6H4-CH2P), 131.5 (d, 
3JC,P = 9.4, m-PPh), 132.0 
(s, p-PPh), 133.3 (d, 1JC,P = 99.3, arom. C(1) of tolyl), 133.5 (s, arom. CH of C6H4-CH2P), 
134.3 (s, arom. CH of C6H4-CH2P), 134.5 (d, 
2JC,P = 9.3, PPh), 135.0 (t, 
3JC,P = 8.4, arom. 
CH of C6H4-CH2P), 137.7 (dd, 
1JC,P = 26.4, 
3JC,P = 6.3, arom. C of C6H4-CH2P), 142.8 (d, 
1JC,P = 25.9, C(2) of tolyl). 
31P{1H} NMR (CDCl3, δ, ppm): -45.08 and 15.35 (two d, 4JP,P 
= 9.2). IR (Nujol mull, ν, cm-1): 1198 s (P=O). HRMS: [M + Na + H]+ calcd for 
C33H30O2P2Na 543.1691, found 543.1440. 
 [6-Methyl-1-(methylthio)benzyl]diphenylphosphine oxide (224). The 
compound was obtained using the procedure described above for oxide 220 using complex 
222 (0.1309 g, 0.2233 mmol). The reaction mixture was separated into two fractions using 
preparative TLC (10:1 ethyl acetate‒acetone). Fraction 1 corresponded to 2,6-
dimethylthioanisole 225 (0.0483 g, 0.317 mmol, 71%, colorless oil). Fraction 2 
corresponded to compound 224 (0.0351 g, 0.0996 mmol, 22%, purple oil). Rf  0.50 (10:1 
ethyl acetate‒acetone). 1H NMR (δ, ppm): 2.04 (s, 3H, CH3), 2.48 (s, 3H, SCH3), 4.24 (d, 
2H, 2JH,P = 14.1, PCH2), 7.10 (m, 2H, arom. H(4), H(5)), 7.33 (m, 1H, arom. H(3)),7.42 
(dt, 4H, 3JH,P = 
3JH,H = 7.7,
 4JH,H = 2.7, o-PPh), 7.49 (dt, 2H, 
3JH,H = 7.4,
 4JH,H = 1.3, p-PPh), 
7.72 (dd, 4H, 3JH,H = 7.2, 
3JH,H = 7.2, m-PPh). 
13C{1H} NMR (δ, ppm): 19.1 (s, CH3), 22.2 
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(s, SCH3), 36.6 (d, 
1JC,P = 67.0, PCH2), 128.6 (d, 
5JC,P = 1.7, arom. CH(5)), 128.8 (d, 
2JC,P 
= 11.8, o-PPh), 129.0 (d, 3JC,P = 4.8, CH(3)), 129.7 (d, 
4JC,P = 2.7, arom. CH(4)), 131.7 (d, 
3JC,P = 9.1, m-PPh)), 132.1 (d, 
4JC,P = 2.8, p-PPh), 132.7 (s, C(6)), 133.5 (s, C(2)), 136.36 
(t, 1JC,P = 9.2, ipso-PPh), 143.5 (s, C(1)). 
31P{1H} NMR (CDCl3, δ, ppm): 15.03.  IR (Nujol 
mull, ν, cm-1): 1187 s (P=O). HRMS: [M + H]+ calcd for C21H22OPS 353.1123, found 
353.1005. 
 (R,R)-1-{(Diphenyloxophosphino)methyl}-7,7-dimethylbicyclo[2.2.1]heptan-
2-one O-Methyloxime (226). Phosphine 205 was exposed to the air to give the 
corresponding oxide as an orange-yellow oil in a quantitative yield. [α]23D -18, [α]23546 -13 
(c 0.099, EtOH). Rf  0.57 (5:3 hexane‒acetone). IR (CH2Cl2, ν, cm-1): 1671 (C=N), 1184 
(P=O). 1H NMR (δ, ppm): 0.81 (s, 3H, CH3), 1.04 (s, 3H, CH3), 1.12 (m, 1H, H(5endo)), 
1.30 (m, 1H, H(6endo)), 1.82 (m, 2H, H(5exo), H(4)), 1.88 (d, 1H, 2J3endo,3exo = 18, 
H(3endo)), 2.15 (t, 1H, 2JH,H = 
3JH,P = 16, PCH
A), 2.40 (m, 2H, H(6exo), H(3exo)), 3.06 
(dd, 1H, 2JH,H = 
3JH,P = 16, PCH
B), 3.72 (s, 3H, OCH3), 7.45 (m, 6H, o- and p-PPh), 7.77 
(m, 2H, m-PPhA), 7.95 (m, 2H, m-PPhB).  13C{1H} NMR (δ, ppm): 19.6 and 19.9 (two 
CH3), 27.3 (d, 
1JC,P = 73, PCH2), 28.0 (CH2, C(5)), 29.4 (CH2, d, 
3JC,P = 5.1, C(6)), 33.8 
(CH2, C(3)), 43.2 (CH, C(4)), 50.3 (quat. C, d, 
3JC,P = 4.6, C(7)), 53.2 (quat. C, d, 
2JC,P = 
4.9, C(1)), 61.7 (OCH3), 128.6 (CH, d, 
2JC,P = 12, o-PPh
A), 128.8 (CH, d, 2JC,P = 12, o-
PPhB), 130.8 (CH, d, 3JC,P = 8.9, m-PPh
A), 131.6 (CH, br. s, p-PPh), 131.7 (CH, d, 3JC,P = 
9.4, m-PPhB), 134.9 (quat. C, d, 1JC,P = 98, ipso-PPh
A), 136.6 (quat. C, d, 1JC,P = 99, ipso-
PPhB), 167.5 (quat. C, d, 4JC,P = 5.3, C=N).  
31P{1H} NMR (CDCl3, δ, ppm): 15.1. 31P{1H} 
NMR (C6D6, δ, ppm): 25.0. HRMS: [M + H]+ calcd for C23H28NO2P 382.1894, found 
382.1894. 
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APPENDIX A 
X-RAY DATA TABLES OF COMPLEX 177 
Table 2. Crystal data, data collection, structure solution and structure refinement for 177. 
Empirical formula  C11 H18 Cl NO Pd 
Formula weight  322.11 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Orthorhombic 
Space group  P2(1)2(1)2(1) 
Unit cell dimensions  a = 6.8825(3) Å α = 90° 
 b = 18.1917(7) Å β = 90° 
 c = 19.6478(7) Å γ = 90° 
Volume 2459.99(17) Å3 
Z 8 
Density (calculated) 1.739 Mg/m3 
Absorption coefficient 1.700 mm-1 
F(000) 1296 
Crystal size 0.29 x 0.12 x 0.08 mm3 
Theta range for data collection 1.53 to 30.19° 
Index ranges -8 ≤ h ≤ 9, -24 ≤ k ≤ 25, -27 ≤ l ≤ 27 
Reflections collected 35022 
Independent reflections 6869 [R(int) = 0.0267] 
Completeness to theta = 30.19°  98.3%  
Absorption correction None 
Max. and min. transmission 0.8831 and 0.6384 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 6869 / 0 / 277 
Goodness-of-fit on F2 1.199 
Final R indices [I>2sigma(I)]  R1 = 0.0193, wR2 = 0.0462 
R indices (all data) R1 = 0.0228, wR2 = 0.0626  
Absolute structure parameter -0.03(2) 
Largest diff. peak and hole 0.601 and -0.486 e.Å-3 
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Table 3. Selected bond lengths for 177. 
Bond                                     d/ Å                         Bond                                     d/ Å
Pd(1)-C(10) 2.024(2) 
Pd(1)-N(1) 2.027(2) 
Pd(1)-Cl(2) 2.3311(7) 
Pd(1)-Cl(1) 2.4793(6) 
Pd(2)-C(30) 2.013(3) 
Pd(2)-N(2) 2.046(2) 
Pd(2)-Cl(1) 2.3292(7) 
Pd(2)-Cl(2) 2.5199(6) 
O(1)-N(1) 1.411(3) 
O(1)-C(11) 1.433(3) 
O(2)-N(2) 1.415(3) 
O(2)-C(31) 1.417(3) 
N(1)-C(2) 1.284(3) 
N(2)-N(22) 1.274(3) 
C(1)-C(2) 1.491(4) 
C(1)-C(10) 1.523(4) 
C(1)-C(7) 1.571(4) 
C(1)-C(6) 1.550(4) 
C(2)-C(3) 1.496(4) 
C(3)-C(4) 1.554(4) 
C(4)-C(5) 1.528(4) 
C(4)-C(7) 1.557(4) 
C(5)-C(6) 1.557(4) 
C(7)-C(9) 1.522(4) 
C(7)-C(8) 1.530(4) 
C(21)-C(22) 1.485(4) 
C(21)-C(30) 1.508(4) 
C(21)-C(26) 1.551(4) 
C(21)-C(27) 1.567 (4) 
C(22)-C(23) 1.499(4) 
C(23)-C(24) 1.545(4) 
C(24)-C(25) 1.541(5) 
C(24)-C(27) 1.556 (4) 
C(25)-C(26) 1.542(5) 
C(27)-C(29) 1.524(4) 
C(27)-C(28) 1.528(4) 
 
Table 4. Selected angles for 177. 
Bond                                     angle/°                         Bond                                     angle/°
C(10)-Pd(1)-N(1) 82.14(10) 
C(10)-Pd(1)-Cl(2) 90.50(8) 
N(1)-Pd(1)-Cl(2) 172.62(6) 
C(10)-Pd(1)-Cl(1) 176.00(8) 
N(1)-Pd(1)-Cl(1) 100.25(6) 
Cl(2)-Pd(1)-Cl(1) 87.13(2) 
C(30)-Pd(2)-N(2) 82.39(10) 
C(30)-Pd(2)-Cl(1) 87.76(9) 
N(2)-Pd(2)-Cl(1) 170.14(6) 
C(30)-Pd(2)-Cl(2) 173.98(9) 
N(2)-Pd(2)-Cl(2) 103.62(6) 
Cl(1)-Pd(2)-Cl(2) 103.62(6) 
Pd(2)-Cl(1)-Pd(1) 93.37(2) 
Pd(1)-Cl(2)-Pd(2) 92.28(2) 
N(1)-O(1)-C(11) 109.93(19) 
N(2)-O(2)-C(31) 110.6(2) 
C(2)-N(1)-O(1) 113.9(2) 
C(2)-N(1)-Pd(1) 116.47(18) 
O(1)-N(1)-Pd(1) 129.58(15) 
C(22)-N(2)-O(2) 113.1(2) 
C(22)-N(2)-Pd(2) 115.73(18) 
O(2)-N(2)-Pd(2) 129.79(17) 
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C(2)-C(1)-C(10) 111.0(2) 
C(2)-C(1)-C(6) 104.3(2) 
C(10)-C(1)-C(6) 117.1(2) 
C(2)-C(1)-C(7) 99.1(2) 
C(10)-C(1)-C(7) 120.6(2) 
C(6)-C(1)-C(7) 102.1(2) 
N(1)-C(2)-C(1) 117.0(2) 
N(1)-C(2)-C(3) 132.7(2) 
C(1)-C(2)-C(3) 110.3(2) 
C(2)-C(3)-C(4) 99.4(2) 
C(5)-C(4)-C(3) 106.7(3) 
C(5)-C(4)-C(7) 102.9(2) 
C(3)-C(4)-C(7) 102.8(2) 
C(4)-C(5)-C(6) 103.4(2) 
C(1)-C(6)-C(5) 103.4(2) 
C(9)-C(7)-C(8) 107.9(3) 
C(9)-C(7)-C(4) 114.1(2) 
C(8)-C(7)-C(4) 114.1(2) 
C(9)-C(7)-C(1) 113.8(2) 
C(8)-C(7)-C(1) 113.4(2) 
C(4)-C(7)-C(1) 93.1(2) 
C(1)-C(10)-Pd(1) 109.25(17) 
C(22)-C(21)-C(30) 112.0(2) 
C(22)-C(21)-C(26) 105.0(2) 
C(30)-C(21)-C(26) 115.8(3) 
C(22)-C(21)-C(27) 98.9(2) 
C(30)-C(21)-C(27) 120.7(2) 
C(26)-C(21)-C(27) 102.1(2) 
N(2)-C(22)-C(21) 118.0(3) 
N(2)-C(22)-C(23) 132.0(3) 
C(21)-C(22)-C(23) 109.8(2) 
C(22)-C(23)-C(24) 99.8(2) 
C(25)-C(24)-C(23) 106.9(3) 
C(25)-C(24)-C(27) 102.2(2) 
C(23)-C(24)-C(27) 103.0(2) 
C(24)-C(25)-C(26) 103.1(2) 
C(25)-C(26)-C(21) 104.0(2) 
C(29)-C(27)-C(28) 107.8(3) 
C(29)-C(27)-C(24) 114.5(2) 
C(28)-C(27)-C(24) 114.7(2) 
C(29)-C(27)-C(21) 113.5(2) 
C(28)-C(27)-C(21) 112.9(2) 
C(24)-C(27)-C(21) 93.1(2) 
C(21)-C(30)-Pd(2) 110.95(18) 
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APPENDIX B 
X-RAY DATA TABLES OF COMPLEX 186 
Table 5.  Crystal data, data collection, structure solution and structure refinement for 156. 
Empirical formula  C24 H42 Cl2 N4 Pd2 
Formula weight  670.31 
Temperature  123(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P21 
Unit cell dimensions  a = 12.1816(17) Å α = 90° 
 b = 7.1564(10) Å β = 109.964(2)° 
 c = 16.823(2) Å γ = 90° 
Volume 1378.4(3) Å3 
Z 2 
Density (calculated) 1.615 Mg/m3 
Absorption coefficient 1.517 mm-1 
F(000) 680 
Crystal color, morphology Yellow, Block 
Crystal size 0.220 x 0.200 x 0.180 mm3 
Theta range for data collection 1.779 to 27.617° 
Index ranges -15 ≤ h ≤ 15, -9 ≤ k ≤ 9, -21 ≤ l ≤ 21 
Reflections collected 16179 
Independent reflections 6351 [R(int) = 0.0329] 
Observed reflections 5902 
Completeness to theta = 25.242°  100.0%  
Absorption correction Multi-scan 
Max. and min. transmission 0.4915 and 0.4383 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 6351 / 1 / 299 
Goodness-of-fit on F2 1.040 
Final R indices [I>2sigma(I)]  R1 = 0.0298, wR2 = 0.0570 
R indices (all data) R1 = 0.0336, wR2 = 0.0596  
Absolute structure parameter -0.04(2) 
Largest diff. peak and hole 0.680 and -0.503 e.Å-3 
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Table 6. Selected bond lengths for 186. 
Bond                                     d/ Å                         Bond                                     d/ Å
Pd(1)-C(3) 1.982(5) 
Pd(1)-N(2) 2.076(5) 
Pd(1)-Cl(1A) 2.3331(14) 
Pd(1)-Cl(1) 2.5012(13) 
Pd(1A)-C(3A) 2.007(5) 
Pd(1A)-N(2A) 2.079(5) 
Pd(1A)-Cl(1) 2.3416(14) 
Pd(1A)-Cl(1A) 2.4799(14) 
N(1)-C(2) 1.271(7) 
N(1)-N(2) 1.495(6) 
N(2)-C(11) 1.474(7) 
N(2)-C(12) 1.475(8) 
C(1)-C(8) 1.507(7) 
C(1)-C(2) 1.521(7) 
C(1)-C(7) 1.557(8) 
C(1)-C(6) 1.569(7) 
C(2)-C(3) 1.501(8) 
C(3)-C(4) 1.548(7) 
C(4)-C(5) 1.513(8) 
C(4)-C(7) 1.545(7) 
C(5)-C(6) 1.551(8) 
C(7)-C(9) 1.533(8) 
C(7)-C(10) 1.536(8) 
N(1A)-C(2A) 1.267(7) 
N(1A)-N(2A) 1.489(6) 
N(2A)-C(11A) 1.468(8) 
N(2A)-C(12A) 1.492(7) 
C(1A)-C(2A) 1.501(7) 
C(1A)-C(8A) 1.507(8) 
C(1A)-C(6A) 1.550(9) 
C(1A)-C(7A) 1.576(7) 
C(2A)-C(3A) 1.491(8) 
C(3A)-C(4A) 1.535(7) 
C(4A)-C(5A) 1.542(8) 
C(4A)-C(7A) 1.565(8) 
C(5A)-C(6A) 1.539(8) 
C(7A)-C(9A) 1.511(7) 
C(7A)-C(10A) 1.534(8) 
 
Table 7. Selected angles for 186. 
Bond                                     angle/°                         Bond                                     angle/°
C(3)-Pd(1)-N(2) 80.8(2) 
C(3)-Pd(1)-Cl(1A) 93.87(18) 
N(2)-Pd(1)-Cl(1A) 174.12(12) 
C(3)-Pd(1)-Cl(1) 174.36(17) 
N(2)-Pd(1)-Cl(1) 97.45(13) 
Cl(1A)-Pd(1)-Cl(1) 88.08(4) 
C(3A)-Pd(1A)-N(2A) 80.8(2) 
C(3A)-Pd(1A)-Cl(1) 94.68(18) 
N(2A)-Pd(1A)-Cl(1) 175.21(14) 
C(3A)-Pd(1A)-Cl(1A) 175.46(16) 
N(2A)-Pd(1A)-Cl(1A) 96.00(13) 
Cl(1)-Pd(1A)-Cl(1A) 88.40(4) 
Pd(1A)-Cl(1)-Pd(1) 91.34(5) 
Pd(1)-Cl(1A)-Pd(1A) 92.08(5) 
C(2)-N(1)-N(2) 108.5(4) 
C(11)-N(2)-C(12) 110.1(5) 
C(11)-N(2)-N(1) 106.4(4) 
C(12)-N(2)-N(1) 104.0(4) 
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C(11)-N(2)-Pd(1) 113.7(4) 
C(12)-N(2)-Pd(1) 110.1(4) 
N(1)-N(2)-Pd(1) 112.1(3) 
C(8)-C(1)-C(2) 116.6(5) 
C(8)-C(1)-C(7) 120.0(5) 
C(2)-C(1)-C(7) 101.0(5) 
C(8)-C(1)-C(6) 115.6(5) 
C(2)-C(1)-C(6) 99.7(4) 
C(7)-C(1)-C(6) 100.6(5) 
N(1)-C(2)-C(3) 125.6(5) 
N(1)-C(2)-C(1) 125.5(5) 
C(3)-C(2)-C(1) 108.6(5) 
C(2)-C(3)-C(4) 100.2(4) 
C(2)-C(3)-Pd(1) 105.9(4) 
C(4)-C(3)-Pd(1) 129.4(4) 
C(5)-C(4)-C(7) 103.9(5) 
C(5)-C(4)-C(3) 108.0(5) 
C(7)-C(4)-C(3) 100.5(4) 
C(4)-C(5)-C(6) 103.7(4) 
C(5)-C(6)-C(1) 103.7(5) 
C(9)-C(7)-C(10) 106.8(5) 
C(9)-C(7)-C(4) 112.6(5) 
C(10)-C(7)-C(4) 116.2(5) 
C(9)-C(7)-C(1) 114.0(5) 
C(10)-C(7)-C(1) 112.6(5) 
C(4)-C(7)-C(1) 94.7(4) 
C(2A)-N(1A)-N(2A) 108.9(4) 
C(11A)-N(2A)-N(1A) 104.8(4) 
C(11A)-N(2A)-C(12A) 109.7(5) 
N(1A)-N(2A)-C(12A) 107.6(4) 
C(11A)-N(2A)-Pd(1A) 109.5(4) 
N(1A)-N(2A)-Pd(1A) 112.9(3) 
C(12A)-N(2A)-Pd(1A) 112.1(4) 
C(2A)-C(1A)-C(8A) 116.4(5) 
C(2A)-C(1A)-C(6A) 107.5(5) 
C(8A)-C(1A)-C(6A) 114.9(4) 
C(2A)-C(1A)-C(7A) 96.5(4) 
C(8A)-C(1A)-C(7A) 117.9(5) 
C(6A)-C(1A)-C(7A) 101.2(5) 
N(1A)-C(2A)-C(3A) 126.5(5) 
N(1A)-C(2A)-C(1A) 124.7(5) 
C(3A)-C(2A)-C(1A) 108.0(5) 
C(2A)-C(3A)-C(4A) 101.5(4) 
C(2A)-C(3A)-Pd(1A) 106.3(4) 
C(4A)-C(3A)-Pd(1A) 129.2(4) 
C(3A)-C(4A)-C(5A) 105.5(5) 
C(3A)-C(4A)-C(7A) 103.5(5) 
C(5A)-C(4A)-C(7A) 101.3(4) 
C(6A)-C(5A)-C(4A) 102.1(5) 
C(5A)-C(6A)-C(1A) 105.6(5) 
C(9A)-C(7A)-C(10A) 107.3(5) 
C(9A)-C(7A)-C(4A) 115.9(5) 
C(10A)-C(7A)-C(4A) 112.6(4) 
C(9A)-C(7A)-C(1A) 113.5(4) 
C(10A)-C(7A)-C(1A) 113.9(5) 
C(4A)-C(7A)-C(1A) 93.4(4) 
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APPENDIX C 
X-RAY DATA TABLES OF COMPLEX 199a 
Table 8. Crystal data, data collection, structure solution and structure refinement for 
199a. 
Empirical formula  C28 H31 Cl N O P Pd 
Formula weight  570.36 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  C2/c 
Unit cell dimensions  a = 27.051(2) Å α = 90° 
 b = 11.8212(11) Å β = 121.429(1)° 
 c = 19.0231(17) Å γ = 90° 
Volume 5190.7(8) Å3 
Z 8 
Density (calculated) 1.460 Mg/m3 
Absorption coefficient 0.900 mm-1 
F(000) 2336 
Crystal color, morphology colourless, needle 
Crystal size 0.40 x 0.13 x 0.10 mm3 
Theta range for data collection 1.764 to 27.508° 
Index ranges -34 ≤ h ≤ 32, -15 ≤ k ≤ 15, -24 ≤ l ≤ 24 
Reflections collected 23130 
Independent reflections 5932 [R(int) = 0.0502] 
Observed reflections 4451 
Completeness to theta = 25.242°  99.9%  
Absorption correction Multi-scan 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 5932 / 0 / 301 
Goodness-of-fit on F2 1.005 
Final R indices [I>2sigma(I)]  R1 = 0.0432, wR2 = 0.0918 
R indices (all data) R1 = 0.0659, wR2 = 0.1021  
Largest diff. peak and hole 1.815 and -1.026 e.Å-3 
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Table 9. Selected bond lengths for 199a. 
Bond                                     d/ Å                         Bond                                     d/ Å
Pd1-C1 2.051(4) 
Pd1-N1 2.064(3) 
Pd1-P1 2.2218(10) 
Pd1-Cl1 2.4019(9) 
C1-C2 1.526(5) 
C2-C3 1.502(5) 
C2-C7 1.539(6) 
C2-C8 1.550(6) 
C3-N1 1.273(5) 
C3-C4 1.507(5) 
N1-O1 1.391(4) 
C4-C9 1.521(6) 
C4-C10 1.545(7) 
C4-C5 1.556(7) 
C5-C6 1.522(8) 
C5-C8 1.548(7) 
C6-C7 1.540(7) 
P1-C17 1.814(4) 
P1-C11 1.820(3) 
P1-C23 1.822(4) 
C11-C12 1.381(5) 
C11-C16 1.395(5) 
C12-C13 1.385(6) 
C13-C14 1.378(6) 
C14-C15 1.371(6) 
C15-C16 1.373(6) 
C17-C22 1.391(6) 
C17-C18 1.391(6) 
C18-C19 1.391(7) 
C19-C20 1.379(9) 
C20-C21 1.371(9) 
C21-C22 1.369(6) 
C23-C24 1.378(5) 
C23-C28 1.390(5) 
C24-C25 1.395(5) 
C25-C26 1.366(7) 
C26-C27 1.352(7) 
C27-C28 1.388(6)
 
Table 10. Selected angles for 199a. 
Bond                                     angle/°                         Bond                                     angle/°
C1-Pd1-N1 81.43(14) 
C1-Pd1-P1 89.70(11) 
N1-Pd1-P1 171.11(9) 
C1-Pd1-Cl1 167.92(12) 
N1-Pd1-Cl1 87.18(9) 
P1-Pd1-Cl1 101.61(4) 
C2-C1-Pd1 106.2(3) 
C3-C2-C1 112.0(3) 
C3-C2-C7 104.8(3) 
C1-C2-C7 116.9(4) 
C3-C2-C8 99.5(3) 
C1-C2-C8 119.9(3) 
C7-C2-C8 101.2(4) 
N1-C3-C2 115.3(3) 
N1-C3-C4 133.6(4) 
C2-C3-C4 111.1(3) 
C3-N1-O1 117.9(3) 
C3-N1-Pd1 116.4(3) 
O1-N1-Pd1 125.6(2) 
C3-C4-C9 113.2(3) 
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C3-C4-C10 109.8(4) 
C9-C4-C10 108.4(4) 
C3-C4-C5 97.7(3) 
C9-C4-C5 114.9(4) 
C10-C4-C5 112.6(4) 
C6-C5-C8 99.6(5) 
C6-C5-C4 111.0(4) 
C8-C5-C4 103.1(4) 
C5-C6-C7 104.8(4) 
C6-C7-C2 102.5(5) 
C5-C8-C2 93.8(3) 
C17-P1-C11 103.65(16) 
C17-P1-C23 106.15(17) 
C11-P1-C23 107.01(16) 
C17-P1-Pd1 115.83(13) 
C11-P1-Pd1 113.28(12) 
C23-P1-Pd1 110.25(12) 
C12-C11-C16 119.0(3) 
C12-C11-P1 123.0(3) 
C16-C11-P1 117.5(3) 
C11-C12-C13 120.4(4) 
C14-C13-C12 119.8(4) 
C15-C14-C13 120.0(4) 
C14-C15-C16 120.5(4) 
C15-C16-C11 120.1(4) 
C22-C17-C18 119.8(4) 
C22-C17-P1 119.3(3) 
C18-C17-P1 120.9(3) 
C19-C18-C17 119.7(5) 
C20-C19-C18 119.2(5) 
C21-C20-C19 121.1(5) 
C20-C21-C22 120.1(6) 
C21-C22-C17 120.0(5) 
C24-C23-C28 118.0(3) 
C24-C23-P1 124.2(3) 
C28-C23-P1 117.7(3) 
C23-C24-C25 120.7(4) 
C26-C25-C24 120.4(5) 
C27-C26-C25 119.4(4) 
C26-C27-C28 121.3(4) 
C27-C28-C23 120.2(4)
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APPENDIX D 
X-RAY DATA TABLES OF COMPLEX 199b 
Table 11. Crystal data, data collection, structure solution and structure refinement for 
199b. 
Empirical formula  C29 H33 Cl N O P Pd 
Formula weight  584.38 
Temperature  123(2) K 
Wavelength  1.54178 Å 
Crystal system  monoclinic 
Space group  P21 
Unit cell dimensions  a = 10.9541(7) Å α = 90° 
 b = 9.1372(7) Å β = 108.297(4)° 
 c = 13.8615(9) Å γ = 90° 
Volume 1317.25(16) Å3 
Z 2 
Density (calculated) 1.473 Mg/m3 
Absorption coefficient 7.353 mm-1 
F(000) 600 
Crystal color, morphology colorless, Needle 
Crystal size 0.186 x 0.117 x 0.042 mm3 
Theta range for data collection 3.358 to 74.506° 
Index ranges -13 ≤ h ≤ 13, -11 ≤ k ≤ 9, -17 ≤ l ≤ 17 
Reflections collected 34115 
Independent reflections 5246 [R(int) = 0.0417] 
Observed reflections 5083 
Completeness to theta = 67.679°  100.0%  
Absorption correction Multi-scan 
Max. and min. transmission 0.4709 and 0.3395 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 5246 / 1 / 310 
Goodness-of-fit on F2 1.042 
Final R indices [I>2sigma(I)]  R1 = 0.0289, wR2 = 0.0696 
R indices (all data) R1 = 0.0305, wR2 = 0.0707  
Absolute structure parameter -0.020(9) 
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Largest diff. peak and hole 0.578 and -0.594 e.Å-3 
Table 12. Selected bond lengths for 199b. 
Bond                                     d/ Å                         Bond                                     d/ Å
Pd1-C1 2.063(5) 
Pd1-N1 2.115(4) 
Pd1-P1 2.2250(12) 
Pd1-Cl1 2.3822(11) 
N1-C3 1.273(6) 
N1-O1 1.414(5) 
O1-C11 1.430(7) 
C1-C2 1.517(6) 
C2-C3 1.500(6) 
C2-C7 1.547(7) 
C2-C8 1.561(6) 
C3-C4 1.519(6) 
C4-C9 1.534(7) 
C4-C10 1.541(7) 
C4-C5 1.562(7) 
C5-C6 1.537(7) 
C5-C8 1.538(7) 
C6-C7 1.557(7) 
P1-C12 1.825(5) 
P1-C18 1.825(5) 
P1-C24 1.843(5) 
C12-C13 1.379(6) 
C12-C17 1.398(6) 
C13-C14 1.388(7) 
C14-C15 1.380(7) 
C15-C16 1.388(7) 
C16-C17 1.383(7) 
C18-C19 1.392(7) 
C18-C23 1.408(7) 
C19-C20 1.397(8) 
C20-C21 1.384(8) 
C21-C22 1.383(8) 
C22-C23 1.385(8) 
C24-C25 1.379(8) 
C24-C29 1.383(7) 
C25-C26 1.389(7) 
C26-C27 1.383(9) 
C27-C28 1.372(10) 
C28-C29 1.392(8) 
 
Table 13. Selected angles for 199b. 
Bond                                     angle/°                         Bond                                     angle/°
C1-Pd1-N1 79.25(17) 
C1-Pd1-P1 90.25(13) 
N1-Pd1-P1 167.59(11) 
C1-Pd1-Cl1 174.23(13) 
N1-Pd1-Cl1 95.05(11) 
P1-Pd1-Cl1 95.31(4) 
C3-N1-O1 114.9(4) 
C3-N1-Pd1 112.9(3) 
O1-N1-Pd1 130.9(3) 
N1-O1-C11 108.9(4) 
C2-C1-Pd1 105.5(3) 
C3-C2-C1 110.7(4) 
C3-C2-C7 106.3(4) 
C1-C2-C7 117.6(4) 
C3-C2-C8 98.5(4) 
C1-C2-C8 121.0(4) 
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C7-C2-C8 100.3(4) 
N1-C3-C2 117.3(4) 
N1-C3-C4 132.1(4) 
C2-C3-C4 110.6(4) 
C3-C4-C9 112.1(4) 
C3-C4-C10 111.3(4) 
C9-C4-C10 109.3(4) 
C3-C4-C5 98.3(4) 
C9-C4-C5 114.3(4) 
C10-C4-C5 111.2(4) 
C6-C5-C8 100.8(4) 
C6-C5-C4 110.6(4) 
C8-C5-C4 102.8(4) 
C5-C6-C7 102.9(4) 
C2-C7-C6 104.0(4) 
C5-C8-C2 94.5(4) 
C12-P1-C18 105.7(2) 
C12-P1-C24 102.1(2) 
C18-P1-C24 105.6(2) 
C12-P1-Pd1 116.17(15) 
C18-P1-Pd1 110.21(16) 
C24-P1-Pd1 116.07(16) 
C13-C12-C17 119.3(4) 
C13-C12-P1 119.7(3) 
C17-C12-P1 121.0(3) 
C12-C13-C14 120.4(4) 
C15-C14-C13 120.2(5) 
C14-C15-C16 119.8(5) 
C17-C16-C15 120.1(4) 
C16-C17-C12 120.2(4) 
C19-C18-C23 119.2(5) 
C19-C18-P1 123.5(4) 
C23-C18-P1 117.3(4) 
C18-C19-C20 120.0(5) 
C21-C20-C19 120.2(5) 
C22-C21-C20 120.1(5) 
C21-C22-C23 120.3(5) 
C22-C23-C18 120.1(5) 
C25-C24-C29 119.3(5) 
C25-C24-P1 118.7(4) 
C29-C24-P1 121.9(4) 
C24-C25-C26 120.6(5) 
C27-C26-C25 119.8(5) 
C28-C27-C26 119.7(4) 
C27-C28-C29 120.5(5) 
C24-C29-C28 120.0(5) 
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Figure 10. 1H NMR spectrum of 174b.  
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Figure 11. 13C{1H} NMR spectrum of 174b. 
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Figure 12. 1H NMR spectrum of 177. 
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Figure 13. 13C{1H} NMR spectrum of 177. 
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Figure 14. 1H NMR spectrum of 178. 
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Figure 15. 13C{1H} NMR spectrum of 178. 
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Figure 16. 1H NMR spectrum of endo-188. 
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Figure 17. 13C{1H} NMR spectrum of endo-188. 
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Figure 18. 1H NMR spectrum of exo-188. 
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Figure 19. 13C{1H} NMR spectrum of exo-188. 
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Figure 20. 1H NMR spectrum of 196a. 
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Figure 21. 13C{1H} NMR spectrum of 196a. 
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Figure 22. 1H NMR spectrum of 196b. 
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Figure 23. 13C{1H} NMR spectrum of 196b. 
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Figure 24. 1H NMR spectrum of 198a. 
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Figure 25. 13C{1H} NMR spectrum of 198a. 
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Figure 26. 1H NMR spectrum of 198b. 
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Figure 27. 13C{1H} NMR spectrum of 198b. 
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Figure 28. 1H NMR spectrum of 199a. 
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Figure 29. 13C{1H} NMR spectrum of 199a. 
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Figure 30. 1H NMR spectrum of 199b. 
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Figure 31. 13C{1H} NMR spectrum of 199b. 
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Figure 32. 1H NMR spectrum of 205. 
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Figure 33. 13C{1H} NMR spectrum of 205. 
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Figure 34. 31P{1H} NMR spectrum of 205. 
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Figure 35. 1H NMR spectrum of 206. 
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Figure 36. 13C{1H} NMR spectrum of 206. 
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Figure 37. 31P{1H} NMR spectrum of 206. 
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Figure 38. 1H NMR spectrum of 210. 
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Figure 39. 13C{1H} NMR spectrum of 210. 
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Figure 40. 31P{1H} NMR spectrum of 210. 
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Figure 41. 1H NMR spectrum of 211. 
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Figure 42. 13C{1H} NMR spectrum of 211. 
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Figure 43. 31P{1H} NMR spectrum of 211. 
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Figure 44. 1H NMR spectrum of 214. 
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Figure 45. 13C{1H} NMR spectrum of 214. 
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Figure 46. 31P{1H} NMR spectrum of 214. 
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Figure 47. 1H NMR spectrum of 216. 
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Figure 48. 13C{1H} NMR spectrum of 216. 
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Figure 49. 31P{1H} NMR spectrum of 216. 
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Figure 50. 1H NMR spectrum of 220. 
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Figure 51. 13C{1H} NMR spectrum of 220. 
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Figure 52. 31P{1H} NMR spectrum of 220. 
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Figure 53. 1H NMR spectrum of 224. 
   
   
 170   
 
 
Figure 54. 13C{1H} NMR spectrum of 224. 
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Figure 55. 31P{1H} NMR spectrum of 224. 
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Figure 56. 1H NMR spectrum of 226. 
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Figure 57. 13C{1H} NMR spectrum of 226. 
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Figure 58. 31P{1H} NMR spectrum of 226. 
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